conceptID,concept,rank,PMID
,prescribing,1,19025811
,lipid,1,19025811
,drugs,1,19025811
,period,1,19025811
,analysis,1,19025811
,health,1,19025811
,health insurance,1,19025811
,insurance,1,19025811
,files,1,19025811
,study,3,19025811
,prescription,2,19025811
,patterns,1,19025811
,physicians,1,19025811
,use,1,19025811
,lipid,1,19025811
,drugs,3,19025811
,germany,1,19025811
,area,1,19025811
,period,2,19025811
,database,1,19025811
,health,2,19025811
,health insurance,2,19025811
,insurance,2,19025811
,files,1,19025811
,random,1,19025811
,random sampling,1,19025811
,sampling,1,19025811
,persons,1,19025811
,large,1,19025811
,organization,1,19025811
,study population,1,19025811
,population,1,19025811
,fibrates,1,19025811
,most,1,19025811
,frequently,1,19025811
,hmgcoa reductase inhibitors,1,19025811
,reductase,1,19025811
,inhibitors,1,19025811
,nicotinic acid,1,19025811
,acid,1,19025811
,derivatives,1,19025811
,prevalence,1,19025811
,treatment,1,19025811
,age,1,19025811
,more,1,19025811
,patients,4,19025811
,not,1,19025811
,continu,1,19025811
,less,1,19025811
,months,1,19025811
,therapy,1,19025811
,ineffective,1,19025811
,due,1,19025811
,short,1,19025811
,episodes,1,19025811
,drug,1,19025811
,drug administration,1,19025811
,administration,2,19025811
,presence,1,19025811
,hyperlipidaemia,4,19025811
,additional,2,19025811
,risk,2,19025811
,risk factors,2,19025811
,factors,2,19025811
,hypertension,2,19025811
,rate,1,19025811
,prescriptions,1,19025811
,alone,1,19025811
,only,1,19025811
,half,1,19025811
,history,1,19025811
,previous,1,19025811
,previous myocardial infarction,1,19025811
,myocardial,1,19025811
,myocardial infarction,1,19025811
,infarction,1,19025811
,arterial,1,19025811
,arterial hypertension,1,19025811
,coronary,1,19025811
,coronary heart disease,1,19025811
,heart,1,19025811
,heart disease,1,19025811
,disease,1,19025811
,chd,1,19025811
,often,1,19025811
,effective,1,19025811
,far,1,19025811
,infrequently,1,19025811
,copyright,1,19025811
,sons,1,19025811
,ltd,1,19025811
,use,1,19025797
,calcium,1,19025797
,calcium channel,1,19025797
,calcium channel blockers,1,19025797
,channel,1,19025797
,channel blockers,1,19025797
,hypertensive,1,19025797
,patients,1,19025797
,purpose,1,19025797
,hypertension,4,19025797
,hypertension treatment,1,19025797
,treatment,1,19025797
,cardiovascular,1,19025797
,cardiovascular disease,1,19025797
,disease,1,19025797
,cvd,2,19025797
,risk,4,19025797
,reports,1,19025797
,association,1,19025797
,calcium,1,19025797
,calcium channel,1,19025797
,calcium channel blockers,1,19025797
,channel,1,19025797
,channel blockers,1,19025797
,use,3,19025797
,studies,1,19025797
,patients,5,19025797
,methods,1,19025797
,knowledge,1,19025797
,attitudes,1,19025797
,practice,1,19025797
,kap,1,19025797
,survey,1,19025797
,mail,1,19025797
,stratified,1,19025797
,stratified random sample,1,19025797
,random,1,19025797
,random sample,1,19025797
,sample,1,19025797
,cardiologists,1,19025797
,internists,1,19025797
,practitioners,1,19025797
,surveys,1,19025797
,population,1,19025797
,population means,1,19025797
,means,1,19025797
,frequencies,1,19025797
,errors,1,19025797
,results,1,19025797
,only,1,19025797
,physicians,3,19025797
,mild,1,19025797
,additional,1,19025797
,risk factors,2,19025797
,factors,2,19025797
,increases,1,19025797
,moderate,1,19025797
,severe,1,19025797
,other,2,19025797
,history,2,19025797
,myocardial,1,19025797
,myocardial infarction,1,19025797
,infarction,1,19025797
,family,1,19025797
,family history,1,19025797
,diabetes,1,19025797
,angina,1,19025797
,initial,1,19025797
,therapy,2,19025797
,mildly,1,19025797
,moderately,2,19025797
,hypertensive,4,19025797
,regimens,1,19025797
,not,1,19025797
,other antihypertensive,1,19025797
,antihypertensive,1,19025797
,antihypertensive therapy,1,19025797
,multiple,1,19025797
,multiple regression,1,19025797
,regression,1,19025797
,regression analysis,1,19025797
,analysis,1,19025797
,proportion,1,19025797
,significantly,1,19025797
,geriatricians,1,19025797
,severity,1,19025797
,indication,1,19025797
,conclusion,1,19025797
,findings,1,19025797
,copyright,1,19025797
,sons,1,19025797
,ltd,1,19025797
,percutaneous,1,18493542
,percutaneous transluminal angioscopy,1,18493542
,transluminal,1,18493542
,angioscopy,1,18493542
,coronary,1,18493542
,intervention,1,18493542
,percutaneous,1,18493542
,percutaneous transluminal coronary angioplasty,1,18493542
,transluminal,1,18493542
,coronary,7,18493542
,coronary angioplasty,2,18493542
,angioplasty,2,18493542
,mechanism,1,18493542
,efficacy,1,18493542
,coronary stenting,1,18493542
,stenting,1,18493542
,acute,3,18493542
,acute myocardial infarction,3,18493542
,myocardial,4,18493542
,myocardial infarction,4,18493542
,infarction,4,18493542
,angioscopy,3,18493542
,patients,9,18493542
,stable,1,18493542
,stable angina,1,18493542
,angina,2,18493542
,thrombi,5,18493542
,intimal,3,18493542
,flaps,2,18493542
,most,2,18493542
,large,4,18493542
,third,1,18493542
,stents,1,18493542
,flap,1,18493542
,split,1,18493542
,inner,1,18493542
,lumen,3,18493542
,thrombolytic,1,18493542
,thrombolytic agents,1,18493542
,additional,1,18493542
,treatments,1,18493542
,unstable,1,18493542
,unstable angina,1,18493542
,hospita,1,18493542
,clinicians,1,18493542
,intervention,1,18493542
,intervention strategy,1,18493542
,strategy,1,18493542
,occlusive,2,18493542
,protruding,1,18493542
,frequency,1,18493542
,balloon,1,18493542
,present,1,18493542
,study,1,18493542
,coronary stent,1,18493542
,stent,1,18493542
,ruptured,1,18493542
,plaque,1,18493542
,consequently,1,18493542
,wide,1,18493542
,vessel,1,18493542
,evaluation,1,18493540
,thrombi,1,18493540
,coronary,1,18493540
,coronary lesions,1,18493540
,lesions,1,18493540
,patients,1,18493540
,acute,1,18493540
,acute myocardial infarction,1,18493540
,myocardial,1,18493540
,myocardial infarction,1,18493540
,infarction,1,18493540
,purpose,1,18493540
,study,1,18493540
,intracoronary,1,18493540
,thrombi,10,18493540
,culprit lesions,1,18493540
,lesions,3,18493540
,patients,7,18493540
,acute,1,18493540
,acute myocardial infarction,1,18493540
,myocardial,1,18493540
,myocardial infarction,1,18493540
,infarction,1,18493540
,ami,3,18493540
,angioscopy,1,18493540
,clinical,1,18493540
,angiographic,1,18493540
,features,1,18493540
,coronary,1,18493540
,coronary lesions,1,18493540
,males,1,18493540
,females,1,18493540
,years,1,18493540
,old,1,18493540
,interventional,1,18493540
,therapy,1,18493540
,red,4,18493540
,mixed,2,18493540
,white,4,18493540
,complete,1,18493540
,complete obstruction,1,18493540
,obstruction,2,18493540
,grade,2,18493540
,more,3,18493540
,frequently,3,18493540
,other,1,18493540
,hand,1,18493540
,incomplete,1,18493540
,grade ii,1,18493540
,iii,1,18493540
,others,4,18493540
,defect,1,18493540
,significantly,1,18493540
,distance,1,18493540
,proximal,1,18493540
,side,1,18493540
,branch,1,18493540
,time,1,18493540
,onset,1,18493540
,results,1,18493540
,blood,1,18493540
,blood flow,1,18493540
,flow,1,18493540
,determinant,1,18493540
,characterization,1,18493540
,lanoteplase,1,18034526
,lanoteplase,7,18034526
,recombinant,1,18034526
,plasminogen,1,18034526
,plasminogen activator,1,18034526
,single,1,18034526
,single bolus,1,18034526
,bolus,1,18034526
,intravenous,1,18034526
,intravenous injection,1,18034526
,injection,1,18034526
,displays,1,18034526
,thrombolytic,1,18034526
,activity,1,18034526
,phase,2,18034526
,trial,1,18034526
,reperfusion,1,18034526
,minutes,2,18034526
,patients,2,18034526
,acute,1,18034526
,acute myocardial infarction,1,18034526
,myocardial,1,18034526
,myocardial infarction,1,18034526
,infarction,1,18034526
,not,1,18034526
,significantly,1,18034526
,superior,1,18034526
,grade,1,18034526
,flow,1,18034526
,preliminary,2,18034526
,results,2,18034526
,iii,1,18034526
,study,3,18034526
,effective,1,18034526
,alteplase,3,18034526
,mortality,1,18034526
,days,1,18034526
,incidence,3,18034526
,death,1,18034526
,major,1,18034526
,bleeding,2,18034526
,heart,1,18034526
,heart failure,1,18034526
,failure,1,18034526
,lower,1,18034526
,large,1,18034526
,greater,1,18034526
,intracranial,1,18034526
,intracranial haemorrhage,1,18034526
,haemorrhage,1,18034526
,mild,1,18034526
,similar,1,18034526
,stroke,1,18034526
,smaller,1,18034526
,adverse events,1,18034526
,events,1,18034526
,more,1,17199221
,complete,1,17199221
,inhibition,1,17199221
,angiotensin,1,17199221
,angiotensin receptor,1,17199221
,receptor,1,17199221
,blockade,1,17199221
,survival,1,17199221
,myocardial,1,17199221
,myocardial infarction,1,17199221
,infarction,1,17199221
,enzyme,1,17199221
,ace,5,17199221
,inhibitors,2,17199221
,role,1,17199221
,management,1,17199221
,patients,3,17199221
,hypertension,1,17199221
,heart,1,17199221
,heart failure,1,17199221
,failure,1,17199221
,myocardial,2,17199221
,myocardial infarction,2,17199221
,infarction,2,17199221
,ace inhibitors,1,17199221
,well,3,17199221
,acute,2,17199221
,chronic,1,17199221
,consistent,1,17199221
,survival,2,17199221
,benefits,1,17199221
,risk,3,17199221
,groups,1,17199221
,recent,1,17199221
,development,2,17199221
,angiotensin,1,17199221
,angiotensin ii,1,17199221
,ang,2,17199221
,receptor,1,17199221
,pharmacological,2,17199221
,therapy,1,17199221
,more,1,17199221
,completely,1,17199221
,actions,1,17199221
,level,1,17199221
,questions,1,17199221
,efficacy,1,17199221
,ace inhibitor,3,17199221
,inhibitor,3,17199221
,experience,1,17199221
,major,1,17199221
,direct,1,17199221
,comparison,1,17199221
,valsartan,2,17199221
,acute myocardial infarction,1,17199221
,trial,1,17199221
,contrast,1,17199221
,arb,1,17199221
,alone,1,17199221
,combination,1,17199221
,regimen,1,17199221
,high,2,17199221
,high risk,2,17199221
,population,1,17199221
,arms,1,17199221
,advance,1,17199221
,additional,1,17199221
,clinical,1,17199221
,value,1,17199221
,survival,1,17018938
,trends,1,17018938
,ventricular,1,17018938
,ventricular hypertrophy,1,17018938
,hypertrophy,1,17018938
,gender,1,17018938
,gender differences,1,17018938
,differences,1,17018938
,study,1,17018938
,objective,1,17018938
,prevalence,3,17018938
,incidence,4,17018938
,ventricular,1,17018938
,ventricular hypertrophy,1,17018938
,hypertrophy,4,17018938
,lvh,12,17018938
,large,1,17018938
,prospective,1,17018938
,prospective cohort study,1,17018938
,cohort,2,17018938
,cohort study,1,17018938
,study,2,17018938
,almost,1,17018938
,participants,2,17018938
,risk,5,17018938
,risk factors,3,17018938
,factors,6,17018938
,predictive,3,17018938
,predictive factors,3,17018938
,appearance,2,17018938
,morbidity,1,17018938
,mortality,2,17018938
,calculations,1,17018938
,material,1,17018938
,methods,2,17018938
,minnesota,1,17018938
,code,2,17018938
,ecg,6,17018938
,first,1,17018938
,visit,1,17018938
,case,1,17018938
,subsequent,1,17018938
,visits,1,17018938
,cases,2,17018938
,time,3,17018938
,diagnosis,4,17018938
,logistic,1,17018938
,logistic regression,1,17018938
,regression,2,17018938
,abnormality,1,17018938
,comparison,1,17018938
,other,2,17018938
,stages,1,17018938
,results,1,17018938
,men,6,17018938
,women,8,17018938
,year,2,17018938
,genders,3,17018938
,age,4,17018938
,systolic,4,17018938
,systolic blood pressure,4,17018938
,blood,5,17018938
,blood pressure,5,17018938
,pressure,5,17018938
,odds ratio,2,17018938
,ratio,4,17018938
,mmhg,1,17018938
,confidence,1,17018938
,confidence interval,1,17018938
,interval,1,17018938
,silent,1,17018938
,silent myocardial infarction,1,17018938
,myocardial,1,17018938
,myocardial infarction,1,17018938
,infarction,1,17018938
,changes,2,17018938
,similar,1,17018938
,angina,1,17018938
,ecg changes,1,17018938
,severe,4,17018938
,smoking,1,17018938
,effect,1,17018938
,coronary,1,17018938
,significantly,1,17018938
,hazard,1,17018938
,hazard ratio,1,17018938
,total,1,17018938
,survival,2,17018938
,conclusions,1,17018938
,presence,1,17018938
,ischemic,1,17018938
,ischemic heart disease,1,17018938
,heart,1,17018938
,heart disease,1,17018938
,disease,1,17018938
,criteria,1,17018938
,detect,1,17018938
,mild,2,17018938
,only,1,17018938
,more,1,17018938
,sensitive,1,17018938
,moderate,1,17018938
,order,1,17018938
,severity,1,17018938
,results,1,17018924
,percutaneous,1,17018924
,percutaneous coronary interventions,1,17018924
,coronary,1,17018924
,interventions,1,17018924
,iceland,1,17018924
,purpose,1,17018924
,potential,1,17018924
,changes,3,17018924
,clinical,3,17018924
,indications,1,17018924
,composition,1,17018924
,patient,2,17018924
,population,3,17018924
,percutaneous,1,17018924
,percutaneous coronary intervention,1,17018924
,coronary,3,17018924
,intervention,1,17018924
,iceland,4,17018924
,success,3,17018924
,rate,7,17018924
,major,1,17018924
,complications,3,17018924
,procedure,2,17018924
,study,3,17018924
,interval,3,17018924
,small,1,17018924
,nation,1,17018924
,pci,11,17018924
,centre,1,17018924
,material,1,17018924
,methods,1,17018924
,first,2,17018924
,registry,1,17018924
,start,1,17018924
,data,1,17018924
,records,1,17018924
,mortality,3,17018924
,total,1,17018924
,annual,1,17018924
,low,2,17018924
,rise,1,17018924
,last,1,17018924
,years,4,17018924
,periods,1,17018924
,procedures,8,17018924
,number,2,17018924
,method,1,17018924
,iii,3,17018924
,use,2,17018924
,stents,2,17018924
,new,1,17018924
,regime,1,17018924
,results,1,17018924
,period,2,17018924
,elective,1,17018924
,subacute,2,17018924
,acute,5,17018924
,increase,1,17018924
,patients,4,17018924
,acute coronary syndromes,1,17018924
,syndromes,1,17018924
,ratio,2,17018924
,unstable,1,17018924
,unstable angina,1,17018924
,angina,1,17018924
,proportionally,1,17018924
,vessel,1,17018924
,proportion,1,17018924
,still,2,17018924
,due,1,17018924
,restenosis,1,17018924
,somewhat,1,17018924
,simultaneously,1,17018924
,coronary bypass,1,17018924
,coronary bypass surgery,1,17018924
,bypass,1,17018924
,bypass surgery,1,17018924
,surgery,1,17018924
,significantly,1,17018924
,elevated,1,17018924
,elevated creatinine,1,17018924
,elevated creatinine kinase levels,1,17018924
,creatinine,1,17018924
,creatinine kinase,1,17018924
,creatinine kinase levels,1,17018924
,kinase,1,17018924
,levels,1,17018924
,acute myocardial infarction,1,17018924
,myocardial,1,17018924
,myocardial infarction,1,17018924
,infarction,1,17018924
,similar,1,17018924
,hospital,1,17018924
,hospital mortality,1,17018924
,conclusions,1,17018924
,national,1,17018924
,basis,1,17018924
,highest,1,17018924
,europe,1,17018924
,increased,1,17018924
,out,1,17018924
,more,1,17018924
,complicated,1,17018924
,widespread,1,17018924
,widespread disease,1,17018924
,disease,1,17018924
,high,1,17018924
,frequency,1,17018924
,ischemic,1,17016277
,ischemic preconditioning,1,17016277
,preconditioning,1,17016277
,myocardial,1,17016277
,myocardial stunning,1,17016277
,anesthesia,1,17016277
,brief,2,17016277
,brief periods,1,17016277
,periods,1,17016277
,ischemia,2,17016277
,heart,1,17016277
,subsequent,1,17016277
,prolonged,1,17016277
,ischemic,6,17016277
,phenomenon,1,17016277
,ischemic preconditioning,3,17016277
,preconditioning,3,17016277
,effects,1,17016277
,markedly,1,17016277
,myocardial,3,17016277
,myocardial ischemic,1,17016277
,injury,2,17016277
,vivo,1,17016277
,volatile,1,17016277
,anesthetics,1,17016277
,myocardium,2,17016277
,infarction,1,17016277
,mechanism,1,17016277
,similar,1,17016277
,contractile,1,17016277
,dysfunction,1,17016277
,brief period,1,17016277
,period,1,17016277
,myocardial ischemia,1,17016277
,restoration,1,17016277
,coronary,1,17016277
,blood,1,17016277
,blood flow,1,17016277
,flow,1,17016277
,absence,1,17016277
,tissue,1,17016277
,necrosis,1,17016277
,process,1,17016277
,myocardial stunning,1,17016277
,clinical,1,17016277
,evidence,1,17016277
,adenosine,1,17016277
,potassium,1,17016277
,potassium channel,1,17016277
,channel,1,17016277
,function,1,17016277
,central,1,17016277
,role,1,17016277
,protection,1,17016277
,regimen,1,16948203
,therapeutic,1,16948203
,activated,1,16948203
,partial,1,16948203
,time,1,16948203
,aptt,1,16948203
,acute,1,16948203
,acute coronary syndrome,1,16948203
,coronary,1,16948203
,syndrome,1,16948203
,low,1,16948203
,low molecular weight heparin,1,16948203
,molecular,1,16948203
,molecular weight,1,16948203
,weight,4,16948203
,heparin,7,16948203
,increasingly,1,16948203
,treatment,2,16948203
,acute,1,16948203
,acute coronary syndrome,1,16948203
,coronary,1,16948203
,syndrome,1,16948203
,acs,3,16948203
,intravenous,1,16948203
,infusion,1,16948203
,still,1,16948203
,australian,1,16948203
,hospitals,1,16948203
,paper,1,16948203
,effectiveness,1,16948203
,regimen,2,16948203
,therapeutic,5,16948203
,activated,1,16948203
,partial,1,16948203
,time,1,16948203
,aptt,6,16948203
,hours,4,16948203
,sequential,1,16948203
,retrospective,1,16948203
,chart,1,16948203
,chart review,1,16948203
,review,1,16948203
,medical,1,16948203
,medical records,1,16948203
,records,1,16948203
,patients,4,16948203
,district hospital,1,16948203
,hospital,1,16948203
,south,1,16948203
,south western,1,16948203
,western,1,16948203
,australia,1,16948203
,not,2,16948203
,thrombolytic,1,16948203
,warfarin,1,16948203
,therapy,3,16948203
,only,2,16948203
,cent,1,16948203
,level,1,16948203
,heparin therapy,2,16948203
,comparison,1,16948203
,groups,2,16948203
,body,3,16948203
,body weight,3,16948203
,factor,1,16948203
,significantly,2,16948203
,different,1,16948203
,threshold,2,16948203
,less,1,16948203
,significant,1,16948203
,proportion,1,16948203
,kg body weight,1,16948203
,findings,1,16948203
,study,1,16948203
,ineffective,1,16948203
,rapid,1,16948203
,achievement,1,16948203
,shock,1,16597285
,review,1,16597285
,pathophysiology,1,16597285
,management,1,16597285
,part,1,16597285
,objective,1,16597285
,pathophysiology,1,16597285
,management,6,16597285
,hypovolaemic,4,16597285
,cardiogenic,6,16597285
,septic,2,16597285
,septic shock,2,16597285
,shock,11,16597285
,presentation,1,16597285
,data,1,16597285
,data sources,1,16597285
,sources,1,16597285
,articles,1,16597285
,abstracts,1,16597285
,review,2,16597285
,studies,2,16597285
,medline,1,16597285
,search,1,16597285
,english,1,16597285
,english language,1,16597285
,language,1,16597285
,literature,1,16597285
,cardiogenic shock,5,16597285
,hypovolaemic shock,2,16597285
,summary,1,16597285
,clinical,1,16597285
,clinical syndrome,1,16597285
,syndrome,1,16597285
,hypotension,1,16597285
,systolic,1,16597285
,systolic blood pressure,1,16597285
,blood,3,16597285
,blood pressure,1,16597285
,blood pressure less,1,16597285
,pressure,2,16597285
,less,3,16597285
,mmhg,2,16597285
,mean,1,16597285
,mean arterial pressure,1,16597285
,mean arterial pressure less,1,16597285
,arterial,1,16597285
,arterial pressure,1,16597285
,greater,1,16597285
,minutes,1,16597285
,oliguria,1,16597285
,urine,1,16597285
,urine output,1,16597285
,output,1,16597285
,consecutive,1,16597285
,hours,1,16597285
,poor,2,16597285
,poor peripheral perfusion,1,16597285
,peripheral,1,16597285
,peripheral perfusion,1,16597285
,perfusion,1,16597285
,clammy,1,16597285
,clammy skin,1,16597285
,skin,1,16597285
,capillary,1,16597285
,capillary refill,1,16597285
,refill,1,16597285
,disorders,1,16597285
,cause,1,16597285
,defect,2,16597285
,low,1,16597285
,intravascular,3,16597285
,volume,3,16597285
,reduction,2,16597285
,myocardial,4,16597285
,understanding,1,16597285
,very,1,16597285
,very little,1,16597285
,little,1,16597285
,past,1,16597285
,years,1,16597285
,treatment,1,16597285
,lesion,1,16597285
,surgical,1,16597285
,correction,1,16597285
,blood loss,1,16597285
,loss,2,16597285
,replacement,2,16597285
,sodium,1,16597285
,colloid,1,16597285
,crystalloid,1,16597285
,fluids,1,16597285
,due,1,16597285
,recent,2,16597285
,developments,1,16597285
,percutaneous,2,16597285
,percutaneous coronary revascularisation,1,16597285
,coronary,3,16597285
,coronary revascularisation,1,16597285
,revascularisation,2,16597285
,techniques,1,16597285
,centers,1,16597285
,emergency,1,16597285
,cardiac,1,16597285
,cardiac catheterisation,1,16597285
,catheterisation,1,16597285
,urgent,3,16597285
,myocardial reperfusion,1,16597285
,reperfusion,1,16597285
,percutaneous transluminal coronary angioplasty,1,16597285
,transluminal,1,16597285
,coronary angioplasty,1,16597285
,angioplasty,1,16597285
,coronary artery,1,16597285
,coronary artery stenting,1,16597285
,artery,1,16597285
,stenting,1,16597285
,selected,1,16597285
,cases,2,16597285
,use,1,16597285
,glycoprotein,1,16597285
,antagonists,1,16597285
,circulation,1,16597285
,intraaortic balloon pump,1,16597285
,balloon,2,16597285
,balloon pump,1,16597285
,pump,1,16597285
,mortality,2,16597285
,acute,2,16597285
,acute myocardial infarction,2,16597285
,myocardial infarction,2,16597285
,infarction,2,16597285
,large,1,16597285
,multicentre trials,1,16597285
,conclusions,1,16597285
,counterpulsation,1,16597285
,patients,1,16597285
,predictor,1,16464184
,health,1,16464184
,health states,1,16464184
,states,1,16464184
,background,1,16464184
,number,1,16464184
,medical,1,16464184
,outcomes,1,16464184
,short,1,16464184
,short form,1,16464184
,form,1,16464184
,mos,1,16464184
,scores,1,16464184
,healthy,2,16464184
,persons,1,16464184
,various,1,16464184
,levels,1,16464184
,health,16,16464184
,objectives,1,16464184
,purpose,1,16464184
,study,1,16464184
,ability,2,16464184
,not,4,16464184
,respondents,2,16464184
,problems,5,16464184
,methods,1,16464184
,structural,1,16464184
,structural equation modeling,1,16464184
,equation,1,16464184
,modeling,1,16464184
,techniques,1,16464184
,illness,4,16464184
,sample,1,16464184
,national,1,16464184
,national survey,1,16464184
,survey,1,16464184
,functional,1,16464184
,functional health,1,16464184
,health status,3,16464184
,status,3,16464184
,results,1,16464184
,correlation,2,16464184
,physical,5,16464184
,physical health,4,16464184
,variance,3,16464184
,correlations,1,16464184
,markedly,1,16464184
,lower,1,16464184
,scales,1,16464184
,mental,3,16464184
,mental health,3,16464184
,independent,1,16464184
,conclusions,1,16464184
,poor,1,16464184
,accounting,1,16464184
,significant,1,16464184
,absolute,1,16464184
,relative,1,16464184
,small,1,16464184
,much,1,16464184
,much better,1,16464184
,better,1,16464184
,job,1,16464184
,general,1,16464184
,findings,1,16464184
,well,1,16464184
,groups,1,16464184
,objective,1,16464184
,measures,1,16464184
,conjunction,1,16464184
,use,1,16464184
,treatment,1,16422031
,dyslipidaemias,1,16422031
,patients,1,16422031
,vascular,1,16422031
,vascular disease,1,16422031
,disease,1,16422031
,revival,1,16422031
,key,1,16422031
,statin,2,16422031
,effect,1,16422031
,concentrations,1,16422031
,lipoprotein,1,16422031
,lipoprotein cholesterol,1,16422031
,cholesterol,2,16422031
,ldl,3,16422031
,epidemiological,1,16422031
,surveys,1,16422031
,healthy,2,16422031
,populations,1,16422031
,other,2,16422031
,variables,3,16422031
,dense,1,16422031
,distribution,1,16422031
,possibly,1,16422031
,predictors,2,16422031
,vascular,3,16422031
,events,2,16422031
,hdl,2,16422031
,levels,2,16422031
,outcome,1,16422031
,plasma,1,16422031
,plasma fibrinogen,1,16422031
,plasma fibrinogen levels,1,16422031
,fibrinogen,1,16422031
,fibrinogen levels,1,16422031
,risk,1,16422031
,healthy subjects,1,16422031
,subjects,1,16422031
,patients,1,16422031
,ischaemic,1,16422031
,ischaemic heart disease,1,16422031
,heart,1,16422031
,heart disease,1,16422031
,disease,1,16422031
,fibrates,1,16422031
,effects,1,16422031
,all,1,16422031
,results,1,16422031
,recent,1,16422031
,bezafibrate,3,16422031
,infarction,1,16422031
,prevention,1,16422031
,bip,2,16422031
,study,1,16422031
,veterans,1,16422031
,veterans administration,1,16422031
,administration,1,16422031
,intervention,1,16422031
,intervention trial,1,16422031
,trial,1,16422031
,interest,1,16422031
,gemfibrozil,2,16422031
,poor,1,16422031
,capacity,2,16422031
,benefits,1,16422031
,actions,2,16422031
,reduction,1,16422031
,quantity,1,16422031
,ciprofibrate,1,16422031
,fenofibrate,1,16422031
,significantly,1,16422031
,greater,1,16422031
,advantage,1,16422031
,more,1,16422031
,effective,1,16422031
,additional,1,16422031
,class,1,16422031
,drugs,1,16422031
,prophylactic,1,16351998
,intravenous,1,16351998
,mannitol,1,16351998
,normal,1,16351998
,normal saline,1,16351998
,saline,1,16351998
,patients,1,16351998
,poor,1,16351998
,renal,1,16351998
,renal function,1,16351998
,function,1,16351998
,prior,1,16351998
,cardiac,1,16351998
,cardiac surgery,1,16351998
,surgery,1,16351998
,time,1,16351998
,multicentre trial,1,16351998
,trial,1,16351998
,background,1,16351998
,postoperative,3,16351998
,acute,3,16351998
,acute renal failure,3,16351998
,renal,4,16351998
,renal failure,3,16351998
,failure,3,16351998
,dialysis,3,16351998
,poor,1,16351998
,poor prognosis,1,16351998
,prognosis,1,16351998
,unaltered,1,16351998
,years,1,16351998
,cardiac,1,16351998
,surgical,1,16351998
,surgical patients,1,16351998
,patients,4,16351998
,risk,2,16351998
,preoperative,2,16351998
,serum,4,16351998
,serum creatinine,4,16351998
,creatinine,4,16351998
,use,1,16351998
,prophylactic,1,16351998
,intravenous,1,16351998
,mannitol,3,16351998
,normal,3,16351998
,normal saline,3,16351998
,saline,3,16351998
,therapy,2,16351998
,addition,1,16351998
,traditional,1,16351998
,methods,2,16351998
,support,1,16351998
,mean,2,16351998
,pre,1,16351998
,intra,1,16351998
,postoperatively,2,16351998
,treatment,2,16351998
,baseline,1,16351998
,results,1,16351998
,patient,3,16351998
,myocardial,1,16351998
,myocardial infarction,1,16351998
,infarction,1,16351998
,stroke,1,16351998
,first,1,16351998
,days,1,16351998
,urea,1,16351998
,peak,1,16351998
,day,1,16351998
,high,1,16351998
,high urine output,1,16351998
,urine,1,16351998
,urine output,1,16351998
,output,1,16351998
,haemodialysis,1,16351998
,conclusion,1,16351998
,effective,1,16351998
,diuresis,1,16351998
,need,1,16351998
,trial,1,16351998
,structure,1,16228908
,function,1,16228908
,formation,1,16228908
,new,1,16228908
,cell,1,16228908
,contacts,1,16228908
,cardiomyocytes,1,16228908
,superfamily,1,16228908
,transmembrane,1,16228908
,adhesion,2,16228908
,adhesion proteins,1,16228908
,proteins,2,16228908
,intercalated discs,1,16228908
,termini,1,16228908
,cardiomyocytes,4,16228908
,anchor,1,16228908
,myofibrils,1,16228908
,contacts,2,16228908
,large,1,16228908
,body,1,16228908
,data,1,16228908
,molecular,1,16228908
,molecular structure,1,16228908
,structure,1,16228908
,function,1,16228908
,little,1,16228908
,temporal,1,16228908
,interactions,1,16228908
,different,1,16228908
,junctional,1,16228908
,structures,2,16228908
,formation,1,16228908
,intercalated disc,2,16228908
,disc,2,16228908
,maturation,1,16228908
,postnatal,1,16228908
,postnatal development,1,16228908
,development,2,16228908
,progression,1,16228908
,compensated,1,16228908
,ventricular,1,16228908
,ventricular hypertrophy,1,16228908
,hypertrophy,1,16228908
,heart,1,16228908
,heart failure,1,16228908
,failure,1,16228908
,animal,1,16228908
,animal models,1,16228908
,models,1,16228908
,patients,1,16228908
,culture,2,16228908
,adult,2,16228908
,rat,1,16228908
,de novo,1,16228908
,order,1,16228908
,dynamics,1,16228908
,cytoskeletal,1,16228908
,cells,2,16228908
,expression,1,16228908
,chimeric,1,16228908
,chimeric proteins,1,16228908
,green,1,16228908
,green fluorescent protein,1,16228908
,fluorescent,1,16228908
,protein,1,16228908
,reporter,1,16228908
,technique,1,16228908
,routine,1,16228908
,method,1,16228908
,basic,1,16228908
,basic research,1,16228908
,research,1,16228908
,complements,1,16228908
,video,1,16228908
,confocal microscopy,1,16228908
,microscopy,1,16228908
,variety,1,16228908
,studies,1,16228908
,cell,1,16228908
,cell biology,1,16228908
,biology,1,16228908
,pharmacology,1,16228908
,ability,1,16228908
,electrically,1,16228908
,network,1,16228908
,possibly,1,16228908
,reimplantation,1,16228908
,myocardium,1,16228908
,new,1,16228908
,healthy,1,16228908
,muscle,1,16228908
,muscle tissue,1,16228908
,tissue,2,16228908
,several,1,16228908
,groups,1,16228908
,successfully,1,16228908
,sites,1,16228908
,myocardial,1,16228908
,myocardial infarcts,1,16228908
,infarcts,1,16228908
,autologous,1,16228908
,cardiomyocyte,1,16228908
,implantation,1,16228908
,cardiac,1,16228908
,repair,1,16228908
,infarction,1,16228908
,advances,1,16228908
,tissue engineering,1,16228908
,engineering,1,16228908
,incidence,1,16228142
,epidemiology,1,16228142
,heart,1,16228142
,heart failure,1,16228142
,failure,1,16228142
,epidemiologic,1,16228142
,data,1,16228142
,framingham,3,16228142
,study,3,16228142
,insights,1,16228142
,population,6,16228142
,burden,1,16228142
,heart,4,16228142
,heart failure,1,16228142
,failure,1,16228142
,chf,16,16228142
,prognosis,1,16228142
,risk,13,16228142
,risk factors,2,16228142
,factors,2,16228142
,general,2,16228142
,general population,2,16228142
,end,1,16228142
,end stage,1,16228142
,stage,1,16228142
,hypertensive,1,16228142
,coronary,1,16228142
,cardiovascular,1,16228142
,cardiovascular disease,1,16228142
,disease,2,16228142
,major,1,16228142
,problem,1,16228142
,most,1,16228142
,affluent,1,16228142
,countries,1,16228142
,populations,1,16228142
,size,1,16228142
,lives,1,16228142
,cardiac,3,16228142
,cardiac patients,1,16228142
,patients,1,16228142
,therapy,3,16228142
,once,1,16228142
,manifest,1,16228142
,recent,1,16228142
,unacceptably,1,16228142
,high,4,16228142
,mortality,3,16228142
,mortality rate,2,16228142
,rate,3,16228142
,median,1,16228142
,survival,1,16228142
,only,3,16228142
,men,6,16228142
,women,6,16228142
,times,1,16228142
,same,1,16228142
,age,2,16228142
,poor,1,16228142
,outlook,1,16228142
,etiologies,1,16228142
,sudden,1,16228142
,sudden death,1,16228142
,death,1,16228142
,prominent,1,16228142
,feature,1,16228142
,population attributable risks,1,16228142
,attributable,2,16228142
,attributable risks,1,16228142
,risks,1,16228142
,hypertension,3,16228142
,greatest,1,16228142
,impact,2,16228142
,events,1,16228142
,much,1,16228142
,lower,1,16228142
,prevalence,1,16228142
,myocardial,1,16228142
,myocardial infarction,1,16228142
,infarction,1,16228142
,attributable risk,1,16228142
,valvular heart disease,1,16228142
,heart disease,1,16228142
,risk factor,2,16228142
,factor,2,16228142
,hazard,1,16228142
,greater,1,16228142
,systolic,1,16228142
,diastolic,1,16228142
,diastolic blood pressure,1,16228142
,blood,1,16228142
,blood pressure,1,16228142
,pressure,1,16228142
,diabetes,3,16228142
,fold,1,16228142
,risk ratios,1,16228142
,ratios,1,16228142
,twice,1,16228142
,large,1,16228142
,cases,1,16228142
,cohort,1,16228142
,dyslipidemia,1,16228142
,cholesterol,2,16228142
,ratio,1,16228142
,not,1,16228142
,total,1,16228142
,total cholesterol,1,16228142
,alone,1,16228142
,enlarged,1,16228142
,enlarged heart,1,16228142
,ray,1,16228142
,vital,1,16228142
,vital capacity,1,16228142
,capacity,1,16228142
,rapid,1,16228142
,rapid heart rate,1,16228142
,heart rate,1,16228142
,usually,1,16228142
,cardiac function,1,16228142
,function,2,16228142
,independent,1,16228142
,xray,1,16228142
,cardiomegaly,1,16228142
,further,1,16228142
,echocardiographic,2,16228142
,ventricular,4,16228142
,ventricular hypertrophy,1,16228142
,hypertrophy,2,16228142
,high risk,1,16228142
,proportional,1,16228142
,degree,1,16228142
,increase,1,16228142
,left,2,16228142
,left ventricular mass,1,16228142
,ventricular mass,1,16228142
,mass,1,16228142
,critical,1,16228142
,value,1,16228142
,compensatory,1,16228142
,pathological,1,16228142
,persons,1,16228142
,conditions,1,16228142
,range,1,16228142
,indicators,1,16228142
,ventricular function,1,16228142
,possible,1,16228142
,upper,1,16228142
,quintile,1,16228142
,good,1,16228142
,testing,1,16228142
,aggressive,1,16228142
,preventive,1,16228142
,preventive measures,1,16228142
,measures,1,16228142
,onset,1,16228142
,treatment,1,16228142
,left ventricular dysfunction,1,16228142
,ventricular dysfunction,1,16228142
,dysfunction,1,16228142
,dysfunctional,1,16228142
,changes,1,16228142
,cell,1,16228140
,cell death,1,16228140
,death,1,16228140
,tissue,1,16228140
,hypoxia,1,16228140
,progression,1,16228140
,heart,1,16228140
,heart failure,1,16228140
,failure,1,16228140
,feature,1,16228140
,heart,9,16228140
,heart failure,5,16228140
,failure,6,16228140
,progressive,3,16228140
,deterioration,3,16228140
,left,1,16228140
,left ventricular function,1,16228140
,ventricular,3,16228140
,ventricular function,1,16228140
,function,1,16228140
,absence,1,16228140
,apparent,1,16228140
,adverse events,1,16228140
,events,1,16228140
,mechanism,1,16228140
,mechanisms,1,16228140
,responsible,1,16228140
,hemodynamic,2,16228140
,not,1,16228140
,others,1,16228140
,hypothesis,1,16228140
,results,1,16228140
,intrinsic,1,16228140
,contractile,1,16228140
,dysfunction,4,16228140
,viable,1,16228140
,cardiomyocytes,2,16228140
,ongoing,2,16228140
,loss,4,16228140
,review,1,16228140
,concept,2,16228140
,cardiac,2,16228140
,cardiac myocyte,1,16228140
,myocyte,3,16228140
,factor,1,16228140
,progression,3,16228140
,ventricular dysfunction,2,16228140
,state,1,16228140
,discussion,2,16228140
,center,1,16228140
,apoptosis,8,16228140
,cell,1,16228140
,cell death,1,16228140
,death,1,16228140
,potential,1,16228140
,mediator,1,16228140
,cardiomyocyte,3,16228140
,recent,1,16228140
,years,1,16228140
,several,1,16228140
,studies,3,16228140
,constituent,1,16228140
,myocytes,2,16228140
,human,1,16228140
,hearts,2,16228140
,animals,1,16228140
,experimentally,1,16228140
,induced,1,16228140
,acute,1,16228140
,acute myocardial infarction,1,16228140
,myocardial,1,16228140
,myocardial infarction,1,16228140
,infarction,1,16228140
,hypertrophied,1,16228140
,well,1,16228140
,conditions,1,16228140
,frequently,1,16228140
,development,2,16228140
,available,1,16228140
,data,1,16228140
,lacking,1,16228140
,part,1,16228140
,issue,1,16228140
,case,1,16228140
,support,1,16228140
,myocardium,1,16228140
,subject,1,16228140
,regional,1,16228140
,hyp,1,16228140
,abnormality,1,16228140
,cardiac myocytes,1,16228140
,exact,1,16228140
,physiologic,1,16228140
,molecular,1,16228140
,factors,1,16228140
,trigger,1,16228140
,stage,1,16228140
,novel,1,16228140
,modalities,1,16228140
,very,1,16228140
,retarding,1,16228140
,process,1,16228140
,transition,1,16228140
,intractable,1,16228140
,monoclonal,2,16100700
,antibody,2,16100700
,development,2,16100700
,icos,4,16100700
,potential,1,16100700
,treatment,2,16100700
,multiple,1,16100700
,multiple sclerosis,1,16100700
,sclerosis,1,16100700
,hemorrhagic,2,16100700
,hemorrhagic shock,2,16100700
,shock,3,16100700
,myocardial,1,16100700
,myocardial infarction,1,16100700
,infarction,1,16100700
,stroke,4,16100700
,phase,6,16100700
,studies,1,16100700
,patients,6,16100700
,acute,3,16100700
,acute exacerbations,2,16100700
,january,2,16100700
,randomized,1,16100700
,trial,8,16100700
,acute ischemic,1,16100700
,ischemic,3,16100700
,ischemic stroke,2,16100700
,compound,2,16100700
,preclinical,2,16100700
,investigation,1,16100700
,cerebral,1,16100700
,cerebral vasospasm,1,16100700
,vasospasm,1,16100700
,head,1,16100700
,head trauma,1,16100700
,trauma,2,16100700
,kidney,1,16100700
,kidney transplantation,1,16100700
,transplantation,1,16100700
,restenosis,1,16100700
,september,2,16100700
,results,1,16100700
,phase ii clinical trial,1,16100700
,clinical,2,16100700
,clinical trial,1,16100700
,global,1,16100700
,life,1,16100700
,life sciences,1,16100700
,sciences,1,16100700
,conference,1,16100700
,new,1,16100700
,new york,1,16100700
,study,1,16100700
,safety,2,16100700
,efficacy,1,16100700
,weekly,1,16100700
,doses,1,16100700
,placebo,2,16100700
,benefit,1,16100700
,recovery,1,16100700
,neurological,1,16100700
,neurological functioning,1,16100700
,functioning,1,16100700
,february,1,16100700
,initiation,1,16100700
,phase ii trial,3,16100700
,mayo,1,16100700
,physician,1,16100700
,alliance,1,16100700
,cardiovascular,1,16100700
,pharmacokinetics,1,16100700
,infarct,2,16100700
,size,1,16100700
,patient,3,16100700
,enrollment,2,16100700
,open,1,16100700
,open label,1,16100700
,label,1,16100700
,end,1,16100700
,company,1,16100700
,several,1,16100700
,centers,1,16100700
,population,1,16100700
,onset,1,16100700
,symptoms,1,16100700
,significant,1,16100700
,difference,1,16100700
,neuroprotection,1,16100700
,rabbit,1,16100700
,model,1,16100700
,focal,1,16100700
,ischemia,1,16100700
,greatest,1,16100700
,reduction,1,16100700
,cortical,1,16100700
,areas,1,16100700
,brain,3,16100700
,neutrophil,2,16100700
,neutrophil infiltration,1,16100700
,infiltration,1,16100700
,parenchyma,1,16100700
,monoclonal antibody,1,16100700
,cell,1,16100700
,cell adhesion,1,16100700
,adhesion,3,16100700
,binding,2,16100700
,receptors,2,16100700
,migration,1,16100700
,neutrophils,1,16100700
,central,1,16100700
,central nervous system,1,16100700
,nervous,1,16100700
,nervous system,1,16100700
,system,1,16100700
,brain inflammation,1,16100700
,inflammation,1,16100700
,neuronal,1,16100700
,loss,1,16100700
,binds,1,16100700
,icams,1,16100700
,university,1,16100700
,washington,1,16100700
,venous,1,16088766
,venous thromboembolism,1,16088766
,thromboembolism,1,16088766
,past,1,16088766
,present,1,16088766
,future,1,16088766
,last,1,16088766
,decades,1,16088766
,advances,1,16088766
,diagnosis,1,16088766
,treatment,3,16088766
,venous,2,16088766
,venous thromboembolism,1,16088766
,thromboembolism,1,16088766
,vte,3,16088766
,pulmonary,1,16088766
,pulmonary embolism,1,16088766
,embolism,1,16088766
,deep,1,16088766
,objective,2,16088766
,documentation,1,16088766
,plethora,1,16088766
,ever,1,16088766
,imaging,1,16088766
,imaging studies,1,16088766
,studies,1,16088766
,modalities,1,16088766
,mortality,2,16088766
,due,1,16088766
,approximately,1,16088766
,hospitalizations,1,16088766
,outpatient,1,16088766
,therapy,1,16088766
,reality,1,16088766
,use,2,16088766
,primary,1,16088766
,prophylaxis,1,16088766
,more,1,16088766
,widespread,1,16088766
,many,2,16088766
,accomplishments,1,16088766
,patients,3,16088766
,high,1,16088766
,undiagnosed,1,16088766
,critical,1,16088766
,need,1,16088766
,role,1,16088766
,history,1,16088766
,testing,1,16088766
,ideal,1,16088766
,development,1,16088766
,biological,1,16088766
,biological marker,1,16088766
,marker,1,16088766
,similar,1,16088766
,creatinine,2,16088766
,troponin,1,16088766
,acute,1,16088766
,acute myocardial infarction,1,16088766
,myocardial,1,16088766
,myocardial infarction,1,16088766
,infarction,1,16088766
,death,1,16083657
,cardiac,1,16083657
,injury,1,16083657
,cases,1,16083657
,blunt,2,16083657
,myocardial,2,16083657
,myocardial injury,1,16083657
,injury,3,16083657
,region,1,16083657
,anterior,1,16083657
,branch,1,16083657
,left,1,16083657
,left coronary artery,1,16083657
,coronary,3,16083657
,coronary artery,2,16083657
,artery,2,16083657
,death,2,16083657
,case,1,16083657
,direct,1,16083657
,myocardial infarction,1,16083657
,infarction,1,16083657
,other,1,16083657
,cardiac,1,16083657
,cardiac arrhythmia,1,16083657
,arrhythmia,1,16083657
,possibly,1,16083657
,secondary,1,16083657
,coronary artery spasm,1,16083657
,artery spasm,1,16083657
,spasm,1,16083657
,apparently,1,16083657
,uncommon,1,16083657
,deaths,1,16083657
,blunt injury,1,16083657
,coronary arteries,1,16083657
,arteries,1,16083657
,difficult,1,16083657
,mab,1,16059812
,genentech,1,16059812
,roche,1,16059812
,development,1,16059812
,humanized monoclonal antibody,1,16059812
,monoclonal,1,16059812
,monoclonal antibody,1,16059812
,antibody,2,16059812
,inhibition,1,16059812
,leukocyte,1,16059812
,leukocyte adhesion,1,16059812
,adhesion,1,16059812
,antibodies,1,16059812
,therapeutic,1,16059812
,therapeutic intervention,1,16059812
,intervention,1,16059812
,indications,1,16059812
,inflammatory,1,16059812
,component,1,16059812
,reperfusion,2,16059812
,reperfusion injury,2,16059812
,injury,2,16059812
,june,1,16059812
,company,2,16059812
,primary,1,16059812
,objectives,1,16059812
,phase,2,16059812
,phase ii trial,1,16059812
,trial,2,16059812
,not,1,16059812
,preliminary,1,16059812
,results,1,16059812
,treatment,1,16059812
,myocardial,1,16059812
,myocardial infarction,1,16059812
,infarction,1,16059812
,currently,1,16059812
,data,1,16059812
,investigators,1,16059812
,studies,1,16059812
,patients,1,16059812
,successfully,1,16059812
,thrombolytics,1,16059812
,planne,1,16059812
,enrollment,1,16059812
,third,1,16059812
,quarter,1,16059812
,february,1,16059812
,brothers,2,16059812
,drug,1,16059812
,probability,1,16059812
,market,1,16059812
,successful,1,16059812
,analysts,1,16059812
,peak,1,16059812
,sales,2,16059812
,time,1,16059812
,dollars,1,16059812
,synthetic,1,16049869
,pentasaccharide,1,16049869
,heparinoid,1,16049869
,factor,1,16049869
,factor xa,1,16049869
,antagonist,1,16049869
,inhibitor,1,16049869
,joint,1,16049869
,development,2,16049869
,sanofi,1,16049869
,organon,1,16049869
,potential,3,16049869
,treatment,6,16049869
,prophylaxis,1,16049869
,deep,1,16049869
,deep vein,1,16049869
,vein,1,16049869
,symptomatic,2,16049869
,pulmonary,8,16049869
,pulmonary embolism,8,16049869
,embolism,8,16049869
,hip,4,16049869
,knee,2,16049869
,knee surgery,2,16049869
,surgery,3,16049869
,coronary,4,16049869
,coronary artery,3,16049869
,coronary artery diseases,3,16049869
,artery,3,16049869
,artery diseases,3,16049869
,diseases,3,16049869
,compound,2,16049869
,phase,8,16049869
,phase iii clinical trials,2,16049869
,iii,5,16049869
,clinical,4,16049869
,clinical trials,2,16049869
,prevention,4,16049869
,dvt,8,16049869
,phase iii trials,3,16049869
,first,2,16049869
,quarter,3,16049869
,phase iib trials,1,16049869
,cardiology,1,16049869
,indications,1,16049869
,europe,1,16049869
,third,1,16049869
,december,1,16049869
,february,3,16049869
,orthopaedic,1,16049869
,orthopaedic surgery,1,16049869
,european,2,16049869
,trial,9,16049869
,patients,7,16049869
,hip fracture,1,16049869
,fracture,1,16049869
,hip replacements,2,16049869
,replacements,2,16049869
,major,1,16049869
,clinical data,2,16049869
,data,2,16049869
,available,2,16049869
,june,1,16049869
,preparations,1,16049869
,enoxaparin,1,16049869
,enoxaparin sodium,1,16049869
,sodium,1,16049869
,open,1,16049869
,study,1,16049869
,unfractionated heparin,1,16049869
,heparin,1,16049869
,unstable,2,16049869
,ang,1,16049869
,percutaneous,1,16049869
,percutaneous transluminal coronary angioplasty,1,16049869
,transluminal,1,16049869
,coronary angioplasty,1,16049869
,angioplasty,1,16049869
,acute,2,16049869
,acute myocardial infarction,2,16049869
,myocardial,2,16049869
,myocardial infarction,2,16049869
,infarction,2,16049869
,time,1,16049869
,good,1,16049869
,ratio,1,16049869
,unstable angina,1,16049869
,angina,1,16049869
,ongoing,1,16049869
,october,2,16049869
,forecast,1,16049869
,sales,2,16049869
,review,1,16049869
,brothers,1,16049869
,product,1,16049869
,chance,1,16049869
,market,1,16049869
,peak,1,16049869
,dollars,1,16049869
,percutaneous,1,15645842
,rescue,1,15645842
,transluminal,1,15645842
,coronary,1,15645842
,coronary angioplasty,1,15645842
,angioplasty,1,15645842
,rescue,2,15645842
,angioplasty,2,15645842
,operation,2,15645842
,acute,1,15645842
,stage,1,15645842
,myocardial,1,15645842
,myocardial infarction,1,15645842
,infarction,1,15645842
,systemic,1,15645842
,thrombolysis,1,15645842
,not,1,15645842
,opening,1,15645842
,artery,2,15645842
,investigations,1,15645842
,recent,1,15645842
,years,1,15645842
,benefit,1,15645842
,only,1,15645842
,patients,1,15645842
,infarcted,1,15645842
,patent,1,15645842
,several,1,15645842
,hours,1,15645842
,evidence,2,15645842
,same,1,15645842
,time,1,15645842
,safety,1,15645842
,technical,1,15645842
,success,1,15645842
,authors,1,15645842
,brief,1,15645842
,review,1,15645842
,literature,1,15645842
,development,1,15645842
,views,1,15645842
,need,1,15645842
,early,1,15645842
,correct,1,15645842
,indication,1,15645842
,role,1,15637893
,cholesterol,1,15637893
,metabolites,1,15637893
,synthesis,1,15637893
,intensive care,1,15637893
,care,1,15637893
,parenteral,1,15637893
,parenteral nutrition,1,15637893
,nutrition,1,15637893
,hypocholesterolaemia,2,15637893
,frequent,2,15637893
,typical,1,15637893
,phenomenon,2,15637893
,many,1,15637893
,acute,2,15637893
,injury,1,15637893
,severe,1,15637893
,infection,1,15637893
,sepsis,1,15637893
,septic,1,15637893
,septic shock,1,15637893
,shock,1,15637893
,catabolic,1,15637893
,serious,3,15637893
,operations,1,15637893
,myocardial,1,15637893
,myocardial infarction,1,15637893
,infarction,1,15637893
,neoplastic,1,15637893
,neoplastic diseases,1,15637893
,diseases,1,15637893
,only,1,15637893
,malnutrition,1,15637893
,energy,1,15637893
,deficiency,3,15637893
,development,2,15637893
,conditions,2,15637893
,opinion,1,15637893
,synthesis,1,15637893
,cholesterol,2,15637893
,cholesterol as,1,15637893
,well,1,15637893
,metabolites,4,15637893
,biosynthesis,2,15637893
,isoprene,2,15637893
,squalene,2,15637893
,lanosterol,1,15637893
,lathosterol,1,15637893
,evidence,1,15637893
,deprivation,2,15637893
,very,1,15637893
,statistically,1,15637893
,statistically significant,1,15637893
,significant,1,15637893
,precursors,1,15637893
,cholesterol biosynthesis,1,15637893
,extremely,1,15637893
,normal,1,15637893
,cell,1,15637893
,mediators,1,15637893
,farnesyl diphosphate,1,15637893
,diphosphate,1,15637893
,disorder,1,15637893
,time,1,15637893
,patients,1,15637893
,damage,1,15637892
,ventricular,1,15637892
,ventricular function,1,15637892
,function,1,15637892
,treatment,1,15637892
,doxorubicin,1,15637892
,patients,1,15637892
,malignant,1,15637892
,malignant lymphomas,1,15637892
,lymphomas,1,15637892
,authors,1,15637892
,clinical,2,15637892
,echocardiographic,2,15637892
,examination,2,15637892
,effect,1,15637892
,chemotherapy,6,15637892
,bolus,1,15637892
,administration,2,15637892
,doxorubicin,1,15637892
,heart,1,15637892
,heart muscle,1,15637892
,muscle,1,15637892
,patients,7,15637892
,nonhodgkin lymphoma,1,15637892
,lymphoma,2,15637892
,hodgkin,1,15637892
,hodgkin lymphoma,1,15637892
,asymptomatic,1,15637892
,decrease,1,15637892
,left,2,15637892
,left ventricular ejection,1,15637892
,left ventricular ejection fraction,1,15637892
,ventricular,2,15637892
,ventricular ejection,1,15637892
,ventricular ejection fraction,1,15637892
,ejection,1,15637892
,ejection fraction,1,15637892
,fraction,1,15637892
,chronic,1,15637892
,cardiotoxicity,2,15637892
,year,3,15637892
,termination,2,15637892
,latent,1,15637892
,myocardial,1,15637892
,myocardial infarction,1,15637892
,infarction,1,15637892
,diastolic,2,15637892
,function,3,15637892
,impaired,2,15637892
,relaxation,1,15637892
,evidence,1,15637892
,systolic,1,15637892
,peripheral,1,15637892
,peripheral stem cells,1,15637892
,stem,1,15637892
,stem cells,1,15637892
,cells,1,15637892
,not,2,15637892
,marked,1,15637892
,deterioration,1,15637892
,left ventricular function,1,15637892
,ventricular function,1,15637892
,treatment,1,15637892
,main,1,15637892
,relapse,1,15637892
,malignant,1,15637892
,malignant disease,1,15637892
,disease,1,15637892
,cardiovascular,1,15637892
,cardiovascular complicationswere,1,15637892
,present,1,15637892
,course,1,15637892
,month,1,15637892
,diagnosis,1,15637892
,chlamydia,1,15529571
,chlamydia pneumoniae,1,15529571
,chlamydia pneumoniae antibodies,1,15529571
,pneumoniae,1,15529571
,antibodies,1,15529571
,inflammatory,1,15529571
,inflammatory reaction,1,15529571
,reaction,1,15529571
,patients,1,15529571
,ischemic,1,15529571
,ischemic heart disease,1,15529571
,heart,1,15529571
,heart disease,1,15529571
,disease,1,15529571
,relationship,2,15529571
,chlamydia,5,15529571
,chlamydia pneumoniae,5,15529571
,chlamydia pneumoniae antibodies,1,15529571
,pneumoniae,5,15529571
,antibodies,10,15529571
,creactive protein,1,15529571
,protein,1,15529571
,crp,4,15529571
,interleukine,1,15529571
,patients,13,15529571
,ischemic,2,15529571
,ischemic heart disease,2,15529571
,heart,2,15529571
,heart disease,2,15529571
,disease,2,15529571
,acute,1,15529571
,acute myocardial infarction,1,15529571
,myocardial,1,15529571
,myocardial infarction,1,15529571
,infarction,1,15529571
,unstable,2,15529571
,unstable angina,2,15529571
,unstable angina pectoris,2,15529571
,angina,2,15529571
,angina pectoris,2,15529571
,stable,1,15529571
,effort,1,15529571
,ang,1,15529571
,igg,7,15529571
,iga,3,15529571
,species,1,15529571
,specific,1,15529571
,indirect,1,15529571
,elisa,2,15529571
,technique,1,15529571
,diagnostics,1,15529571
,israel,1,15529571
,commercially,1,15529571
,available,1,15529571
,kit,1,15529571
,clb,1,15529571
,netherlands,1,15529571
,radial,1,15529571
,immunodiffusion,1,15529571
,present,2,15529571
,greatest,1,15529571
,percentage,1,15529571
,sign,1,15529571
,chronic,1,15529571
,chlamydia pneumoniae infection,2,15529571
,infection,2,15529571
,positive,3,15529571
,only,1,15529571
,difference,1,15529571
,not,2,15529571
,not significant,1,15529571
,significant,1,15529571
,presence,1,15529571
,inflammatory,1,15529571
,inflammatory reaction,1,15529571
,reaction,1,15529571
,neutrophils,1,15529571
,process,1,15529571
,high,1,15321090
,high dose,1,15321090
,dose,1,15321090
,alfentanil,1,15321090
,sole,1,15321090
,anaesthetic,1,15321090
,anaesthetic induction,1,15321090
,induction,1,15321090
,agent,1,15321090
,caesarean section,1,15321090
,section,1,15321090
,patient,1,15321090
,severe,1,15321090
,ischaemic,1,15321090
,ischaemic heart disease,1,15321090
,heart,1,15321090
,heart disease,1,15321090
,disease,1,15321090
,woman,1,15321090
,weeks,1,15321090
,weeks gestation,1,15321090
,gestation,1,15321090
,preeclampsia,1,15321090
,intrauterine,1,15321090
,intrauterine growth restriction,1,15321090
,growth,1,15321090
,restriction,1,15321090
,past,1,15321090
,past medical history,1,15321090
,medical,1,15321090
,medical history,1,15321090
,history,1,15321090
,myocardial,1,15321090
,myocardial infarction,1,15321090
,infarction,1,15321090
,angina,1,15321090
,moderate,1,15321090
,effort,1,15321090
,noninsulin dependent diabetes,1,15321090
,noninsulin dependent diabetes mellitus,1,15321090
,dependent,1,15321090
,diabetes,1,15321090
,diabetes mellitus,1,15321090
,chronic,1,15321090
,chronic obstructive airways disease,1,15321090
,obstructive airways disease,1,15321090
,airways,1,15321090
,airways disease,1,15321090
,disease,1,15321090
,hypercholesterolaemia,1,15321090
,onset,1,15321090
,unstable,1,15321090
,ang,1,15321090
,cardiac,1,15321090
,cardiac failure,1,15321090
,failure,1,15321090
,fetal,2,15321090
,fetal condition,1,15321090
,condition,1,15321090
,urgent,1,15321090
,delivery,1,15321090
,caesarean section,1,15321090
,section,1,15321090
,general,1,15321090
,general anaesthesia,1,15321090
,anaesthesia,1,15321090
,high,1,15321090
,high dose,1,15321090
,dose,1,15321090
,alfentanil,1,15321090
,sole,1,15321090
,induction,1,15321090
,agent,1,15321090
,minimal,1,15321090
,change,1,15321090
,successful,1,15321090
,maternal,1,15321090
,outcome,1,15321090
,applications,1,14632008
,echocardiography,1,14632008
,left,1,14632008
,left ventricle,1,14632008
,ventricle,1,14632008
,other,1,14632008
,chambers,1,14632008
,structural,1,14632008
,detail,1,14632008
,authors,1,14632008
,system,1,14632008
,quantitative,1,14632008
,threedimensional echocardiography,1,14632008
,echocardiography,1,14632008
,echo,1,14632008
,now,1,14632008
,analysis,1,14632008
,heart,2,14632008
,heart chambers,1,14632008
,chambers,2,14632008
,valves,2,14632008
,structures,2,14632008
,image,1,14632008
,image acquisition,1,14632008
,acquisition,1,14632008
,scanning,1,14632008
,magnetic,1,14632008
,magnetic field,1,14632008
,field,1,14632008
,device,1,14632008
,borders,1,14632008
,cardiac,2,14632008
,cardiac structures,1,14632008
,manually,1,14632008
,smooth,1,14632008
,subdivision,1,14632008
,surface,1,14632008
,mitral,2,14632008
,tricuspid,1,14632008
,tricuspid annuli,1,14632008
,annuli,1,14632008
,term,1,14632008
,fourier series,1,14632008
,series,1,14632008
,other,1,14632008
,orifices,1,14632008
,ellipses,1,14632008
,anatomic,1,14632008
,labeling,1,14632008
,identification,1,14632008
,chordae,1,14632008
,coronary,1,14632008
,coronary sinus,1,14632008
,sinus,1,14632008
,septum,1,14632008
,right,1,14632008
,ventricular,2,14632008
,apex,1,14632008
,dimensions,1,14632008
,shape,1,14632008
,function,1,14632008
,cardiac components,1,14632008
,components,1,14632008
,relationships,1,14632008
,distance,1,14632008
,angle,1,14632008
,methods,1,14632008
,capability,1,14632008
,flexibility,1,14632008
,clinical,1,14632008
,applications,1,14632008
,modeling,1,14632008
,heart motion,1,14632008
,motion,1,14632008
,mechanism,1,14632008
,functional,1,14632008
,functional mitral regurgitation,1,14632008
,mitral regurgitation,1,14632008
,regurgitation,1,14632008
,tracking,1,14632008
,ventricular remodeling,1,14632008
,remodeling,1,14632008
,pharmacological,1,14600906
,radionuclide,1,14600906
,radionuclide ventriculography,1,14600906
,ventriculography,1,14600906
,detection,1,14600906
,myocardial,2,14600906
,myocardial contractile,1,14600906
,contractile,1,14600906
,reserve,1,14600906
,patients,1,14600906
,myocardial infarction,1,14600906
,infarction,1,14600906
,comparison,1,14600906
,low,2,14600906
,low dose,2,14600906
,dose,2,14600906
,dobutamine,1,14600906
,dipyridamole,1,14600906
,background,1,14600906
,low,10,14600906
,low dose,10,14600906
,dose,10,14600906
,pharmacological,1,14600906
,pharmacological stress,1,14600906
,stress,2,14600906
,stress echocardiography,2,14600906
,echocardiography,2,14600906
,dobutamine,10,14600906
,dipyridamole,9,14600906
,infusion,2,14600906
,recognition,1,14600906
,myocardial,3,14600906
,viability,2,14600906
,dependence,1,14600906
,adequate,1,14600906
,acoustic,1,14600906
,window,1,14600906
,observer,1,14600906
,experience,1,14600906
,mild,1,14600906
,degree,1,14600906
,wall,1,14600906
,wall motion,1,14600906
,motion,1,14600906
,changes,1,14600906
,assessment,1,14600906
,objective,1,14600906
,study,2,14600906
,ability,1,14600906
,radionuclide,5,14600906
,radionuclide ventriculography,5,14600906
,ventriculography,5,14600906
,contractile,2,14600906
,reserve,2,14600906
,patients,4,14600906
,myocardial infarction,2,14600906
,infarction,2,14600906
,functional,4,14600906
,functional recovery,4,14600906
,recovery,4,14600906
,coronary,2,14600906
,coronary angioplasty,1,14600906
,angioplasty,3,14600906
,methods,1,14600906
,group,2,14600906
,consecutive,1,14600906
,years,1,14600906
,male,1,14600906
,female,1,14600906
,previous,1,14600906
,previous myocardial infarction,1,14600906
,regional,6,14600906
,diagnostic,1,14600906
,diagnostic cardiac catheterization,1,14600906
,cardiac,1,14600906
,cardiac catheterization,1,14600906
,catheterization,1,14600906
,significant,1,14600906
,coronary artery,1,14600906
,coronary artery stenosis,1,14600906
,artery,1,14600906
,artery stenosis,1,14600906
,stenosis,1,14600906
,patient,1,14600906
,equilibrium,1,14600906
,rest,1,14600906
,minutes,1,14600906
,ventricular,1,14600906
,global,1,14600906
,ejection,5,14600906
,ejection fractions,3,14600906
,fractions,3,14600906
,increase,1,14600906
,ejection fraction,2,14600906
,fraction,2,14600906
,posterolateral,1,14600906
,regions,4,14600906
,infarcted,2,14600906
,well,1,14600906
,followup,2,14600906
,period,2,14600906
,index,1,14600906
,weeks,1,14600906
,successful,1,14600906
,order,1,14600906
,infarct,1,14600906
,zone,1,14600906
,results,1,14600906
,analyzed,1,14600906
,segments,2,14600906
,depressed,2,14600906
,mean,1,14600906
,resting,1,14600906
,value,6,14600906
,baseline,1,14600906
,positive,3,14600906
,positive predictive value,2,14600906
,predictive,4,14600906
,predictive value,4,14600906
,negative,3,14600906
,negative predictive value,2,14600906
,most,1,14600906
,severe,1,14600906
,dyskinesia,1,14600906
,conclusion,1,14600906
,rate,1,14600906
,responses,1,14600906
,imaging,1,14600906
,superior,1,14600906
,prognostic,1,14600906
,bradykinin,1,12937626
,bradykinin b2 receptor,1,12937626
,receptor,1,12937626
,potential,1,12937626
,therapeutic,1,12937626
,target,1,12937626
,kinins,5,12937626
,peptide,1,12937626
,peptide hormones,1,12937626
,hormones,1,12937626
,well,1,12937626
,physiological,1,12937626
,physiological effects,1,12937626
,effects,3,12937626
,stimulation,3,12937626
,bradykinin,1,12937626
,receptors,1,12937626
,strong,1,12937626
,properties,1,12937626
,vasodilation,1,12937626
,plasma,1,12937626
,extravasation,1,12937626
,activation,1,12937626
,mast,1,12937626
,mast cells,1,12937626
,cells,1,12937626
,fibroblasts,1,12937626
,macrophages,1,12937626
,sensory,1,12937626
,sensory neurons,1,12937626
,neurons,1,12937626
,release,2,12937626
,nitric oxide,2,12937626
,oxide,2,12937626
,prostaglandins,1,12937626
,leukotrienes,1,12937626
,cytokines,1,12937626
,role,1,12937626
,variety,1,12937626
,inflammatory,1,12937626
,inflammatory diseases,1,12937626
,diseases,2,12937626
,pain,2,12937626
,receptor,7,12937626
,antagonists,4,12937626
,perennial rhinitis,1,12937626
,rhinitis,2,12937626
,asthma,2,12937626
,brain,1,12937626
,brain edema,1,12937626
,edema,2,12937626
,clinical,1,12937626
,clinical trials,1,12937626
,recently,1,12937626
,potential,3,12937626
,therapeutic,3,12937626
,utility,1,12937626
,discovery,1,12937626
,orally,2,12937626
,active,2,12937626
,identification,1,12937626
,novel,2,12937626
,indications,1,12937626
,use,1,12937626
,other,1,12937626
,hand,1,12937626
,antihypertensive,1,12937626
,peptides,1,12937626
,vasodilatory,1,12937626
,fibrinolytic,1,12937626
,due,1,12937626
,autacoids,1,12937626
,prostacyclin,1,12937626
,tissue,2,12937626
,tissue plasminogen activator,1,12937626
,plasminogen,1,12937626
,plasminogen activator,1,12937626
,recent,1,12937626
,finding,1,12937626
,ischemic,1,12937626
,ischemic preconditioning,1,12937626
,preconditioning,1,12937626
,agonists,2,12937626
,therapeutic agents,1,12937626
,cardiovascular,2,12937626
,medicine,1,12937626
,interaction,1,12937626
,blockade,1,12937626
,approaches,1,12937626
,useful,1,12937626
,treatment,2,12937626
,arthritis,1,12937626
,colitis,1,12937626
,pancreatitis,1,12937626
,sep,1,12937626
,sis,1,12937626
,tissue injury,1,12937626
,injury,1,12937626
,possibly,1,12937626
,infections,1,12937626
,hepatorenal syndrome,1,12937626
,syndrome,1,12937626
,alzheimers,1,12937626
,alzheimers disease,1,12937626
,disease,1,12937626
,lung,1,12937626
,lung cancer,1,12937626
,cancer,1,12937626
,cardiovascular diseases,1,12937626
,hypertension,1,12937626
,cardiac,1,12937626
,cardiac hypertrophy,1,12937626
,hypertrophy,1,12937626
,restenosis,1,12937626
,myocardial,1,12937626
,myocardial infarction,1,12937626
,infarction,1,12937626
,diabetic,1,12937626
,gene,1,12937625
,gene therapy,1,12937625
,therapy,1,12937625
,potential,1,12937625
,treatment,1,12937625
,restenosis,1,12937625
,myocardial,1,12937625
,myocardial infarction,1,12937625
,infarction,1,12937625
,cardiovascular,5,12937625
,cardiovascular disease,2,12937625
,disease,2,12937625
,cause,1,12937625
,mortality,1,12937625
,morbidity,1,12937625
,countries,1,12937625
,most,1,12937625
,conventional,1,12937625
,conventional therapy,1,12937625
,therapy,4,12937625
,inefficient,1,12937625
,symptoms,1,12937625
,causes,1,12937625
,disorder,1,12937625
,gene,6,12937625
,gene therapy,3,12937625
,novel,2,12937625
,approach,2,12937625
,prevention,2,12937625
,treatment,3,12937625
,cardiovascular diseases,1,12937625
,diseases,1,12937625
,gene transfer,3,12937625
,transfer,3,12937625
,somatic,2,12937625
,somatic cells,2,12937625
,cells,2,12937625
,better,1,12937625
,major,1,12937625
,development,1,12937625
,intense,1,12937625
,investigation,1,12937625
,potential,1,12937625
,medicine,1,12937625
,advances,1,12937625
,molecular,1,12937625
,molecular biology,1,12937625
,biology,1,12937625
,improvement,1,12937625
,technology,1,12937625
,target,1,12937625
,target genes,1,12937625
,genes,1,12937625
,recently,1,12937625
,transfection,1,12937625
,cis,1,12937625
,element,1,12937625
,oligonucleotides,1,12937625
,tool,1,12937625
,new,1,12937625
,class,1,12937625
,antigene,1,12937625
,strategies,1,12937625
,article,1,12937625
,successful,1,12937625
,successful treatment,1,12937625
,restenosis,1,12937625
,myocardial,1,12937625
,myocardial infarction,1,12937625
,infarction,1,12937625
,strategy,1,12937625
,efficient,1,12937625
,method,1,12937625
,effect,1,12906139
,basic,1,12906139
,basic fibroblast growth factor,1,12906139
,fibroblast,1,12906139
,fibroblast growth factor,1,12906139
,growth,1,12906139
,growth factor,1,12906139
,factor,1,12906139
,microcapsules,1,12906139
,angiogenesis,1,12906139
,infarcted,1,12906139
,rabbit,1,12906139
,myocardium,1,12906139
,objectives,1,12906139
,effect,1,12906139
,basic,1,12906139
,basic fibroblast growth factor,1,12906139
,fibroblast,1,12906139
,fibroblast growth factor,1,12906139
,growth,1,12906139
,growth factor,1,12906139
,factor,1,12906139
,microcapsules,4,12906139
,angiogenesis,3,12906139
,infarcted,4,12906139
,myocardial,2,12906139
,regions,1,12906139
,methods,1,12906139
,myocardial infarction,1,12906139
,infarction,1,12906139
,new,1,12906139
,new zealand,1,12906139
,new zealand rabbits,1,12906139
,rabbits,1,12906139
,root,1,12906139
,left,1,12906139
,left anterior,1,12906139
,left anterior descending coronary artery,1,12906139
,anterior,2,12906139
,anterior descending coronary artery,2,12906139
,descending,2,12906139
,coronary,2,12906139
,coronary artery,2,12906139
,artery,3,12906139
,group,13,12906139
,control,1,12906139
,group ii,4,12906139
,blank,2,12906139
,microcapsule,4,12906139
,iii,2,12906139
,microg,1,12906139
,bfgf,3,12906139
,myocardium,1,12906139
,epicardium,1,12906139
,circumflex,1,12906139
,circumflex artery,1,12906139
,infarct,2,12906139
,size,2,12906139
,ventricle,2,12906139
,weight,2,12906139
,ratio,1,12906139
,immunohistochemical,1,12906139
,examinations,1,12906139
,weeks,1,12906139
,later,1,12906139
,results,2,12906139
,microvessel,1,12906139
,counts,1,12906139
,less,1,12906139
,conclusions,1,12906139
,administration,1,12906139
,rabbit,1,12906139
,model,1,12906139
,effective,1,12906139
,reduction,1,12906139
,serum,1,12906138
,levels,1,12906138
,vascular,1,12906138
,vascular endothelial growth factor,1,12906138
,endothelial,1,12906138
,endothelial growth factor,1,12906138
,growth,1,12906138
,growth factor,1,12906138
,factor,1,12906138
,patients,1,12906138
,acute,1,12906138
,acute myocardial infarction,1,12906138
,myocardial,1,12906138
,myocardial infarction,1,12906138
,infarction,1,12906138
,objective,1,12906138
,serum,7,12906138
,serum vascular endothelial growth factor,1,12906138
,vascular,1,12906138
,vascular endothelial growth factor,1,12906138
,endothelial,1,12906138
,endothelial growth factor,1,12906138
,growth,1,12906138
,growth factor,1,12906138
,factor,1,12906138
,vegf,8,12906138
,concentrations,6,12906138
,several,1,12906138
,coronary,1,12906138
,coronary heart disease,1,12906138
,heart,1,12906138
,heart disease,1,12906138
,disease,1,12906138
,patients,6,12906138
,materials,1,12906138
,methods,1,12906138
,immunosorbent,1,12906138
,assay,1,12906138
,elisa,1,12906138
,venous,1,12906138
,venous blood,1,12906138
,blood,1,12906138
,stable,1,12906138
,stable angina,1,12906138
,stable angina pectoris,1,12906138
,angina,2,12906138
,angina pectoris,2,12906138
,sap,3,12906138
,unstable,1,12906138
,unstable angina,1,12906138
,unstable angina pectoris,1,12906138
,acute,1,12906138
,acute myocardial infarction,1,12906138
,myocardial,1,12906138
,myocardial infarction,1,12906138
,infarction,1,12906138
,ami,4,12906138
,thrombolytic,3,12906138
,thrombolytic therapy,3,12906138
,therapy,3,12906138
,age,1,12906138
,healthy,1,12906138
,healthy volunteers,1,12906138
,volunteers,1,12906138
,controls,1,12906138
,results,1,12906138
,control,3,12906138
,subjects,3,12906138
,differences,1,12906138
,not,1,12906138
,statistical,1,12906138
,statistical significance,1,12906138
,significance,1,12906138
,significantly,1,12906138
,synchronous,1,12906138
,serum creatine,1,12906138
,creatine,1,12906138
,creatine kinase,1,12906138
,kinase,1,12906138
,isoenzyme,1,12906138
,contents,1,12906138
,hours,1,12906138
,thrombolysis,1,12906138
,conclusion,1,12906138
,present,1,12906138
,study,1,12906138
,serum concentrations,1,12906138
,markedly,1,12906138
,elevated,1,12906138
,levels,1,12906138
,most,1,12906138
,sensitive,1,12906138
,indexes,1,12906138
,reperfusion,1,12906138
,dynamic,1,12903774
,changes,1,12903774
,serum,1,12903774
,serum vascular endothelial growth factor,1,12903774
,vascular,1,12903774
,vascular endothelial growth factor,1,12903774
,vascular endothelial growth factor levels,1,12903774
,endothelial,1,12903774
,endothelial growth factor,1,12903774
,growth,1,12903774
,growth factor,1,12903774
,factor,1,12903774
,levels,1,12903774
,rat,1,12903774
,myocardial,1,12903774
,myocardial infarction,1,12903774
,infarction,1,12903774
,model,1,12903774
,objective,1,12903774
,dynamic,1,12903774
,changes,1,12903774
,serum,6,12903774
,serum vascular endothelial growth factor,1,12903774
,vascular,1,12903774
,vascular endothelial growth factor,1,12903774
,endothelial,1,12903774
,endothelial growth factor,1,12903774
,growth,1,12903774
,growth factor,1,12903774
,factor,1,12903774
,vegf,7,12903774
,levels,2,12903774
,rat,2,12903774
,model,2,12903774
,acute,2,12903774
,acute myocardial infarction,2,12903774
,myocardial,5,12903774
,myocardial infarction,5,12903774
,infarction,5,12903774
,materials,1,12903774
,methods,1,12903774
,adult,1,12903774
,male,1,12903774
,rats,3,12903774
,approximately,1,12903774
,study,2,12903774
,coronary,2,12903774
,coronary artery,2,12903774
,artery,2,12903774
,artery ligation,1,12903774
,ligation,3,12903774
,different,1,12903774
,duration,1,12903774
,infarct,1,12903774
,animals,4,12903774
,surgically,1,12903774
,controls,3,12903774
,blood,1,12903774
,blood samples,1,12903774
,samples,1,12903774
,right,1,12903774
,right atrium,1,12903774
,atrium,1,12903774
,sham,4,12903774
,concentrations,1,12903774
,sensitive,1,12903774
,assay,1,12903774
,rabbit,1,12903774
,polyclonal antibody,1,12903774
,antibody,1,12903774
,antibody specific,1,12903774
,specific,1,12903774
,results,1,12903774
,control,1,12903774
,control animals,1,12903774
,mean,1,12903774
,concentration,1,12903774
,hours,1,12903774
,level,3,12903774
,significantly,2,12903774
,peak,1,12903774
,then,1,12903774
,weeks,1,12903774
,conclusion,1,12903774
,present,1,12903774
,markedly,1,12903774
,role,1,12903774
,angiogenesis,1,12903774
,dobutamine,1,12899396
,magnetic,1,12899396
,magnetic resonance,1,12899396
,magnetic resonance imaging,1,12899396
,resonance,1,12899396
,imaging,1,12899396
,contractile,1,12899396
,reserve,1,12899396
,dysfunctional,1,12899396
,myocardium,1,12899396
,comparison,1,12899396
,fluorodeoxyglucose,1,12899396
,fluorodeoxyglucose positron emission tomography,1,12899396
,positron,1,12899396
,positron emission tomography,1,12899396
,emission,1,12899396
,tomography,1,12899396
,objective,1,12899396
,study,1,12899396
,residual,1,12899396
,myocardial,3,12899396
,viability,1,12899396
,patients,3,12899396
,chronic,2,12899396
,myocardial infarction,2,12899396
,infarction,2,12899396
,ventricular,2,12899396
,ventricular dysfunction,2,12899396
,dysfunction,2,12899396
,methods,1,12899396
,eleven,1,12899396
,identification,1,12899396
,viable,2,12899396
,myocardium,1,12899396
,dobutamine,2,12899396
,infusion,1,12899396
,coronary,1,12899396
,coronary angiography,1,12899396
,angiography,1,12899396
,ventriculography,1,12899396
,mri,1,12899396
,rest,3,12899396
,stress,2,12899396
,systolic,3,12899396
,wall,3,12899396
,thickening,3,12899396
,results,2,12899396
,significant,1,12899396
,difference,1,12899396
,contractile,2,12899396
,reserve,2,12899396
,present,1,12899396
,scar,1,12899396
,regions,2,12899396
,conclusions,1,12899396
,akinesia,1,12899396
,dyskinesia,1,12899396
,stimulation,1,12899396
,clopidogrel,1,12879116
,inhibitor,1,12879116
,platelet,1,12879116
,adp,1,12879116
,adp receptors,1,12879116
,receptors,1,12879116
,platelets,2,12879116
,key,1,12879116
,role,1,12879116
,development,1,12879116
,ischemic,3,12879116
,complications,1,12879116
,arterial,1,12879116
,circulation,1,12879116
,antiplatelet therapy,1,12879116
,therapy,1,12879116
,effective,2,12879116
,treatment,1,12879116
,prevention,1,12879116
,events,1,12879116
,numerous,1,12879116
,clinical,3,12879116
,clinical studies,2,12879116
,studies,2,12879116
,therapeutic,1,12879116
,therapeutic efficacy,1,12879116
,efficacy,1,12879116
,aspirin,2,12879116
,point,1,12879116
,antiplatelet agent,1,12879116
,agent,1,12879116
,gold,1,12879116
,gold standard,1,12879116
,standard,1,12879116
,practice,1,12879116
,clopidogrel,3,12879116
,thienopyridine,1,12879116
,compound,1,12879116
,platelet,1,12879116
,platelet aggregation,1,12879116
,aggregation,1,12879116
,binding,1,12879116
,adp,2,12879116
,adp receptors,2,12879116
,receptors,2,12879116
,results,1,12879116
,large,1,12879116
,randomized,1,12879116
,study,1,12879116
,administration,1,12879116
,patients,1,12879116
,atherosclerotic,1,12879116
,atherosclerotic vascular disease,1,12879116
,vascular,2,12879116
,vascular disease,1,12879116
,disease,1,12879116
,more,1,12879116
,risk,1,12879116
,ischemic stroke,1,12879116
,stroke,1,12879116
,myocardial,1,12879116
,myocardial infarction,1,12879116
,infarction,1,12879116
,death,1,12879116
,present,1,12879116
,article,1,12879116
,activation,1,12879116
,pharmacology,1,12879116
,inhibitor,1,12879116
,mechanisms,1,12879116
,serial,1,12876825
,troponin,1,12876825
,measurements,1,12876825
,recurrent,1,12876825
,recurrent myocardial infarction,1,12876825
,myocardial,2,12876825
,myocardial infarction,2,12876825
,infarction,2,12876825
,initial,1,12876825
,acute,1,12876825
,acute myocardial infarction,1,12876825
,serial,1,12876825
,serum,1,12876825
,serum troponin,1,12876825
,troponin,2,12876825
,ckmb,2,12876825
,measurements,1,12876825
,patients,5,12876825
,emergency,1,12876825
,emergency department,1,12876825
,department,1,12876825
,diagnosis,1,12876825
,acute,1,12876825
,acute myocardial infarction,1,12876825
,myocardial,2,12876825
,myocardial infarction,2,12876825
,infarction,3,12876825
,ami,4,12876825
,patient,2,12876825
,normalized,1,12876825
,percentage,1,12876825
,maximum,2,12876825
,concentration,1,12876825
,time,2,12876825
,value,2,12876825
,kinetic,2,12876825
,decay,1,12876825
,linear,3,12876825
,correlation,3,12876825
,uncomplicated,1,12876825
,coefficients,2,12876825
,recurrent,1,12876825
,recurrent myocardial infarction,1,12876825
,clinical,1,12876825
,clinical findings,1,12876825
,findings,1,12876825
,electrocardiographic,1,12876825
,electrocardiographic abnormalities,1,12876825
,abnormalities,1,12876825
,abnormal,1,12876825
,results,1,12876825
,less,1,12876825
,cutoff,1,12876825
,groups,1,12876825
,completely,1,12876825
,separated,1,12876825
,extension,1,12876825
,accuracy,1,12876825
,sensitivity,1,12876825
,specif,1,12876825
,conclusion,1,12876825
,modeling,1,12876825
,differentiates,1,12876825
,complicated,1,12876825
,courses,1,12876825
,complications,1,12847577
,glycoprotein,1,12847577
,inhibitors,1,12847577
,new,2,12847577
,class,1,12847577
,antiplatelet drugs,1,12847577
,drugs,5,12847577
,inhibitors,4,12847577
,effective,1,12847577
,acute,1,12847577
,acute coronary syndromes,1,12847577
,coronary,3,12847577
,syndromes,1,12847577
,unstable,1,12847577
,unstable angina,1,12847577
,angina,1,12847577
,myocardial,1,12847577
,myocardial infarction,1,12847577
,myocardial infarction as,1,12847577
,infarction,1,12847577
,well,1,12847577
,adjunct therapy,1,12847577
,therapy,3,12847577
,interventions,1,12847577
,morbidity,1,12847577
,mortality,1,12847577
,final,1,12847577
,common,1,12847577
,pathway,1,12847577
,platelet,2,12847577
,platelet activation,1,12847577
,activation,1,12847577
,platelet aggregation,1,12847577
,aggregation,1,12847577
,response,1,12847577
,potential,1,12847577
,bleeding,4,12847577
,concern,1,12847577
,use,2,12847577
,risk,1,12847577
,patients,2,12847577
,combination,1,12847577
,combination drug,1,12847577
,combination drug therapy,1,12847577
,drug,2,12847577
,drug therapy,1,12847577
,heparin,1,12847577
,aspirin,1,12847577
,thienopyridines,1,12847577
,thrombolytics,1,12847577
,oral,2,12847577
,oral anticoagulants,1,12847577
,anticoagulants,1,12847577
,not,1,12847577
,individual,1,12847577
,weight,1,12847577
,basis,1,12847577
,late,1,12847577
,removal,1,12847577
,vascular,1,12847577
,vascular access,1,12847577
,access,1,12847577
,sheaths,1,12847577
,early,1,12847577
,clinical,2,12847577
,clinical trials,2,12847577
,modifications,1,12847577
,patient,1,12847577
,patient management,1,12847577
,management,1,12847577
,data,1,12847577
,more,1,12847577
,recent,1,12847577
,mostly,1,12847577
,intervention,1,12847577
,rate,1,12847577
,group,2,12847577
,placebo,1,12847577
,acceptable,1,12847577
,several,1,12847577
,unresolved,1,12847577
,unresolved issues,1,12847577
,infrequently,1,12847577
,severe,1,12847577
,oral administration,1,12847577
,administration,1,12847577
,challenges,1,12847577
,optimal,1,12847577
,drugdrug interactions,1,12847577
,interactions,1,12847577
,longterm effects,1,12847577
,effects,1,12847577
,monitoring,1,12847577
,better,1,12847577
,titration,1,12847577
,complications,1,12847577
,cardiovascular,1,12847577
,treatment,1,12847577
,time,1,12847577
,value,1,12845757
,quantitative,1,12845757
,analysis,1,12845757
,serum,1,12845757
,ctnt,1,12845757
,diagnosis,1,12845757
,cardiac,1,12845757
,cardiac disease,1,12845757
,disease,1,12845757
,myocardial,1,12845757
,myocardial injury,1,12845757
,injury,1,12845757
,serum,5,12845757
,ctnt,8,12845757
,ckmb,4,12845757
,patients,14,12845757
,ami,3,12845757
,operation,6,12845757
,cardioplegia,2,12845757
,open,1,12845757
,open heart operation,1,12845757
,heart,4,12845757
,heart operation,4,12845757
,thoracotomy,2,12845757
,surgery,2,12845757
,healthy,2,12845757
,people,2,12845757
,concentration,1,12845757
,micrograms/l,3,12845757
,more,1,12845757
,specific,1,12845757
,sensitive,1,12845757
,myocardial,4,12845757
,myocardial injury,4,12845757
,injury,4,12845757
,multiple,1,12845757
,still,1,12845757
,normal,2,12845757
,level,1,12845757
,specificity,1,12845757
,sensitivity,1,12845757
,diagnostic,1,12845757
,period,1,12845757
,assay,1,12845757
,degree,1,12845757
,quantitative,1,12845757
,analysis,1,12845757
,routine,1,12845757
,examination,1,12845757
,diagnosis,1,12845757
,effect,1,12845755
,myosin,1,12845755
,myosin antibody,1,12845755
,antibody,1,12845755
,prognosis,1,12845755
,patients,1,12845755
,acute,1,12845755
,acute myocardial infarction,1,12845755
,myocardial,1,12845755
,myocardial infarction,1,12845755
,infarction,1,12845755
,study,1,12845755
,myosin,1,12845755
,myosin antibody,1,12845755
,antibody,1,12845755
,ama,7,12845755
,serum,2,12845755
,patients,6,12845755
,myocardial,2,12845755
,myocardial infarction,2,12845755
,infarction,3,12845755
,ami,8,12845755
,relationship,1,12845755
,prognosis,3,12845755
,acute,1,12845755
,elisa,1,12845755
,ventricular,4,12845755
,structure,1,12845755
,cardiac,1,12845755
,cardiac function,1,12845755
,function,2,12845755
,echocardiography,1,12845755
,end,1,12845755
,first,1,12845755
,week,1,12845755
,group,6,12845755
,parameters,1,12845755
,left,1,12845755
,groups,2,12845755
,results,1,12845755
,positive,4,12845755
,rate,1,12845755
,negative,3,12845755
,health,1,12845755
,donors,1,12845755
,locations,1,12845755
,similar,1,12845755
,significant,1,12845755
,differences,1,12845755
,class,1,12845755
,wall,1,12845755
,wall motion,1,12845755
,motion,1,12845755
,ventricular aneurysm,1,12845755
,aneurysm,1,12845755
,mortality,1,12845755
,ama negative,1,12845755
,autoimmune,2,12845755
,marker,1,12845755
,autoimmune response,1,12845755
,response,1,12845755
,place,1,12845755
,ventricular remodeling,1,12845755
,remodeling,1,12845755
,effect,1,12845754
,puerarin,1,12845754
,myocardial,1,12845754
,myocardial infarct,1,12845754
,infarct,1,12845754
,area,1,12845754
,dogs,1,12845754
,possible,1,12845754
,mechanism,1,12845754
,effect,1,12845754
,puerarin,5,12845754
,ischemic,2,12845754
,ischemic myocardium,1,12845754
,myocardium,2,12845754
,dogs,3,12845754
,acute,1,12845754
,acute myocardial infarction,1,12845754
,myocardial,2,12845754
,myocardial infarction,1,12845754
,infarction,1,12845754
,ami,5,12845754
,possible,1,12845754
,mechanism,1,12845754
,group,10,12845754
,control,4,12845754
,control group,3,12845754
,model,1,12845754
,saline,1,12845754
,period,1,12845754
,days,2,12845754
,coronary,4,12845754
,coronary angiography,1,12845754
,angiography,2,12845754
,ligation,2,12845754
,coronary artery,2,12845754
,artery,2,12845754
,parameters,1,12845754
,operation,1,12845754
,infarct,3,12845754
,area,3,12845754
,vessel,2,12845754
,density,2,12845754
,smaller,1,12845754
,group c.,1,12845754
,significant,2,12845754
,augmentation,2,12845754
,collateral,2,12845754
,collateral vessels,1,12845754
,vessels,1,12845754
,platelet,2,12845754
,platelet aggregation,2,12845754
,aggregation,2,12845754
,blood,2,12845754
,blood viscosity,2,12845754
,viscosity,2,12845754
,phase,1,12845754
,indexes,1,12845754
,capillaries,1,12845754
,distribution,1,12845754
,zone,1,12845754
,day,1,12845754
,statistically,1,12845754
,statistically significant,1,12845754
,opening,1,12845754
,formation,1,12845754
,coronary collateral circulation,1,12845754
,collateral circulation,1,12845754
,circulation,1,12845754
,increase,1,12845754
,microcirculation,1,12845754
,myocardial infarct,1,12845754
,exchanger,1,12845338
,therapeutic,1,12845338
,target,1,12845338
,cardiovascular,1,12845338
,isoforms,2,12845338
,exchanger,1,12845338
,nhe,5,12845338
,date,1,12845338
,isoform,2,12845338
,plasma,1,12845338
,plasma membrane,1,12845338
,membrane,1,12845338
,cardiomyocytes,1,12845338
,regulation,1,12845338
,intracellular,1,12845338
,cell,1,12845338
,cell volume,1,12845338
,volume,1,12845338
,normal,1,12845338
,physiological,1,12845338
,conditions,1,12845338
,myocardial,2,12845338
,activate,2,12845338
,activation,1,12845338
,injury,3,12845338
,several,3,12845338
,amiloride,1,12845338
,analogs,1,12845338
,ischemiareperfusion injury,2,12845338
,number,1,12845338
,experimental,1,12845338
,experimental models,1,12845338
,models,2,12845338
,infarction,1,12845338
,enzyme,1,12845338
,release,1,12845338
,arrhythmias,1,12845338
,endpoint,1,12845338
,recently,1,12845338
,inhibitors,2,12845338
,effect,2,12845338
,animal,1,12845338
,animal models,1,12845338
,cariporide,1,12845338
,eniporide,1,12845338
,currently,1,12845338
,phase,1,12845338
,phase ii clinical trials,1,12845338
,clinical,1,12845338
,clinical trials,1,12845338
,efficacy,1,12845338
,activity,1,12845338
,lymphocytes,1,12845338
,vascular,1,12845338
,vascular smooth muscle,1,12845338
,smooth,1,12845338
,smooth muscle,1,12845338
,smooth muscle cells,1,12845338
,muscle,1,12845338
,muscle cells,1,12845338
,cells,1,12845338
,spontaneously,1,12845338
,spontaneously hypertensive rats,1,12845338
,hypertensive,2,12845338
,rats,1,12845338
,patients,1,12845338
,further,2,12845338
,research,1,12845338
,role,1,12845338
,pathogenesis,1,12845338
,hypertension,2,12845338
,stimuli,1,12845338
,results,1,12845338
,studies,1,12845338
,cardiac,3,12845338
,animals,1,12845338
,investigations,1,12845338
,out,1,12845338
,involvement,1,12845338
,cardiac hypertrophy,2,12845338
,hypertrophy,2,12845338
,available,1,12845338
,data,1,12845338
,useful,1,12845338
,target,1,12845338
,site,2,12845338
,myocardial ischemia,1,12845338
,ischemia,1,12845338
,novel,1,12845338
,pharmacological,1,12845338
,modulation,1,12845338
,determination,1,12840917
,ckmb,1,12840917
,activity,1,12840917
,protein,1,12840917
,protein concentration,1,12840917
,concentration,1,12840917
,application,1,12840917
,diagnosis,1,12840917
,ami,1,12840917
,activity,2,12840917
,protein,3,12840917
,protein concentration,2,12840917
,concentration,2,12840917
,ckmb,5,12840917
,patients,4,12840917
,ami,3,12840917
,normal,1,12840917
,persons,1,12840917
,peak,3,12840917
,times,1,12840917
,similar,1,12840917
,values,2,12840917
,different,1,12840917
,value,1,12840917
,much,2,12840917
,lower,1,12840917
,measurement,1,12840917
,protein level,1,12840917
,level,1,12840917
,earlier,1,12840917
,clinical,1,12818019
,causes,1,12818019
,death,1,12818019
,persons,1,12818019
,nursing,1,12818019
,nursing home,1,12818019
,home,1,12818019
,objective,1,12818019
,causes,1,12818019
,death,7,12818019
,persons,9,12818019
,nursing,5,12818019
,nursing home,5,12818019
,home,5,12818019
,design,1,12818019
,major,5,12818019
,clinical,1,12818019
,cause,5,12818019
,years,2,12818019
,period,3,12818019
,prospective,1,12818019
,prospective study,1,12818019
,study,1,12818019
,author,1,12818019
,physicians,1,12818019
,care,1,12818019
,either,1,12818019
,transfer,1,12818019
,general,1,12818019
,general hospital,1,12818019
,hospital,1,12818019
,large,1,12818019
,patients,1,12818019
,men,2,12818019
,women,2,12818019
,age,1,12818019
,measurements,1,12818019
,main,1,12818019
,results,1,12818019
,total,1,12818019
,not,1,12818019
,not significant,1,12818019
,significant,1,12818019
,sudden,1,12818019
,sudden cardiac death,1,12818019
,cardiac,1,12818019
,cardiac death,1,12818019
,myocardial,1,12818019
,myocardial infarction,1,12818019
,infarction,2,12818019
,refractory,1,12818019
,congestive,1,12818019
,congestive heart failure,1,12818019
,heart,1,12818019
,heart failure,1,12818019
,failure,3,12818019
,stroke,1,12818019
,cerebral,1,12818019
,cerebral hemorrhage,1,12818019
,hemorrhage,1,12818019
,pulmonary,3,12818019
,pulmonary embolism,1,12818019
,embolism,1,12818019
,mesenteric,1,12818019
,vascular,2,12818019
,surgery,1,12818019
,peripheral,1,12818019
,peripheral vascular disease,1,12818019
,vascular disease,1,12818019
,disease,7,12818019
,aneurysm,2,12818019
,aorta,1,12818019
,abdominal,2,12818019
,abdominal aneurysm,1,12818019
,pneumonia,1,12818019
,urosepsis,1,12818019
,bacterial,1,12818019
,bacterial endocarditis,1,12818019
,endocarditis,1,12818019
,abdominal abscess,1,12818019
,abscess,1,12818019
,gastrointestinal,3,12818019
,biliary,1,12818019
,biliary tract,1,12818019
,tract,1,12818019
,decubiti,1,12818019
,gangrene,1,12818019
,lower,1,12818019
,lower extremity,1,12818019
,extremity,1,12818019
,osteomyelitis,1,12818019
,cancer,2,12818019
,renal,2,12818019
,renal failure,2,12818019
,hematologic,2,12818019
,hematologic disorders,2,12818019
,disorders,2,12818019
,chronic,2,12818019
,chronic obstructive pulmonary disease,2,12818019
,obstructive pulmonary disease,2,12818019
,pulmonary disease,2,12818019
,conclusions,1,12818019
,cardiovascular,1,12818019
,cardiovascular disease,1,12818019
,deaths,7,12818019
,second,1,12818019
,infectious,1,12818019
,infectious disease,1,12818019
,accounting,1,12818019
,seasonal,1,12812610
,seasonal variation,1,12812610
,variation,1,12812610
,deaths,1,12812610
,fatal,1,12812610
,myocardial,1,12812610
,myocardial infarction,1,12812610
,infarction,1,12812610
,primary,1,12812610
,cardiac,2,12812610
,cardiac arrest,1,12812610
,arrest,1,12812610
,sudden,1,12812610
,sudden cardiac death,1,12812610
,cardiac death,1,12812610
,death,1,12812610
,refractory,1,12812610
,congestive,1,12812610
,congestive heart failure,1,12812610
,heart,1,12812610
,heart failure,1,12812610
,failure,1,12812610
,persons,1,12812610
,new,1,12812610
,new york,1,12812610
,new york city,1,12812610
,city,1,12812610
,objective,1,12812610
,seasonal,2,12812610
,seasonal variation,2,12812610
,variation,2,12812610
,cardiac,13,12812610
,cardiac deaths,6,12812610
,deaths,7,12812610
,persons,10,12812610
,nursing,5,12812610
,nursing home,5,12812610
,home,5,12812610
,new,3,12812610
,new york,3,12812610
,new york city,3,12812610
,city,3,12812610
,design,1,12812610
,prospective,1,12812610
,prospective study,1,12812610
,study,1,12812610
,major,2,12812610
,clinical,1,12812610
,cause,2,12812610
,death,6,12812610
,years,2,12812610
,period,4,12812610
,author,1,12812610
,physicians,1,12812610
,care,1,12812610
,transfer,1,12812610
,general,1,12812610
,general hospital,1,12812610
,hospital,1,12812610
,fatal,3,12812610
,myocardial,3,12812610
,myocardial infarction,3,12812610
,infarction,3,12812610
,primary,3,12812610
,cardiac arrest,3,12812610
,arrest,3,12812610
,sudden,3,12812610
,sudden cardiac death,3,12812610
,cardiac death,3,12812610
,refractory,3,12812610
,congestive,3,12812610
,congestive heart failure,3,12812610
,heart,3,12812610
,heart failure,3,12812610
,failure,3,12812610
,large,1,12812610
,patients,1,12812610
,causes,1,12812610
,men,1,12812610
,women,1,12812610
,age,1,12812610
,time,1,12812610
,measurements,1,12812610
,main,1,12812610
,results,1,12812610
,december,3,12812610
,march,3,12812610
,april,1,12812610
,july,1,12812610
,august,1,12812610
,november,1,12812610
,frequency,2,12812610
,significantly,2,12812610
,greater,2,12812610
,incidence,2,12812610
,times,2,12812610
,average,2,12812610
,other,2,12812610
,periods,2,12812610
,conclusion,1,12812610
,panniculectomy,1,12774339
,obese,1,12774339
,gynecologic,1,12774339
,patients,1,12774339
,background,1,12774339
,clear,1,12774339
,morbid obesity,2,12774339
,obesity,2,12774339
,serious,1,12774339
,risk,1,12774339
,women,3,12774339
,major,4,12774339
,intraabdominal,4,12774339
,gynecologic,5,12774339
,gynecologic surgery,1,12774339
,surgery,4,12774339
,many,1,12774339
,malignancies,1,12774339
,benign,1,12774339
,conditions,2,12774339
,best,1,12774339
,surg,1,12774339
,surgeon,1,12774339
,incision,1,12774339
,adequate,2,12774339
,exposure,3,12774339
,acceptables,1,12774339
,complications,3,12774339
,panniculectomy,6,12774339
,approach,1,12774339
,peritoneal,1,12774339
,peritoneal cavity,1,12774339
,cavity,1,12774339
,increasingly,1,12774339
,recent,1,12774339
,reports,1,12774339
,straightforward,1,12774339
,acceptable,2,12774339
,rate,1,12774339
,not,1,12774339
,cosmetic,1,12774339
,cosmetic procedure,1,12774339
,procedure,1,12774339
,aims,1,12774339
,experience,1,12774339
,obese,2,12774339
,service,1,12774339
,methods,1,12774339
,medical,2,12774339
,medical records,1,12774339
,records,1,12774339
,quetelet index,2,12774339
,index,2,12774339
,large,1,12774339
,dependent,1,12774339
,pannus,1,12774339
,october,1,12774339
,data,1,12774339
,demographics,1,12774339
,concomitant,1,12774339
,operative,3,12774339
,indications,1,12774339
,results,2,12774339
,postoperative,3,12774339
,outcomes,1,12774339
,abstracted,1,12774339
,analysis,1,12774339
,mean,4,12774339
,age,1,12774339
,years,1,12774339
,mean body mass,1,12774339
,body,1,12774339
,body mass,1,12774339
,mass,1,12774339
,height,1,12774339
,time,1,12774339
,min,1,12774339
,estimated,1,12774339
,estimated blood loss,1,12774339
,blood,1,12774339
,blood loss,1,12774339
,loss,1,12774339
,patients,4,12774339
,intraoperative,1,12774339
,urologic,1,12774339
,urologic injuries,1,12774339
,injuries,2,12774339
,sequelae,1,12774339
,bowel,1,12774339
,vascular,1,12774339
,neurologic,1,12774339
,wound,1,12774339
,wound breakdown,1,12774339
,breakdown,1,12774339
,complete,1,12774339
,superficial,1,12774339
,infection,1,12774339
,deep,1,12774339
,deep venous thromboses,1,12774339
,venous,1,12774339
,venous thromboses,1,12774339
,thromboses,1,12774339
,pulmonary,1,12774339
,pulmonary emboli,1,12774339
,fascial,1,12774339
,dehiscences,1,12774339
,postoperative period,1,12774339
,period,1,12774339
,myocardial,1,12774339
,myocardial infarction,1,12774339
,infarction,1,12774339
,day,2,12774339
,sepsis,1,12774339
,conclusions,1,12774339
,risks,2,12774339
,secondary,1,12751013
,splenic,1,12751013
,splenic rupture,1,12751013
,rupture,1,12751013
,thrombolysis,1,12751013
,acute,1,12751013
,acute myocardial infarction,1,12751013
,myocardial,1,12751013
,myocardial infarction,1,12751013
,infarction,1,12751013
,secondary,2,12751013
,splenic,3,12751013
,splenic rupture,3,12751013
,rupture,3,12751013
,thrombolysis,4,12751013
,acute,6,12751013
,acute myocardial infarction,3,12751013
,myocardial,4,12751013
,myocardial infarction,4,12751013
,infarction,4,12751013
,history,2,12751013
,admission,2,12751013
,findings,1,12751013
,male,1,12751013
,male patient,1,12751013
,patient,4,12751013
,acute chest pain,1,12751013
,chest,1,12751013
,chest pain,1,12751013
,pain,1,12751013
,signs,1,12751013
,acute anterior myocardial infarction,1,12751013
,anterior,2,12751013
,anterior myocardial infarction,1,12751013
,ecg,1,12751013
,usual,1,12751013
,contraindications,2,12751013
,systemic,1,12751013
,lysis,1,12751013
,well,1,12751013
,symptoms,1,12751013
,completely,1,12751013
,hours,1,12751013
,later,2,12751013
,acute abdomen,1,12751013
,abdomen,1,12751013
,severe,1,12751013
,circulatory,1,12751013
,circulatory shock,1,12751013
,shock,1,12751013
,investigations,1,12751013
,ultrasound,1,12751013
,massive,1,12751013
,intraabdominal,1,12751013
,bleeding,1,12751013
,treatment,1,12751013
,course,1,12751013
,emergency,1,12751013
,laparotomy,1,12751013
,retro,1,12751013
,weeks,2,12751013
,ladder,1,12751013
,his,1,12751013
,left,1,12751013
,left side,1,12751013
,side,1,12751013
,rare,1,12751013
,case,2,12751013
,vessel,1,12751013
,disease,1,12751013
,angioplasty,1,12751013
,ramus,1,12751013
,stable,1,12751013
,conclusions,1,12751013
,intravenous,1,12751013
,method,1,12751013
,choice,1,12751013
,past,1,12751013
,great,1,12751013
,number,1,12751013
,patients,2,12751013
,extensive,1,12751013
,interpretation,1,12751013
,aim,1,12751013
,alteration,1,12751013
,use,1,12751013
,not,1,12751013
,health,1,12751013
,insufficient,1,12751013
,morning,1,12749780
,sudden,1,12749780
,sudden cardiac death,1,12749780
,cardiac,1,12749780
,cardiac death,1,12749780
,death,1,12749780
,variation,1,12749780
,cardiac,3,12749780
,cardiac function,1,12749780
,function,1,12749780
,peak,1,12749780
,early,2,12749780
,morning,5,12749780
,years,1,12749780
,ago,1,12749780
,circadian rhythm,1,12749780
,rhythm,1,12749780
,platelet,2,12749780
,same,1,12749780
,time,1,12749780
,day,1,12749780
,healthy,1,12749780
,young,1,12749780
,male,1,12749780
,subjects,2,12749780
,hours,2,12749780
,sympathetic nervous system,1,12749780
,nervous,1,12749780
,nervous system,1,12749780
,system,1,12749780
,activity,1,12749780
,heart,1,12749780
,heart rate,1,12749780
,rate,1,12749780
,ability,1,12749780
,abrupt,1,12749780
,rise,1,12749780
,blood,1,12749780
,blood pressure,1,12749780
,pressure,1,12749780
,trigger,1,12749780
,factors,2,12749780
,high,2,12749780
,incidence,1,12749780
,sudden,3,12749780
,sudden cardiac death,2,12749780
,cardiac death,2,12749780
,death,3,12749780
,primary,1,12749780
,primary prevention,1,12749780
,prevention,2,12749780
,sudden death,1,12749780
,patients,1,12749780
,cardiovascular,2,12749780
,risk,2,12749780
,many,1,12749780
,strategies,1,12749780
,implantable,1,12749780
,implantable cardioverterdefibrillators,1,12749780
,antiarrhythmic,1,12749780
,antihypertensive,1,12749780
,antihypertensive therapies,1,12749780
,therapies,1,12749780
,more,1,12749780
,recently,1,12749780
,aspirin,2,12749780
,cardiovascular risk factors,1,12749780
,risk factors,1,12749780
,continuous,1,12749780
,administration,1,12749780
,platelet aggregation,1,12749780
,aggregation,1,12749780
,formation,1,12749780
,effective,1,12749780
,therapy,1,12749780
,myocardial,1,12749780
,myocardial infarction,1,12749780
,infarction,1,12749780
,evaluation,1,12689473
,traffic,1,12689473
,cardiovascular,1,12689473
,risk,1,12689473
,paper,1,12689473
,risk,13,12689473
,myocardial,2,12689473
,myocardial infarction,2,12689473
,infarction,3,12689473
,traffic,1,12689473
,noise,4,12689473
,conceptual,1,12689473
,risk assessment,2,12689473
,assessment,3,12689473
,national,1,12689473
,national research council,1,12689473
,research,2,12689473
,council,1,12689473
,cardiovascular,2,12689473
,set,1,12689473
,evaluation,3,12689473
,evaluation criteria,1,12689473
,criteria,2,12689473
,severity,1,12689473
,health,6,12689473
,effect,2,12689473
,frequency,1,12689473
,exposures,1,12689473
,relevant,2,12689473
,size,1,12689473
,validity,2,12689473
,quantification,1,12689473
,calculated,1,12689473
,lifetime risks,1,12689473
,risks,1,12689473
,standard,1,12689473
,methods,1,12689473
,quantitative,1,12689473
,cancer,2,12689473
,cancer risk,1,12689473
,estimation,1,12689473
,international,1,12689473
,international agency,1,12689473
,agency,1,12689473
,classification,1,12689473
,epidemiological,1,12689473
,evidence,1,12689473
,other,3,12689473
,adverse effects,1,12689473
,effects,1,12689473
,regulatory,1,12689473
,toxicology,1,12689473
,severe,1,12689473
,sound,1,12689473
,sound pressure levels,1,12689473
,pressure,1,12689473
,levels,3,12689473
,major,1,12689473
,portion,1,12689473
,german,1,12689473
,german population,1,12689473
,population,1,12689473
,noise levels,1,12689473
,lifetime risk,2,12689473
,environmental,1,12689473
,environmental hazards,1,12689473
,hazards,1,12689473
,contexts,1,12689473
,association,1,12689473
,noise exposure,2,12689473
,exposure,2,12689473
,chance,1,12689473
,bias,1,12689473
,out,1,12689473
,confidence,1,12689473
,methodological quality,1,12689473
,quality,1,12689473
,studies,1,12689473
,consistency,1,12689473
,findings,1,12689473
,relations,1,12689473
,recent,1,12689473
,occupational,1,12689473
,study,1,12689473
,biological,1,12689473
,interpretation,1,12689473
,available,1,12689473
,information,1,12689473
,conclusion,1,12689473
,probable,1,12689473
,conclusions,1,12689473
,regulation,1,12689473
,high,1,12689473
,high risk,1,12689473
,potential,1,12689473
,uncertain,1,12689473
,causality,1,12689473
,question,1,12689473
,science,1,12689473
,public,1,12689473
,public health,1,12689473
,order,1,12689473
,human,1,12689473
,redox,1,12687197
,regulation,1,12687197
,neutrophils,1,12687197
,monocytes,1,12687197
,different,1,12687197
,types,1,12687197
,myocardial,1,12687197
,myocardial infarction,1,12687197
,infarction,1,12687197
,common,1,12687197
,aspect,1,12687197
,mechanism,1,12687197
,occurrence,1,12687197
,myocardial,5,12687197
,myocardial infarction,5,12687197
,infarction,7,12687197
,presence,2,12687197
,absence,2,12687197
,pathologic,1,12687197
,electrocardiogram,1,12687197
,systemic,1,12687197
,inflammatory,1,12687197
,process,2,12687197
,involvement,1,12687197
,activated,2,12687197
,neutrophils,3,12687197
,monocytes,3,12687197
,oxygen,2,12687197
,oxygen radical,1,12687197
,radical,1,12687197
,production,3,12687197
,damage,2,12687197
,endothelial,1,12687197
,endothelial cells,1,12687197
,cells,1,12687197
,cardiomyocyte,2,12687197
,lipid,3,12687197
,membranes,1,12687197
,redox,3,12687197
,regulation,1,12687197
,study,1,12687197
,patients,5,12687197
,means,1,12687197
,test,1,12687197
,significant,2,12687197
,increase,1,12687197
,phagocyte,1,12687197
,functional,2,12687197
,activity,1,12687197
,parameters,1,12687197
,neutrophil,4,12687197
,hydrogen,1,12687197
,hydrogen peroxide,1,12687197
,peroxide,1,12687197
,acid,1,12687197
,prevalence,1,12687197
,lipid peroxidation,2,12687197
,peroxidation,2,12687197
,cardiomyocytes,1,12687197
,destruction,1,12687197
,metabolism,2,12687197
,activation,2,12687197
,difference,2,12687197
,superoxide,2,12687197
,plasma,2,12687197
,superoxide dismutase,1,12687197
,types,2,12687197
,not,1,12687197
,only,1,12687197
,sufficient,1,12687197
,reserve,2,12687197
,membrane,1,12687197
,additional,1,12687197
,source,1,12687197
,active,1,12687197
,active oxygen,1,12687197
,forms,1,12687197
,probably,1,12687197
,reaction,1,12687197
,protease,1,12687197
,participation,1,12687197
,more,1,12687197
,chemiluminescence,1,12687197
,index,1,12687197
,exhaustion,1,12687197
,potential,1,12687197
,decrease,1,12687197
,antioxidant,1,12687197
,conditions,1,12687197
,heterogeneity,1,12687197
,mechanisms,1,12687197
,ischemic,1,12687197
,ischemic heart disease,1,12687197
,heart,1,12687197
,heart disease,1,12687197
,disease,1,12687197
,disease aggravation,1,12687197
,periodontal,1,12666980
,medicine,1,12666980
,concepts,1,12666980
,pregnancy,1,12666980
,term,1,12666980
,periodontal,5,12666980
,medicine,1,12666980
,study,1,12666980
,contribution,1,12666980
,periodontal infections,1,12666980
,infections,1,12666980
,several,2,12666980
,systemic,4,12666980
,conditions,3,12666980
,atherosclerosis,1,12666980
,myocardial,1,12666980
,myocardial infarction,1,12666980
,infarction,1,12666980
,diabetes,1,12666980
,premature,2,12666980
,premature delivery,1,12666980
,delivery,1,12666980
,early,1,12666980
,reports,1,12666980
,linkage,1,12666980
,periodontitis,3,12666980
,further,1,12666980
,support,1,12666980
,additional,1,12666980
,epidemiological,1,12666980
,epidemiological studies,1,12666980
,studies,1,12666980
,evidence,1,12666980
,maternal,1,12666980
,risk,2,12666980
,risk factor,1,12666980
,factor,1,12666980
,risk indicator,1,12666980
,indicator,1,12666980
,pregnancies,1,12666980
,low,1,12666980
,low birthweight,1,12666980
,birthweight,1,12666980
,potential,2,12666980
,mechanisms,2,12666980
,infectious,2,12666980
,challenge,2,12666980
,origin,1,12666980
,inflammation,1,12666980
,modifier,1,12666980
,parturition,1,12666980
,preliminary,1,12666980
,data,1,12666980
,model,2,12666980
,pathogens,1,12666980
,mother,1,12666980
,gain,1,12666980
,access,1,12666980
,compartment,1,12666980
,aspects,1,12666980
,only,1,12666980
,clarification,1,12666980
,pathogenesis,1,12666980
,accurate,1,12666980
,diagnoses,1,12666980
,successful,1,12666980
,therapies,1,12666980
,concept,1,12666980
,patient,1,12666980
,effects,1,12666980
,chronic,1,12666980
,chronic infectious,1,12666980
,inflammatory,1,12666980
,condition,1,12666980
,profession,1,12666980
,effect,1,12557918
,abana,1,12557918
,formulation,1,12557918
,lipid,1,12557918
,lipid peroxidation,1,12557918
,peroxidation,1,12557918
,experimental,1,12557918
,myocardial,1,12557918
,myocardial infarction,1,12557918
,infarction,1,12557918
,rats,1,12557918
,present,1,12557918
,study,1,12557918
,antioxidant,3,12557918
,role,1,12557918
,formulation,2,12557918
,abana,2,12557918
,isoproterenol,4,12557918
,myocardial,4,12557918
,myocardial infarction,2,12557918
,infarction,2,12557918
,rats,1,12557918
,myocardial necrosis,2,12557918
,necrosis,2,12557918
,significant,3,12557918
,increase,2,12557918
,serum,1,12557918
,serum iron,1,12557918
,iron,2,12557918
,content,1,12557918
,decrease,1,12557918
,plasma,1,12557918
,plasma iron,1,12557918
,iron binding,1,12557918
,iron binding capacity,1,12557918
,binding,1,12557918
,binding capacity,1,12557918
,capacity,1,12557918
,ceruloplasmin,1,12557918
,ceruloplasmin activity,1,12557918
,activity,1,12557918
,glutathione,3,12557918
,glutathione level,1,12557918
,level,1,12557918
,lipid,2,12557918
,lipid peroxides,1,12557918
,peroxides,1,12557918
,levels,1,12557918
,administration,1,12557918
,activities,1,12557918
,enzymes,1,12557918
,superoxide,1,12557918
,superoxide dismutase,1,12557918
,catalase,1,12557918
,glutathione peroxidase,1,12557918
,peroxidase,1,12557918
,glutathione reductase,1,12557918
,reductase,1,12557918
,significantly,1,12557918
,heart,1,12557918
,marked,1,12557918
,reversal,1,12557918
,metabolic,1,12557918
,changes,1,12557918
,conclusion,1,12557918
,effect,1,12557918
,lipid peroxidation,1,12557918
,peroxidation,1,12557918
,enzyme,1,12557918
,systems,1,12557918
,myocardial,1,12555432
,acute,1,12555432
,cardiomyopathy,1,12555432
,coronary,1,12555432
,coronary spasm,1,12555432
,spasm,1,12555432
,well,1,12555432
,pheochromocytoma,2,12555432
,excess,1,12555432
,catecholamines,1,12555432
,responsible,1,12555432
,development,1,12555432
,acute,4,12555432
,acute myopathy,1,12555432
,myopathy,1,12555432
,rare,2,12555432
,cases,2,12555432
,similar,2,12555432
,cardiac,1,12555432
,incident,1,12555432
,intense,3,12555432
,intense emotional,2,12555432
,emotional,2,12555432
,emotional stress,2,12555432
,stress,3,12555432
,study,1,12555432
,case,2,12555432
,old,1,12555432
,female,1,12555432
,history,1,12555432
,cardiovascular,1,12555432
,cardiovascular disorder,1,12555432
,disorder,1,12555432
,prolonged,1,12555432
,chest,2,12555432
,chest pain,1,12555432
,pain,1,12555432
,acute coronary syndrome,1,12555432
,coronary,2,12555432
,syndrome,1,12555432
,immediately,1,12555432
,major,1,12555432
,psychological,1,12555432
,psychological stress,1,12555432
,admission,2,12555432
,electrocardiogram,1,12555432
,sharp,1,12555432
,decrease,1,12555432
,amplitude,1,12555432
,right,1,12555432
,right chest,1,12555432
,extended,1,12555432
,qt interval,1,12555432
,interval,1,12555432
,ischemia,1,12555432
,lower,1,12555432
,leads,1,12555432
,few,1,12555432
,days,1,12555432
,electrical,1,12555432
,signs,3,12555432
,akinesia,1,12555432
,initially,1,12555432
,echocardiography,1,12555432
,completely,1,12555432
,clinical,3,12555432
,clinical examination,1,12555432
,examination,1,12555432
,out,1,12555432
,diagnosis,1,12555432
,myocardial,1,12555432
,myocardial necrosis,1,12555432
,necrosis,1,12555432
,acute myocarditis,1,12555432
,myocarditis,1,12555432
,direct,1,12555432
,evidence,1,12555432
,coronary spasm,1,12555432
,spasm,1,12555432
,outcome,1,12555432
,positive,1,12555432
,complete,1,12555432
,reversibility,1,12555432
,clinical signs,2,12555432
,organic,1,12555432
,sequelae,1,12555432
,probably,1,12555432
,cardiomyopathy,1,12555432
,occurrence,1,12555432
,account,1,12555432
,occlusion,1,12555431
,main,1,12555431
,coronary,1,12555431
,coronary artery,1,12555431
,artery,1,12555431
,angioplasty,1,12555431
,occlusion,3,12555431
,main,3,12555431
,coronary,4,12555431
,coronary artery,4,12555431
,artery,4,12555431
,rare,1,12555431
,fatal,1,12555431
,subjects,1,12555431
,conditions,1,12555431
,survival,2,12555431
,dominant,1,12555431
,right,1,12555431
,right coronary artery,1,12555431
,all,1,12555431
,rapidly,1,12555431
,functional,2,12555431
,time,2,12555431
,introduction,1,12555431
,efficient,1,12555431
,collateral,1,12555431
,system,1,12555431
,patient,2,12555431
,long,1,12555431
,risk,1,12555431
,myocardial,1,12555431
,myocardial infarction,1,12555431
,infarction,1,12555431
,often,1,12555431
,cardiogenic,1,12555431
,cardiogenic shock,1,12555431
,shock,1,12555431
,poor,1,12555431
,poor prognosis,1,12555431
,prognosis,1,12555431
,study,1,12555431
,case,1,12555431
,left,2,12555431
,left main coronary artery,2,12555431
,coronary artery occlusion,1,12555431
,artery occlusion,1,12555431
,unstable,1,12555431
,increase,1,12555431
,levels,1,12555431
,angioplasty,2,12555431
,successfully,1,12555431
,short,1,12555431
,results,1,12555431
,coronary artery angioplasty,1,12555431
,artery angioplasty,1,12555431
,ventricular,1,12555344
,late,1,12555344
,potentials,1,12555344
,myocardial,1,12555344
,myocardial infarction,1,12555344
,infarction,1,12555344
,comparison,1,12555344
,thrombolysis,1,12555344
,primary,1,12555344
,angioplasty,1,12555344
,conventional,1,12555344
,conventional treatment,1,12555344
,treatment,1,12555344
,objectives,1,12555344
,aim,1,12555344
,study,2,12555344
,prevalence,4,12555344
,ventricular,1,12555344
,late,2,12555344
,potentials,2,12555344
,vlp,5,12555344
,acute,1,12555344
,acute phase,1,12555344
,phase,1,12555344
,myocardial,3,12555344
,myocardial infarction,2,12555344
,infarction,2,12555344
,treatment,4,12555344
,methods,1,12555344
,results,1,12555344
,retrospective,1,12555344
,retrospective study,1,12555344
,out,1,12555344
,period,1,12555344
,january,1,12555344
,involved,1,12555344
,patients,1,12555344
,primary,2,12555344
,less,1,12555344
,hours,2,12555344
,onset,2,12555344
,symptoms,2,12555344
,intravenous,1,12555344
,tpa,2,12555344
,angioplasty,3,12555344
,cases,1,12555344
,standard,2,12555344
,heparin,1,12555344
,perfusion,2,12555344
,effective,1,12555344
,following,2,12555344
,criteria,2,12555344
,simultaneously,1,12555344
,present,2,12555344
,pain,1,12555344
,sedation,1,12555344
,regression,1,12555344
,dysfunction,2,12555344
,iii,1,12555344
,creatine,1,12555344
,creatine phosphokinase,1,12555344
,phosphokinase,1,12555344
,cpk,1,12555344
,peak,1,12555344
,hour,1,12555344
,treatment success,1,12555344
,success,1,12555344
,thrombolysis,3,12555344
,score,1,12555344
,arterial,1,12555344
,arterial perfusion,1,12555344
,residual,1,12555344
,stenosis,1,12555344
,artery,1,12555344
,day,1,12555344
,total,1,12555344
,duration,1,12555344
,signal,1,12555344
,signal amplitude,1,12555344
,amplitude,1,12555344
,last,1,12555344
,terminal,1,12555344
,part,1,12555344
,group,4,12555344
,reperfusion,3,12555344
,subgroup,2,12555344
,incidence,1,12555344
,conclusions,1,12555344
,significantly,1,12555344
,case,1,12555344
,observed,1,12555344
,possible,1,12555344
,explanations,1,12555344
,abnormally high,1,12555344
,high,1,12555344
,high prevalence,1,12555344
,reocclusion,1,12555344
,initially,1,12555344
,successful,1,12555344
,myocardial reperfusion,1,12555344
,reperfusion therapy,1,12555344
,therapy,1,12555344
,heart,1,12555318
,heart failure,1,12555318
,failure,1,12555318
,role,1,12555318
,various,1,12555318
,circulation,1,12555318
,assistance,1,12555318
,techniques,1,12555318
,currently,1,12555318
,main,1,12555318
,types,2,12555318
,cardiac,1,12555318
,cardiac assist devices,1,12555318
,assist,4,12555318
,devices,6,12555318
,centrifugal,2,12555318
,centrifugal pumps,2,12555318
,pumps,2,12555318
,implantable,1,12555318
,ventricular,1,12555318
,ventricular assist devices,1,12555318
,total,1,12555318
,total artificial heart,1,12555318
,artificial,1,12555318
,artificial heart,1,12555318
,heart,2,12555318
,efficacy,1,12555318
,limited,1,12555318
,other,1,12555318
,now,1,12555318
,choice,1,12555318
,various,1,12555318
,severity,1,12555318
,heart failure,1,12555318
,failure,1,12555318
,time,1,12555318
,implantation,2,12555318
,biventricular,1,12555318
,disease,1,12555318
,potential,1,12555318
,recovery,1,12555318
,patients,1,12555318
,morphology,1,12555318
,device,1,12555318
,available,1,12555318
,team,1,12555318
,results,1,12555318
,early,1,12555318
,immunohistochemical,1,12536966
,study,1,12536966
,basic,1,12536966
,basic fibroblast growth factor,1,12536966
,fibroblast,1,12536966
,fibroblast growth factor,1,12536966
,growth,1,12536966
,growth factor,1,12536966
,factor,1,12536966
,early,1,12536966
,myocardial,1,12536966
,myocardial infarction,1,12536966
,infarction,1,12536966
,expression,1,12536966
,basic,1,12536966
,basic fibroblast growth factor,1,12536966
,fibroblast,1,12536966
,fibroblast growth factor,1,12536966
,growth,1,12536966
,growth factor,1,12536966
,factor,1,12536966
,first,1,12536966
,cases,3,12536966
,early,2,12536966
,myocardial,2,12536966
,myocardial infarction,2,12536966
,infarction,3,12536966
,results,1,12536966
,proven,1,12536966
,infarcts,5,12536966
,positive,5,12536966
,nuclei,2,12536966
,myocardium,3,12536966
,vascular,2,12536966
,vascular endothelium,2,12536966
,endothelium,2,12536966
,cytoplasm,1,12536966
,border,1,12536966
,zone,1,12536966
,strong,1,12536966
,strong positive,1,12536966
,mild,2,12536966
,control,2,12536966
,control group,2,12536966
,group,2,12536966
,samples,1,12536966
,only,1,12536966
,significantly,1,12536966
,lower,1,12536966
,significant,1,12536966
,difference,1,12536966
,findings,1,12536966
,method,1,12536966
,morphologic,1,12536966
,morphologic diagnosis,1,12536966
,diagnosis,1,12536966
,sudden,1,12536966
,sudden cardiac death,1,12536966
,cardiac,1,12536966
,cardiac death,1,12536966
,death,1,12536966
,expression,1,12536423
,bax,1,12536423
,bax protein,1,12536423
,protein,1,12536423
,human,1,12536423
,inhibitor,1,12536423
,accelerator,1,12536423
,apoptosis,1,12536423
,general,1,12536423
,myocyte,1,12536423
,death,1,12536423
,myocardial,1,12536423
,myocardial infarctions,1,12536423
,infarctions,1,12536423
,necrosis,1,12536423
,recently,1,12536423
,involvement,1,12536423
,apoptosis,2,12536423
,loss,1,12536423
,myocytes,3,12536423
,mechanism,1,12536423
,development,1,12536423
,cardiac,1,12536423
,cardiac failure,1,12536423
,failure,1,12536423
,ischemic,1,12536423
,origin,1,12536423
,expression,1,12536423
,protooncogenes,1,12536423
,positive,2,12536423
,immunoreactivity,2,12536423
,heart,1,12536423
,acute,1,12536423
,acute mi,1,12536423
,only,1,12536423
,areas,2,12536423
,infarcted,1,12536423
,tissues,1,12536423
,overexpressed,1,12536423
,bax,1,12536423
,salvaged,1,12536423
,old,1,12536423
,immunohistochemical,1,12536421
,studies,1,12536421
,vascular,1,12536421
,vascular endothelial growth factor,1,12536421
,endothelial,1,12536421
,endothelial growth factor,1,12536421
,growth,1,12536421
,growth factor,1,12536421
,factor,1,12536421
,vegf,1,12536421
,postmortem,1,12536421
,postmortem diagnosis,1,12536421
,diagnosis,1,12536421
,sudden,1,12536421
,coronary,1,12536421
,death,1,12536421
,expression,4,12536421
,vegf,3,12536421
,myocardium,3,12536421
,heart,2,12536421
,sudden,1,12536421
,coronary,1,12536421
,death,1,12536421
,scd,4,12536421
,control,3,12536421
,control group,3,12536421
,group,4,12536421
,quantitatively,1,12536421
,immunohistochemistry,1,12536421
,method,1,12536421
,image,3,12536421
,image analysis,3,12536421
,analysis,3,12536421
,statistical,3,12536421
,process,3,12536421
,results,2,12536421
,local,2,12536421
,infarcted,1,12536421
,strong,1,12536421
,strong positive,1,12536421
,positive,4,12536421
,area,1,12536421
,rate,1,12536421
,only,1,12536421
,mild,1,12536421
,index,1,12536421
,significant,1,12536421
,difference,1,12536421
,groups,1,12536421
,immunohistochemical,1,12536421
,immunohistochemical staining,1,12536421
,staining,1,12536421
,objective,1,12536421
,marker,1,12536421
,postmortem,1,12536421
,postmortem diagnosis,1,12536421
,diagnosis,1,12536421
,methodological study,1,12515154
,study,1,12515154
,preparation,1,12515154
,novel,1,12515154
,myocardial,1,12515154
,myocardial perfusion,1,12515154
,myocardial perfusion imaging,1,12515154
,perfusion,1,12515154
,perfusion imaging,1,12515154
,imaging,1,12515154
,imaging agent,1,12515154
,agent,1,12515154
,study,2,12515154
,methods,1,12515154
,bis,1,12515154
,tris,1,12515154
,phosphine,1,12515154
,myocardial,3,12515154
,myocardial perfusion,2,12515154
,perfusion,2,12515154
,agent,2,12515154
,optimum,3,12515154
,scheme,3,12515154
,technetium,1,12515154
,labeling,2,12515154
,basis,2,12515154
,effects,1,12515154
,conditions,1,12515154
,radiochemical,4,12515154
,purity,4,12515154
,orthogonal,1,12515154
,experimental,1,12515154
,experimental design,1,12515154
,design,1,12515154
,myocardial perfusion imaging,1,12515154
,perfusion imaging,1,12515154
,imaging,4,12515154
,stannous chloride,1,12515154
,chloride,1,12515154
,reduction,1,12515154
,method,1,12515154
,preparation,1,12515154
,separation,1,12515154
,purification,1,12515154
,quality,2,12515154
,quality control,1,12515154
,control,1,12515154
,chromatography,1,12515154
,experiments,1,12515154
,stability,2,12515154
,vitro,2,12515154
,sterility,1,12515154
,animals,1,12515154
,out,1,12515154
,complex,1,12515154
,factors,1,12515154
,significant,1,12515154
,effect,2,12515154
,cross,1,12515154
,efficiency,1,12515154
,min,1,12515154
,later,1,12515154
,good,1,12515154
,testing,1,12515154
,range,1,12515154
,prepared,1,12515154
,product,1,12515154
,sterile,1,12515154
,rabbits,1,12515154
,tracer,1,12515154
,early,1,12515154
,heart,1,12515154
,myocardial imaging,1,12515154
,results,1,12515154
,methodological study,1,12515154
,not,1,12515154
,only,1,12515154
,high,1,12515154
,procedure,1,12515154
,kit,1,12515154
,evaluation,1,12515148
,usage,1,12515148
,serum,1,12515148
,serum troponini,1,12515148
,troponini,1,12515148
,myoglobin,1,12515148
,myoglobin measurements,1,12515148
,measurements,1,12515148
,acute,1,12515148
,acute myocardial infarction,1,12515148
,myocardial,1,12515148
,myocardial infarction,1,12515148
,infarction,1,12515148
,purpose,1,12515148
,study,1,12515148
,sensitivity,2,12515148
,indicators,1,12515148
,early,3,12515148
,early diagnosis,2,12515148
,diagnosis,2,12515148
,acute,1,12515148
,acute myocardial infarction,1,12515148
,myocardial,1,12515148
,myocardial infarction,1,12515148
,infarction,1,12515148
,ami,13,12515148
,duration,1,12515148
,serum,4,12515148
,decision,2,12515148
,experimental,1,12515148
,golden,1,12515148
,indicator,2,12515148
,later,1,12515148
,inspection,2,12515148
,effect,1,12515148
,assessment,1,12515148
,recovery,2,12515148
,concentrations,2,12515148
,ctni,12,12515148
,patients,6,12515148
,corpuscle,1,12515148
,chemiluminescence,1,12515148
,serum concentrations,1,12515148
,unstable,1,12515148
,unstable angina,1,12515148
,angina,1,12515148
,skeletal,1,12515148
,skeletal muscle,1,12515148
,muscle,3,12515148
,normal,2,12515148
,group,3,12515148
,dynamic,2,12515148
,analysis,2,12515148
,periods,1,12515148
,hours,1,12515148
,days,1,12515148
,heart,1,12515148
,aching,1,12515148
,results,1,12515148
,positive,3,12515148
,rate,2,12515148
,groups,3,12515148
,values,2,12515148
,significantly,2,12515148
,value,4,12515148
,times,3,12515148
,high,2,12515148
,significant,1,12515148
,difference,1,12515148
,comparison,1,12515148
,early stage,1,12515148
,stage,1,12515148
,onset,1,12515148
,hrs,3,12515148
,then,1,12515148
,time,1,12515148
,period,1,12515148
,state,1,12515148
,day,1,12515148
,still,1,12515148
,normality,1,12515148
,data,1,12515148
,high sensitivity,1,12515148
,specific,1,12515148
,cardiac,2,12515148
,cardiac muscle,2,12515148
,special,2,12515148
,clinical,1,12515148
,muscle damage,1,12515148
,damage,1,12515148
,longest,1,12515148
,best,1,12515148
,terminal,1,12515148
,reversal,1,12470385
,slow,1,12470385
,slow flow phenomenon,1,12470385
,flow,1,12470385
,phenomenon,1,12470385
,primary,1,12470385
,stenting,1,12470385
,bailout,1,12470385
,administration,1,12470385
,abciximab,1,12470385
,background,1,12470385
,slow,7,12470385
,flow,11,12470385
,phenomenon,5,12470385
,increasingly,1,12470385
,serious,1,12470385
,problem,1,12470385
,coronary,4,12470385
,coronary angioplasty,2,12470385
,angioplasty,4,12470385
,stenting,1,12470385
,more,3,12470385
,often,2,12470385
,highly,1,12470385
,thrombogenic,1,12470385
,setting,1,12470385
,acute,2,12470385
,acute myocardial infarction,2,12470385
,myocardial,2,12470385
,myocardial infarction,2,12470385
,infarction,2,12470385
,treatment,1,12470385
,complication,3,12470385
,not,1,12470385
,study,2,12470385
,authors,1,12470385
,efficacy,1,12470385
,abciximab,5,12470385
,antiplatelet drug,1,12470385
,drug,2,12470385
,treating,1,12470385
,primary,5,12470385
,percutaneous,1,12470385
,percutaneous transluminal coronary angioplasty,1,12470385
,transluminal,1,12470385
,ptca,4,12470385
,ami,3,12470385
,methods,1,12470385
,instances,1,12470385
,persistent,2,12470385
,slow flow phenomenon,1,12470385
,consecutive,1,12470385
,patients,8,12470385
,common,1,12470385
,cardiogenic,1,12470385
,cardiogenic shock,1,12470385
,shock,1,12470385
,cases,1,12470385
,injection,1,12470385
,procedure,1,12470385
,bailout,2,12470385
,measure,1,12470385
,coronary angiography,1,12470385
,angiography,1,12470385
,out,1,12470385
,results,1,12470385
,group,2,12470385
,contrast,1,12470385
,timi flow,1,12470385
,only,1,12470385
,significantly,1,12470385
,mortality,1,12470385
,first,1,12470385
,followup,1,12470385
,conclusion,1,12470385
,small,1,12470385
,significant,1,12470385
,improvement,1,12470385
,intravenous,1,12470385
,frequent,1,12470385
,use,1,12470385
,development,1,12470385
,larger,1,12470385
,studies,1,12470385
,lifesaving,1,12470385
,effect,1,12470385
,administration,1,12470385
,failure,1,12470384
,ticlopidine,1,12470384
,case,1,12470384
,clopidogrel,1,12470384
,aim,1,12470384
,ticlopidine,7,12470384
,use,1,12470384
,coronary,3,12470384
,coronary artery,1,12470384
,coronary artery stenting,1,12470384
,artery,1,12470384
,stenting,3,12470384
,haematological,3,12470384
,monitoring,5,12470384
,intervals,1,12470384
,patients,7,12470384
,risk,1,12470384
,authors,1,12470384
,ability,1,12470384
,course,3,12470384
,coronary stenting,2,12470384
,procedures,3,12470384
,methods,1,12470384
,results,1,12470384
,consecutive,1,12470384
,twice,1,12470384
,twice daily,1,12470384
,daily,1,12470384
,weeks,3,12470384
,addition,1,12470384
,prior,1,12470384
,home,1,12470384
,information,1,12470384
,monitoring procedures,1,12470384
,full,2,12470384
,significant,1,12470384
,neutrophil,1,12470384
,neutrophil count,1,12470384
,count,2,12470384
,patient,1,12470384
,patient compliance,1,12470384
,compliance,1,12470384
,full blood count,1,12470384
,blood,1,12470384
,blood count,1,12470384
,subacute,1,12470384
,stent,1,12470384
,thrombosis,1,12470384
,months,1,12470384
,deaths,1,12470384
,myocardial,1,12470384
,myocardial infarction,1,12470384
,infarction,1,12470384
,target,1,12470384
,target vessel,1,12470384
,vessel,1,12470384
,revascularization,1,12470384
,conclusion,1,12470384
,well,1,12470384
,not,2,12470384
,increase,1,12470384
,cardiac,1,12470384
,cardiac events,1,12470384
,events,1,12470384
,team,1,12470384
,adequate,1,12470384
,followup,1,12470384
,only,1,12470384
,need,1,12470384
,licensed,1,12470384
,antiplatelet agent,1,12470384
,agent,1,12470384
,lower,1,12470384
,profile,1,12470384
,clinical,1,12470383
,angiographic,1,12470383
,results,1,12470383
,registry,1,12470383
,optimal,1,12470383
,evaluation,1,12470383
,trial,1,12470383
,background,1,12470383
,safety,2,12470383
,efficacy,1,12470383
,santa rosa,1,12470383
,rosa,1,12470383
,usa,1,12470383
,angiographic,3,12470383
,clinical,3,12470383
,outcomes,2,12470383
,registry,1,12470383
,optimal,1,12470383
,evaluation,1,12470383
,trial,3,12470383
,single,2,12470383
,implantation,2,12470383
,patients,5,12470383
,novel,1,12470383
,coronary,4,12470383
,coronary stent,1,12470383
,stent,3,12470383
,methods,1,12470383
,angina,4,12470383
,lesion,3,12470383
,native,2,12470383
,coronary artery,2,12470383
,artery,2,12470383
,diameter,4,12470383
,prospective,1,12470383
,observational,1,12470383
,observational trial,1,12470383
,followup,4,12470383
,months,4,12470383
,angiography,1,12470383
,primary,2,12470383
,primary endpoint,1,12470383
,endpoint,1,12470383
,major,3,12470383
,cardiac,1,12470383
,cardiac events,1,12470383
,events,1,12470383
,myocardial,1,12470383
,myocardial infarction,1,12470383
,infarction,1,12470383
,target,3,12470383
,target lesion,2,12470383
,revascularization,1,12470383
,bleeding,1,12470383
,complications,1,12470383
,thrombotic occlusions,1,12470383
,occlusions,1,12470383
,secondary,1,12470383
,endpoints,1,12470383
,survival,2,12470383
,restenosis,2,12470383
,total,1,12470383
,male,1,12470383
,age,1,12470383
,years,1,12470383
,stable,2,12470383
,unstable,1,12470383
,angina pectoris,3,12470383
,target vessel,1,12470383
,vessel,1,12470383
,reference,1,12470383
,results,1,12470383
,minimal,1,12470383
,lumen,1,12470383
,lumen diameter,1,12470383
,rate,2,12470383
,stenosis,1,12470383
,criterion,1,12470383
,survival rate,1,12470383
,deaths,1,12470383
,infarctions,1,12470383
,bypass,1,12470383
,bypass surgery,1,12470383
,surgery,1,12470383
,interventions,1,12470383
,revascularizations,1,12470383
,free,1,12470383
,conclusion,1,12470383
,high,1,12470383
,percentage,1,12470383
,small,1,12470383
,small vessels,1,12470383
,vessels,1,12470383
,outcome,1,12470383
,previous,1,12470383
,effective,1,12470383
,device,1,12470383
,treatment,1,12470383
,lesions,1,12470383
,stable angina,1,12470383
,stable angina pectoris,1,12470383
,clinical,1,12470376
,angiographic,1,12470376
,results,1,12470376
,acs,1,12470376
,duet,2,12470376
,mark,1,12470376
,coronary,1,12470376
,coronary stent,1,12470376
,stent,1,12470376
,system,1,12470376
,study,1,12470376
,background,1,12470376
,duet,3,12470376
,study,1,12470376
,prospective,1,12470376
,efficacy,1,12470376
,safety,1,12470376
,evaluation,1,12470376
,acs,1,12470376
,coronary,4,12470376
,stainless steel,1,12470376
,steel,1,12470376
,stent,3,12470376
,aims,1,12470376
,primary,1,12470376
,objective,1,12470376
,incidence,2,12470376
,mace,2,12470376
,major,1,12470376
,cardiac,1,12470376
,cardiac events,1,12470376
,events,2,12470376
,secondary,1,12470376
,objectives,1,12470376
,acute,1,12470376
,success,1,12470376
,rate,2,12470376
,restenosis,2,12470376
,reocclusion,1,12470376
,quantitative,1,12470376
,coronary angiography,1,12470376
,angiography,1,12470376
,months,3,12470376
,occurrence,1,12470376
,hospital,1,12470376
,methods,1,12470376
,patients,7,12470376
,february,1,12470376
,june,1,12470376
,european,1,12470376
,centers,1,12470376
,successful,1,12470376
,stent placement,1,12470376
,placement,1,12470376
,ticlopidine,1,12470376
,month,2,12470376
,aspirin,1,12470376
,investigators,1,12470376
,familiarity,1,12470376
,system,1,12470376
,first,1,12470376
,center,1,12470376
,separate,1,12470376
,leadin,1,12470376
,population,5,12470376
,majority,1,12470376
,male,1,12470376
,unstable,1,12470376
,ang,2,12470376
,stable,1,12470376
,previous,2,12470376
,previous myocardial infarction,1,12470376
,myocardial,1,12470376
,myocardial infarction,1,12470376
,infarction,1,12470376
,percutaneous,1,12470376
,percutaneous transluminal coronary angioplasty,1,12470376
,transluminal,1,12470376
,coronary angioplasty,1,12470376
,angioplasty,1,12470376
,history,1,12470376
,stroke,1,12470376
,target,1,12470376
,target vessel,1,12470376
,vessel,1,12470376
,anterior,1,12470376
,descending,1,12470376
,artery,3,12470376
,circumflex,1,12470376
,circumflex artery,1,12470376
,right,1,12470376
,right coronary artery,1,12470376
,coronary artery,1,12470376
,results,2,12470376
,stented,1,12470376
,multiple,1,12470376
,stents,1,12470376
,angiographic,1,12470376
,followup,2,12470376
,available,1,12470376
,minimal,1,12470376
,lumen,1,12470376
,lumen diameter,1,12470376
,diameter,3,12470376
,mld,2,12470376
,residual,3,12470376
,stenosis,2,12470376
,data,2,12470376
,binary,1,12470376
,ste,1,12470376
,procedure,1,12470376
,subacute,1,12470376
,occlusions,1,12470376
,alive,1,12470376
,free,1,12470376
,anginal,1,12470376
,complaints,1,12470376
,conclusion,1,12470376
,current,1,12470376
,registry,1,12470376
,other,1,12470376
,low,1,12470376
,clinical,1,12470376
,clinical events,1,12470376
,low,1,12470375
,clinical,1,12470375
,restenosis,1,12470375
,new,1,12470375
,flexible,1,12470375
,stainless steel,1,12470375
,steel,1,12470375
,tube,1,12470375
,intracoronary,1,12470375
,intracoronary stent,1,12470375
,stent,2,12470375
,safety,1,12470375
,feasibility study,1,12470375
,study,1,12470375
,background,1,12470375
,coronary,5,12470375
,coronary stents,1,12470375
,stents,2,12470375
,frequency,1,12470375
,increasingly,1,12470375
,complex,2,12470375
,coronary lesions,1,12470375
,lesions,4,12470375
,treatment,1,12470375
,symptomatic,1,12470375
,coronary artery,2,12470375
,coronary artery disease,2,12470375
,artery,2,12470375
,artery disease,2,12470375
,disease,2,12470375
,new,1,12470375
,stainless steel,1,12470375
,steel,1,12470375
,coronary stent,1,12470375
,stent,6,12470375
,maximum,1,12470375
,flexibility,1,12470375
,tracking,1,12470375
,high,1,12470375
,radial,1,12470375
,strength,1,12470375
,aims,1,12470375
,safety,3,12470375
,patients,5,12470375
,specific,1,12470375
,objectives,1,12470375
,deployment,3,12470375
,success,2,12470375
,angiographic,1,12470375
,residual,1,12470375
,stenosis,1,12470375
,flow,1,12470375
,absence,1,12470375
,complications,2,12470375
,clinical,4,12470375
,methods,1,12470375
,april,1,12470375
,january,1,12470375
,stable,1,12470375
,unstable,1,12470375
,angina,2,12470375
,angina pectoris,1,12470375
,anatomically,1,12470375
,lad,2,12470375
,lcx,1,12470375
,results,2,12470375
,failure,1,12470375
,patient,3,12470375
,long,1,12470375
,proximal,1,12470375
,lesion,2,12470375
,procedure,1,12470375
,myocardial,1,12470375
,myocardial infarction,1,12470375
,infarction,1,12470375
,hospital,1,12470375
,month,1,12470375
,additional,1,12470375
,only,1,12470375
,experienced,1,12470375
,recurrence,1,12470375
,ccs,1,12470375
,ccs class,1,12470375
,class,1,12470375
,days,1,12470375
,sudden,1,12470375
,sudden death,1,12470375
,death,1,12470375
,anginal,1,12470375
,complaints,1,12470375
,target,1,12470375
,target lesion,1,12470375
,repeat,1,12470375
,repeat ptca,1,12470375
,ptca,1,12470375
,other,1,12470375
,event,1,12470375
,conclusion,1,12470375
,first,1,12470375
,experience,1,12470375
,acceptable,1,12470375
,good,1,12470375
,ultrasound,1,12470374
,enhancement,1,12470374
,thrombolytic,1,12470374
,thrombolytic therapy,1,12470374
,therapy,1,12470374
,observations,1,12470374
,mechanisms,1,12470374
,fibrinolytic,1,12470374
,fibrinolytic therapy,1,12470374
,therapy,2,12470374
,proven,1,12470374
,approach,1,12470374
,reperfusion,1,12470374
,coronary,1,12470374
,coronary arteries,1,12470374
,arteries,1,12470374
,myocardial,2,12470374
,myocardial infarction,1,12470374
,infarction,1,12470374
,reduced,1,12470374
,mortality,1,12470374
,preservation,1,12470374
,ventricular,1,12470374
,ventricular function,1,12470374
,function,1,12470374
,amount,1,12470374
,muscle,1,12470374
,loss,1,12470374
,proportional,1,12470374
,duration,1,12470374
,ischemia,1,12470374
,complications,1,12470374
,not,4,12470374
,infrequent,1,12470374
,adjuvant,1,12470374
,adjuvant therapy,1,12470374
,ultrasound,5,12470374
,rate,3,12470374
,fibrinolysis,2,12470374
,concentrations,1,12470374
,lytic,2,12470374
,equivalent,1,12470374
,degree,1,12470374
,clot,3,12470374
,lysis,1,12470374
,noninvasive,1,12470374
,low,1,12470374
,intensities,1,12470374
,high,1,12470374
,frequencies,1,12470374
,parameters,1,12470374
,vivo,2,12470374
,significantly,1,12470374
,vitro,1,12470374
,models,1,12470374
,pure,1,12470374
,fibrin,3,12470374
,well,1,12470374
,whole,1,12470374
,whole blood,1,12470374
,blood,1,12470374
,blood clots,1,12470374
,clots,1,12470374
,enhancement,1,12470374
,effects,1,12470374
,mechanism,1,12470374
,exposure,1,12470374
,mechanical,1,12470374
,mechanical fragmentation,1,12470374
,fragmentation,1,12470374
,size,1,12470374
,degradation,1,12470374
,products,1,12470374
,flow,1,12470374
,flow rate,1,12470374
,thrombi,1,12470374
,probably,1,12470374
,changes,1,12470374
,ultrastructure,1,12470374
,fibers,2,12470374
,smaller,1,12470374
,increased,1,12470374
,transport,1,12470374
,agent,2,12470374
,alteration,1,12470374
,binding,2,12470374
,affinity,1,12470374
,maximum,1,12470374
,presence,1,12470374
,further,1,12470374
,acceleration,1,12470374
,thrombolysis,1,12470374
,comparison,1,12470368
,abciximab,1,12470368
,intracoronary,1,12470368
,thrombolysis,1,12470368
,early,1,12470368
,coronary,1,12470368
,coronary stent,1,12470368
,coronary stent thrombosis,1,12470368
,stent,1,12470368
,thrombosis,1,12470368
,aims,1,12470368
,study,1,12470368
,treatment,1,12470368
,early,3,12470368
,coronary,5,12470368
,coronary stent,3,12470368
,coronary stent thrombosis,3,12470368
,stent,4,12470368
,thrombosis,3,12470368
,intracoronary,2,12470368
,urokinase,2,12470368
,platelet,1,12470368
,platelet glycoprotein,1,12470368
,platelet glycoprotein iib/iiia,1,12470368
,glycoprotein,1,12470368
,receptor,1,12470368
,abciximab,11,12470368
,methods,1,12470368
,results,1,12470368
,patients,11,12470368
,stents,1,12470368
,immediately,1,12470368
,identification,1,12470368
,days,3,12470368
,alone,2,12470368
,additional,2,12470368
,balloon,2,12470368
,balloon angioplasty,2,12470368
,angioplasty,3,12470368
,bolus,1,12470368
,implantation,1,12470368
,grade,1,12470368
,flow,1,12470368
,group,14,12470368
,repeat,3,12470368
,percutaneous,1,12470368
,percutaneous transluminal coronary angioplasty,1,12470368
,transluminal,1,12470368
,coronary angioplasty,1,12470368
,ptca,1,12470368
,urgent,1,12470368
,coronary artery,1,12470368
,coronary artery bypass,1,12470368
,coronary artery bypass graft,1,12470368
,coronary artery bypass graft surgery,1,12470368
,artery,1,12470368
,artery bypass graft,1,12470368
,bypass,1,12470368
,bypass graft,1,12470368
,graft,1,12470368
,surgery,1,12470368
,cab,1,12470368
,residual,1,12470368
,thrombus,1,12470368
,refractory,1,12470368
,ischemia,1,12470368
,revascularization,2,12470368
,myocardial,1,12470368
,myocardial infarction,1,12470368
,infarction,1,12470368
,cardiogenic,2,12470368
,cardiogenic shock,2,12470368
,shock,2,12470368
,cerebral,1,12470368
,cerebral hemorrhage,1,12470368
,hemorrhage,1,12470368
,pneumonia,1,12470368
,heart,1,12470368
,heart failure,1,12470368
,failure,1,12470368
,overall,1,12470368
,complications,2,12470368
,surgical,1,12470368
,surgical repair,1,12470368
,repair,1,12470368
,groin,1,12470368
,conclusion,1,12470368
,need,1,12470368
,procedures,1,12470368
,risk,1,12470368
,events,1,12470368
,clinical,1,12470364
,angiographic,1,12470364
,results,1,12470364
,stent,2,12470364
,first,1,12470364
,international,1,12470364
,endovascular,1,12470364
,study,1,12470364
,background,1,12470364
,safety,2,12470364
,efficacy,1,12470364
,mark,1,12470364
,stent,8,12470364
,angiographic,2,12470364
,clinical,3,12470364
,outcomes,1,12470364
,study,2,12470364
,first,2,12470364
,international,1,12470364
,endovascular,1,12470364
,single,2,12470364
,implantation,2,12470364
,restenosis,3,12470364
,rate,3,12470364
,outcome,2,12470364
,patients,5,12470364
,novel,1,12470364
,coronary,4,12470364
,coronary stent,1,12470364
,methods,1,12470364
,angina,4,12470364
,lesion,3,12470364
,native,2,12470364
,coronary artery,2,12470364
,artery,2,12470364
,diameter,4,12470364
,prospective,1,12470364
,observational,1,12470364
,observational trial,1,12470364
,trial,2,12470364
,followup,4,12470364
,months,4,12470364
,angiography,1,12470364
,primary,2,12470364
,primary endpoint,1,12470364
,endpoint,1,12470364
,major,3,12470364
,cardiac,1,12470364
,cardiac events,1,12470364
,events,1,12470364
,myocardial,2,12470364
,myocardial infarction,1,12470364
,infarction,1,12470364
,target,3,12470364
,target lesion,2,12470364
,revascularization,1,12470364
,days,2,12470364
,procedure,1,12470364
,bleeding,1,12470364
,complications,1,12470364
,subacute,1,12470364
,thrombosis,1,12470364
,specific,1,12470364
,endpoints,2,12470364
,secondary,1,12470364
,survival,2,12470364
,results,1,12470364
,total,1,12470364
,male,1,12470364
,age,1,12470364
,years,1,12470364
,stable,2,12470364
,unstable,1,12470364
,angina pectoris,3,12470364
,silent,1,12470364
,ischemia,1,12470364
,target vessel,1,12470364
,vessel,1,12470364
,minimal,1,12470364
,lumen,1,12470364
,lumen diameter,1,12470364
,pre,1,12470364
,post,1,12470364
,stenosis,1,12470364
,criterion,1,12470364
,month,1,12470364
,survival rate,1,12470364
,deaths,1,12470364
,myocardial infarctions,1,12470364
,infarctions,1,12470364
,bypass,1,12470364
,bypass surgery,1,12470364
,surgery,1,12470364
,revascularizations,1,12470364
,free,1,12470364
,conclusion,1,12470364
,previous,1,12470364
,effective,1,12470364
,device,1,12470364
,treatment,1,12470364
,lesions,1,12470364
,stable angina,1,12470364
,stable angina pectoris,1,12470364
,augmentation,1,12470363
,reperfusion,1,12470363
,noninvasive,1,12470363
,delivery,1,12470363
,ultrasound,1,12470363
,need,1,12470363
,alternative,1,12470363
,noninvasive,2,12470363
,methods,1,12470363
,rapid,1,12470363
,effective,1,12470363
,recanalization,1,12470363
,arteries,1,12470363
,veins,1,12470363
,immediately,1,12470363
,admission,2,12470363
,hospital,1,12470363
,prior,1,12470363
,delivery,2,12470363
,ultrasound,3,12470363
,potential,1,12470363
,various,2,12470363
,types,1,12470363
,blood,1,12470363
,blood vessels,1,12470363
,vessels,1,12470363
,acute,1,12470363
,acute myocardial infarction,1,12470363
,myocardial,1,12470363
,myocardial infarction,1,12470363
,infarction,1,12470363
,strokes,1,12470363
,ischemic,1,12470363
,limbs,1,12470363
,obliteration,1,12470363
,av fistulas,1,12470363
,fistulas,1,12470363
,patients,1,12470363
,hemodialysis,1,12470363
,retinal,1,12470363
,retinal vein,1,12470363
,retinal vein thrombosis,1,12470363
,vein,2,12470363
,vein thrombosis,2,12470363
,thrombosis,2,12470363
,deep,1,12470363
,deep vein,1,12470363
,deep vein thrombosis,1,12470363
,prosthetic heart,1,12470363
,prosthetic heart valves,1,12470363
,heart,1,12470363
,heart valves,1,12470363
,valves,1,12470363
,far,1,12470363
,systems,2,12470363
,several,1,12470363
,animal,1,12470363
,animal models,1,12470363
,models,1,12470363
,mode,1,12470363
,continuous,1,12470363
,pulse,1,12470363
,diffuse,1,12470363
,pulsed,1,12470363
,beam,1,12470363
,frequency,1,12470363
,khz,1,12470363
,mhz,1,12470363
,intensity,1,12470363
,general,1,12470363
,lower,1,12470363
,frequencies,1,12470363
,better,2,12470363
,penetration,1,12470363
,overlying,1,12470363
,tissue,1,12470363
,skin,1,12470363
,fat,1,12470363
,bone,1,12470363
,probably,1,12470363
,efficacy,1,12470363
,severe,1,12457152
,mitral,1,12457152
,mitral regurgitation,1,12457152
,regurgitation,1,12457152
,secondary,1,12457152
,partial,1,12457152
,papillary,1,12457152
,papillary muscle,1,12457152
,papillary muscle rupture,1,12457152
,muscle,1,12457152
,muscle rupture,1,12457152
,rupture,1,12457152
,myocardial,1,12457152
,myocardial infarction,1,12457152
,infarction,1,12457152
,scenario,1,12457152
,not,3,12457152
,patient,1,12457152
,myocardial,1,12457152
,myocardial infarction,1,12457152
,infarction,1,12457152
,cardiac,1,12457152
,shock,1,12457152
,new,1,12457152
,systolic,1,12457152
,systolic murmur,1,12457152
,murmur,1,12457152
,cause,2,12457152
,common,1,12457152
,mechanical,1,12457152
,mechanical problems,1,12457152
,problems,1,12457152
,probably,1,12457152
,root,1,12457152
,complications,1,12457152
,transthoracic,1,12457152
,transthoracic echocardiography,1,12457152
,echocardiography,2,12457152
,next,1,12457152
,patients,1,12457152
,diagnosis,1,12457152
,partial,1,12457152
,papillary,1,12457152
,papillary muscle,1,12457152
,papillary muscle rupture,1,12457152
,muscle,1,12457152
,muscle rupture,1,12457152
,rupture,1,12457152
,transesophageal,1,12457152
,transesophageal echocardiography,1,12457152
,management,1,12457147
,unstable,1,12457147
,unstable angina,1,12457147
,angina,1,12457147
,new,1,12457147
,approaches,1,12457147
,great,1,12457147
,understanding,1,12457147
,unstable,1,12457147
,unstable angina,1,12457147
,angina,1,12457147
,relationship,1,12457147
,acute,1,12457147
,acute coronary syndromes,1,12457147
,coronary,1,12457147
,syndromes,1,12457147
,myocardial,1,12457147
,myocardial infarction,1,12457147
,infarction,1,12457147
,last,1,12457147
,decade,1,12457147
,20th century,1,12457147
,century,1,12457147
,information,2,12457147
,ecg,1,12457147
,ecg changes,1,12457147
,changes,1,12457147
,serum,1,12457147
,cardiac,1,12457147
,cardiac markers,1,12457147
,markers,1,12457147
,well,1,12457147
,conclusions,1,12457147
,numerous,1,12457147
,large,1,12457147
,randomized,1,12457147
,interventional,1,12457147
,now,2,12457147
,traditional,1,12457147
,clinical,1,12457147
,picture,1,12457147
,clinicians,1,12457147
,patients,2,12457147
,diagnostic,1,12457147
,prognostic,1,12457147
,categories,1,12457147
,risk,1,12457147
,stratification,1,12457147
,precision,1,12457147
,decision,1,12457147
,selection,1,12457147
,noninvasive,1,12457147
,invasive,1,12457147
,evaluation,1,12457147
,management,1,12457147
,strategies,1,12457147
,optimal,1,12457147
,glycoprotein,1,12431350
,receptor,1,12431350
,antagonists,1,12431350
,acute,1,12431350
,acute myocardial infarction,1,12431350
,myocardial,1,12431350
,myocardial infarction,1,12431350
,infarction,1,12431350
,primary,1,12431350
,coronary,1,12431350
,coronary stenting,1,12431350
,stenting,1,12431350
,not,1,12431350
,always,1,12431350
,effective,1,12431350
,glycoprotein,1,12431350
,antagonists,1,12431350
,effective,1,12431350
,complications,1,12431350
,prior,1,12431350
,coronary,2,12431350
,interventions,1,12431350
,studies,2,12431350
,flow,2,12431350
,abciximab,2,12431350
,slow,1,12431350
,phenomenon,2,12431350
,case,1,12431350
,not,1,12431350
,thrombotic occlusion,1,12431350
,occlusion,1,12431350
,artery,1,12431350
,further,1,12431350
,refractory,1,12431350
,medical,1,12431345
,costs,1,12431345
,intravascular,2,12431345
,intravascular ultrasound,2,12431345
,ultrasound,2,12431345
,optimization,1,12431345
,stent,1,12431345
,deployment,1,12431345
,results,1,12431345
,randomized,1,12431345
,restenosis,1,12431345
,stenting,1,12431345
,study,1,12431345
,objective,1,12431345
,intravascular,2,12431345
,intravascular ultrasound,2,12431345
,ultrasound,2,12431345
,ivus,12,12431345
,deployment,3,12431345
,stents,1,12431345
,aim,1,12431345
,study,2,12431345
,acute,3,12431345
,medical,4,12431345
,costs,9,12431345
,use,1,12431345
,results,2,12431345
,restenosis,1,12431345
,stenting,1,12431345
,methods,1,12431345
,patients,1,12431345
,routine,1,12431345
,stent,3,12431345
,guidance,3,12431345
,clinical,2,12431345
,followup,1,12431345
,months,3,12431345
,hospitalization,1,12431345
,cost,3,12431345
,accounting,1,12431345
,system,1,12431345
,time,2,12431345
,implantation,1,12431345
,repeat,1,12431345
,lesion,2,12431345
,revascularizations,1,12431345
,exchange,1,12431345
,exchange rate,1,12431345
,rate,1,12431345
,euro,1,12431345
,us dollar,1,12431345
,dollar,1,12431345
,catheters,1,12431345
,need,1,12431345
,more,1,12431345
,balloons,1,12431345
,group,9,12431345
,euros,4,12431345
,clinical events,1,12431345
,events,1,12431345
,myocardial,1,12431345
,myocardial infarction,1,12431345
,infarction,1,12431345
,unstable,1,12431345
,unstable angina,1,12431345
,angina,1,12431345
,revascularization,4,12431345
,number,2,12431345
,procedures,3,12431345
,control,2,12431345
,control group,2,12431345
,cumulative,1,12431345
,only,1,12431345
,slightly,1,12431345
,lower,1,12431345
,sensitivity,1,12431345
,analysis,1,12431345
,variations,2,12431345
,unit,1,12431345
,well,1,12431345
,length,1,12431345
,hospital,1,12431345
,range,1,12431345
,conclusions,1,12431345
,optimization,1,12431345
,not,1,12431345
,prognostic,1,12212260
,effect,1,12212260
,angina,1,12212260
,acute,1,12212260
,acute myocardial infarction,1,12212260
,myocardial,1,12212260
,myocardial infarction,1,12212260
,infarction,1,12212260
,elderly,1,12212260
,patients,1,12212260
,objective,1,12212260
,present,2,12212260
,study,2,12212260
,acute,3,12212260
,acute myocardial infarction,3,12212260
,myocardial,4,12212260
,myocardial infarction,4,12212260
,infarction,4,12212260
,protection,3,12212260
,early,1,12212260
,adult,4,12212260
,patients,9,12212260
,effect,3,12212260
,ischemic,2,12212260
,ischemic preconditioning,2,12212260
,preconditioning,2,12212260
,heart,4,12212260
,methods,1,12212260
,retrospectively,1,12212260
,angina,5,12212260
,outcomes,2,12212260
,years,2,12212260
,old,2,12212260
,elderly,7,12212260
,results,1,12212260
,congestive,3,12212260
,congestive heart failure,2,12212260
,heart failure,2,12212260
,failure,2,12212260
,more,2,12212260
,frequent,2,12212260
,previous,3,12212260
,cardiogenic,2,12212260
,cardiogenic shock,1,12212260
,shock,3,12212260
,combined,1,12212260
,end,2,12212260
,end points,2,12212260
,death,2,12212260
,contrast,1,12212260
,presence,2,12212260
,absence,1,12212260
,incidence,1,12212260
,significantly,1,12212260
,smaller,1,12212260
,infarct,1,12212260
,size,1,12212260
,ang,1,12212260
,conclusions,1,12212260
,significant,1,12212260
,occurrence,1,12212260
,variation,1,12212118
,blood,1,12212118
,blood lipids,1,12212118
,lipids,1,12212118
,circulatory,1,12212118
,endocrine,1,12212118
,factors,1,12212118
,patients,1,12212118
,acute,1,12212118
,acute myocardial infarction,1,12212118
,myocardial,1,12212118
,myocardial infarction,1,12212118
,infarction,1,12212118
,objective,1,12212118
,dynamic,3,12212118
,variations,3,12212118
,blood,4,12212118
,blood lipids,4,12212118
,lipids,5,12212118
,circulatory,2,12212118
,endocrine,2,12212118
,factors,2,12212118
,acute,3,12212118
,acute myocardial infarction(,1,12212118
,myocardial,2,12212118
,myocardial infarction(,1,12212118
,infarction(,1,12212118
,ami,2,12212118
,patients,2,12212118
,methods,1,12212118
,plasma,1,12212118
,levels,4,12212118
,anp,2,12212118
,insulin,4,12212118
,serum,4,12212118
,serum lipids,1,12212118
,1st,3,12212118
,3rd,3,12212118
,day,6,12212118
,acute myocardial infarction,1,12212118
,myocardial infarction,1,12212118
,infarction,1,12212118
,results,1,12212118
,level,2,12212118
,significant,2,12212118
,difference,2,12212118
,week,1,12212118
,highest,2,12212118
,then,1,12212118
,value,1,12212118
,markedly,1,12212118
,days,1,12212118
,later,1,12212118
,only,1,12212118
,concentration,1,12212118
,concentrations,2,12212118
,other,1,12212118
,phases,1,12212118
,conclusion,1,12212118
,primary,1,12212118
,characteristics,1,12212118
,increment,1,12212118
,acute phase,1,12212118
,phase,1,12212118
,present,1,12212118
,effect,1,12212118
,metabolism,1,12212118
,cytokines,1,12212118
,national,1,12189341
,heart,2,12189341
,heart failure,2,12189341
,failure,2,12189341
,project,1,12189341
,health,1,12189341
,health care,1,12189341
,care,2,12189341
,administration,1,12189341
,initiative,1,12189341
,medicare,1,12189341
,second,1,12189341
,series,1,12189341
,health,1,12189341
,health care,1,12189341
,care,4,12189341
,administration,1,12189341
,initiatives,2,12189341
,medicare,2,12189341
,heart,4,12189341
,heart failure,4,12189341
,failure,4,12189341
,first,1,12189341
,article,2,12189341
,history,1,12189341
,hcfa,1,12189341
,projects,1,12189341
,current,1,12189341
,priority,1,12189341
,areas,1,12189341
,acute,1,12189341
,acute myocardial infarction,1,12189341
,myocardial,1,12189341
,myocardial infarction,1,12189341
,infarction,1,12189341
,pneumonia,1,12189341
,diabetes,1,12189341
,breast,1,12189341
,breast cancer,1,12189341
,cancer,1,12189341
,details,1,12189341
,objectives,1,12189341
,design,1,12189341
,national,1,12189341
,quality,1,12189341
,quality improvement,1,12189341
,improvement,2,12189341
,project,1,12189341
,goal,1,12189341
,inpatient,1,12189341
,chf,1,12189341
,circulatory,1,12189287
,circulatory assist,1,12189287
,assist,1,12189287
,devices,1,12189287
,update,1,12189287
,mechanical,2,12189287
,circulatory,2,12189287
,circulatory assist,1,12189287
,assist,3,12189287
,devices,6,12189287
,clinical,1,12189287
,practice,1,12189287
,bridge,3,12189287
,transplantation,2,12189287
,late,1,12189287
,1960s,1,12189287
,first,1,12189287
,artificial,2,12189287
,artificial heart,1,12189287
,heart,2,12189287
,permanent,2,12189287
,therapy,2,12189287
,few,1,12189287
,artificial hearts,1,12189287
,hearts,1,12189287
,today,1,12189287
,last,1,12189287
,several,1,12189287
,years,1,12189287
,shift,1,12189287
,use,3,12189287
,left,1,12189287
,left ventricular assist devices,1,12189287
,ventricular,2,12189287
,ventricular assist devices,2,12189287
,cardiac,1,12189287
,cardiac transplan,1,12189287
,transplan,1,12189287
,interest,1,12189287
,recovery,2,12189287
,patients,1,12189287
,myocarditis,1,12189287
,cardiomyopathy,1,12189287
,myocardial,1,12189287
,myocardial infarction,1,12189287
,infarction,1,12189287
,cardiotomy,1,12189287
,review,1,12189287
,basic,1,12189287
,information,1,12189287
,present,1,12189287
,individual,1,12189287
,indications,1,12189287
,timing,1,12189287
,implantation,1,12189287
,other,1,12189287
,related,1,12189287
,right,1,12189287
,right heart,1,12189287
,right heart failure,1,12189287
,heart failure,1,12189287
,failure,1,12189287
,pulmonary,1,12189287
,pulmonary hypertension,1,12189287
,hypertension,1,12189287
,arrhythmias,1,12189287
,anticoagulation,1,12189287
,infections,1,12189287
,closing,1,12189287
,future,1,12189287
,chf,1,12189287
,sequence,1,12098794
,sequence analysis,1,12098794
,analysis,1,12098794
,expression,1,12098794
,cdna,1,12098794
,human,1,12098794
,cardiac,1,12098794
,cardiac myosin,1,12098794
,myosin,1,12098794
,myosin light chain,1,12098794
,light,1,12098794
,chain,1,12098794
,preparation,1,12098794
,monoclonal,1,12098794
,monoclonal antibody,1,12098794
,antibody,1,12098794
,product,1,12098794
,nucleotide,1,12098794
,nucleotide sequence,1,12098794
,sequence,3,12098794
,cdna,2,12098794
,ventricular,1,12098794
,ventricular myosin,1,12098794
,myosin,2,12098794
,myosin light chain,2,12098794
,light,2,12098794
,chain,2,12098794
,chinese,1,12098794
,patients,1,12098794
,differences,1,12098794
,acid,2,12098794
,comparison,1,12098794
,amino acid,1,12098794
,amino acid sequence,1,12098794
,product,2,12098794
,production,1,12098794
,specific,1,12098794
,monoclonal,2,12098794
,monoclonal antibodies,2,12098794
,antibodies,2,12098794
,poly,1,12098794
,well,1,12098794
,diagnosis,1,12098794
,kits,1,12098794
,acute,1,12098794
,acute myocardial infarction,1,12098794
,myocardial,1,12098794
,myocardial infarction,1,12098794
,infarction,1,12098794
,china,1,12098794
,patent,1,12098794
,application,1,12098794
,number,1,12098794
,detailed,1,12098794
,studies,1,12098794
,physiological,1,12098794
,function,1,12098794
,cardiac,1,12098794
,cardiac myosin,1,12098794
,lab,1,12098794
,clinical,1,12089960
,clinical characteristics,1,12089960
,characteristics,1,12089960
,patients,1,12089960
,ischemic,1,12089960
,heart,1,12089960
,heart failure,1,12089960
,failure,1,12089960
,major,1,12089960
,cause,1,12089960
,heart,7,12089960
,heart failure,3,12089960
,failure,3,12089960
,coronary,3,12089960
,coronary heart disease,1,12089960
,heart disease,2,12089960
,disease,2,12089960
,prevalence,5,12089960
,progression,1,12089960
,objective,1,12089960
,study,1,12089960
,analysis,1,12089960
,clinical,1,12089960
,risk,2,12089960
,risk factors,2,12089960
,factors,2,12089960
,resting,2,12089960
,hemodynamic,1,12089960
,parameters,1,12089960
,patients,4,12089960
,ischemic,3,12089960
,methods,1,12089960
,ischemic heart disease,1,12089960
,ejection,1,12089960
,ejection fraction,1,12089960
,fraction,1,12089960
,echocardiographic,2,12089960
,examination,1,12089960
,groups,1,12089960
,group,15,12089960
,results,1,12089960
,mean,1,12089960
,age,1,12089960
,years,2,12089960
,ischemic cardiomyopathy,1,12089960
,cardiomyopathy,2,12089960
,old,1,12089960
,old myocardial infarction,1,12089960
,myocardial,3,12089960
,myocardial infarction,2,12089960
,infarction,2,12089960
,more,1,12089960
,frequent,1,12089960
,greater,3,12089960
,incidence,1,12089960
,dyspnea,2,12089960
,resting heart rate,1,12089960
,heart rate,2,12089960
,rate,2,12089960
,radiologic,1,12089960
,cardiomegaly,1,12089960
,present,2,12089960
,findings,1,12089960
,kinetic,1,12089960
,abnormalities,1,12089960
,diastolic,2,12089960
,diastolic dysfunction,2,12089960
,dysfunction,4,12089960
,conclusion,1,12089960
,myocardial dysfunction,1,12089960
,lower,1,12089960
,contrast,1,12089960
,dominant,1,12089960
,symptom,1,12089960
,systolic,1,12089960
,systolic dysfunction,1,12089960
,majority,1,12089960
,not,1,12089960
,differences,1,12089960
,age,1,12089928
,factor,1,12089928
,functional,1,12089928
,functional capacity,1,12089928
,capacity,1,12089928
,cardiac,1,12089928
,performance,1,12089928
,patients,1,12089928
,chronic,1,12089928
,myocardial,1,12089928
,myocardial infarction,1,12089928
,infarction,1,12089928
,old,2,12089928
,old age,1,12089928
,age,3,12089928
,not,2,12089928
,contraindication,1,12089928
,cardiac,5,12089928
,cardiac rehabilitation,1,12089928
,rehabilitation,3,12089928
,prognosis,1,12089928
,patients,5,12089928
,chronic,2,12089928
,myocardial,6,12089928
,myocardial infarction,4,12089928
,infarction,6,12089928
,objective,1,12089928
,paper,1,12089928
,study,2,12089928
,factor,1,12089928
,performance,3,12089928
,exercise,5,12089928
,capacity,5,12089928
,admission,1,12089928
,rehabilitation programmes,1,12089928
,methods,1,12089928
,department,1,12089928
,internal,1,12089928
,internal medicine,1,12089928
,medicine,1,12089928
,rehabilitation hospital,1,12089928
,hospital,1,12089928
,groups,2,12089928
,group,4,12089928
,more,1,12089928
,years,1,12089928
,clinical,1,12089928
,features,1,12089928
,factors,3,12089928
,symptoms,1,12089928
,regional,1,12089928
,global,1,12089928
,abnormalities,1,12089928
,functional,2,12089928
,functional capacity,2,12089928
,exercise testing,2,12089928
,testing,2,12089928
,bicycle,1,12089928
,results,1,12089928
,similar,2,12089928
,point,1,12089928
,view,1,12089928
,prevalence,1,12089928
,risk,1,12089928
,risk factors,1,12089928
,location,1,12089928
,ejection,1,12089928
,ejection fraction,1,12089928
,fraction,1,12089928
,smaller,1,12089928
,statistical,1,12089928
,statistical significance,1,12089928
,significance,1,12089928
,lower,2,12089928
,levels,2,12089928
,cardiac rate,1,12089928
,rate,1,12089928
,index,1,12089928
,metabolic,1,12089928
,metabolic equivalent,1,12089928
,equivalent,1,12089928
,significantly,1,12089928
,marked,1,12089928
,last,1,12089928
,size,1,12089928
,status,1,12089928
,well,1,12089928
,impact,1,12086210
,second,1,12086210
,imaging,1,12086210
,determination,1,12086210
,global,1,12086210
,regional,1,12086210
,left,1,12086210
,left ventricular function,1,12086210
,ventricular,1,12086210
,ventricular function,1,12086210
,function,1,12086210
,2d echocardiography,1,12086210
,echocardiography,1,12086210
,comparison,1,12086210
,spect,1,12086210
,aims,1,12086210
,impact,1,12086210
,second,1,12086210
,mode,1,12086210
,imaging,3,12086210
,echocardiographic,1,12086210
,determination,2,12086210
,ejection,1,12086210
,ejection fraction,1,12086210
,fraction,1,12086210
,wall,1,12086210
,wall motion,1,12086210
,motion,1,12086210
,score,1,12086210
,index,1,12086210
,spect,6,12086210
,independent,2,12086210
,reference,1,12086210
,methods,2,12086210
,consecutive,1,12086210
,patients,1,12086210
,echocardiography,2,12086210
,study,1,12086210
,hours,1,12086210
,estimatede,1,12086210
,method,1,12086210
,nuclear,1,12086210
,results,3,12086210
,same,1,12086210
,segmentation,1,12086210
,scoring,1,12086210
,system,1,12086210
,percentages,1,12086210
,segments,2,12086210
,suboptimal,1,12086210
,endocardial,1,12086210
,border,1,12086210
,detection,1,12086210
,correlation,4,12086210
,coefficients,3,12086210
,agreement,5,12086210
,acceptable,1,12086210
,modalities,1,12086210
,mean,1,12086210
,difference,1,12086210
,echo,2,12086210
,good,1,12086210
,better,2,12086210
,observers,2,12086210
,systematic,1,12086210
,differences,3,12086210
,random,1,12086210
,conclusions,1,12086210
,use,1,12086210
,number,1,12086210
,gain,1,12086210
,interobserver variability,1,12086210
,variability,1,12086210
,excellent,1,12086210
,role,1,12029195
,angiotensin,1,12029195
,angiotensin receptor,1,12029195
,angiotensin receptor blockers,1,12029195
,receptor,1,12029195
,heart,1,12029195
,heart failure,1,12029195
,failure,1,12029195
,effectiveness,1,12029195
,ace,7,12029195
,ace inhibitors,6,12029195
,inhibitors,6,12029195
,morbidity,2,12029195
,mortality,3,12029195
,patients,2,12029195
,heart,5,12029195
,heart failure,5,12029195
,failure,5,12029195
,attributable,1,12029195
,suppression,1,12029195
,angiotensin,9,12029195
,angiotensin ii,3,12029195
,production,2,12029195
,chronic,1,12029195
,therapy,2,12029195
,ii levels,1,12029195
,levels,1,12029195
,incompletely,1,12029195
,high,1,12029195
,recently,1,12029195
,angiotensin receptor,6,12029195
,angiotensin receptor blockers,4,12029195
,receptor,6,12029195
,block,1,12029195
,effects,2,12029195
,available,1,12029195
,combination,2,12029195
,short,2,12029195
,short term,2,12029195
,term,2,12029195
,studies,1,12029195
,angiotensin receptor blocker,2,12029195
,many,1,12029195
,hemodynamic,2,12029195
,clinical,2,12029195
,features,1,12029195
,study,4,12029195
,losartan,2,12029195
,survival,1,12029195
,effect,1,12029195
,addition,1,12029195
,ace inhibitor,1,12029195
,inhibitor,1,12029195
,favorable,1,12029195
,ongoing,1,12029195
,valsartan,2,12029195
,trial,1,12029195
,candesartan,1,12029195
,assessment,1,12029195
,reduction,1,12029195
,optimal,1,12029195
,myocardial,2,12029195
,myocardial infarction,2,12029195
,infarction,2,12029195
,antagonist,1,12029195
,acute,1,12029195
,acute myocardial infarction,1,12029195
,role,1,12029195
,alone,1,12029195
,management,1,12029195
,ventricular,1,12029195
,ventricular dysfunction,1,12029195
,dysfunction,1,12029195
,chf,1,12029195
,current,1,12026765
,trends,1,12026765
,defibrillator,1,12026765
,development,1,12026765
,recent,1,12026765
,release,1,12026765
,national,1,12026765
,service,1,12026765
,coronary,1,12026765
,coronary artery,1,12026765
,coronary artery disease,1,12026765
,artery,1,12026765
,artery disease,1,12026765
,disease,1,12026765
,article,1,12026765
,defibrillator,1,12026765
,availability,1,12026765
,training,1,12026765
,acute,2,12026765
,providers,1,12026765
,services,1,12026765
,ward,1,12026765
,areas,1,12026765
,surgeries,1,12026765
,ambulances,1,12026765
,personnel,1,12026765
,skills,1,12026765
,defibrillation,1,12026765
,key,1,12026765
,management,1,12026765
,acute myocardial infarction,1,12026765
,myocardial,1,12026765
,myocardial infarction,1,12026765
,infarction,1,12026765
,plasminogen,1,12000063
,plasminogen activator,1,12000063
,plasminogen activator inhibitor,1,12000063
,plasminogen activator inhibitor type,1,12000063
,inhibitor,1,12000063
,type,1,12000063
,adults,1,12000063
,down,1,12000063
,down syndrome,1,12000063
,syndrome,1,12000063
,protection,1,12000063
,macrovascular disease,1,12000063
,disease,1,12000063
,present,1,12000063
,study,1,12000063
,adults,1,12000063
,down,2,12000063
,down syndrome,2,12000063
,syndrome,2,12000063
,plasminogen,2,12000063
,plasminogen activator,2,12000063
,plasminogen activator inhibitor,2,12000063
,inhibitor,2,12000063
,blood,1,12000063
,control,1,12000063
,subjects,2,12000063
,age,1,12000063
,gender,1,12000063
,body,1,12000063
,body mass,1,12000063
,mass,1,12000063
,low,1,12000063
,incidence,1,12000063
,atherosclerotic,1,12000063
,atherosclerotic vascular disease,1,12000063
,vascular,1,12000063
,vascular disease,1,12000063
,disease,1,12000063
,complications,1,12000063
,attributable,1,12000063
,instability,1,12000063
,myocardial,1,12000063
,myocardial infarction,1,12000063
,infarction,1,12000063
,unstable,1,12000063
,ang,1,12000063
,life,1,12000063
,life expectancy,1,12000063
,expectancy,1,12000063
,acute,1,12000055
,acute myocardial infarction,1,12000055
,myocardial,1,12000055
,myocardial infarction,1,12000055
,infarction,1,12000055
,vascular,1,12000055
,vascular remodeling,1,12000055
,remodeling,1,12000055
,intravascular,1,12000055
,intravascular ultrasound,1,12000055
,ultrasound,1,12000055
,outward,2,12000055
,predominates,1,12000055
,lesions,2,12000055
,responsible,2,12000055
,acute,1,12000055
,acute myocardial infarction,1,12000055
,myocardial,1,12000055
,myocardial infarction,1,12000055
,infarction,1,12000055
,negative,1,12000055
,remodeling,2,12000055
,far,1,12000055
,more,1,12000055
,chronic,1,12000055
,chronic stable ang,1,12000055
,stable,1,12000055
,ang,1,12000055
,total,1,12000055
,lipoprotein,1,12000055
,ratio,1,12000055
,frequency,1,12000054
,left,1,12000054
,ventricular,1,12000054
,rupture,1,12000054
,patients,1,12000054
,acute,1,12000054
,acute myocardial infarction,1,12000054
,myocardial,1,12000054
,myocardial infarction,1,12000054
,infarction,1,12000054
,primary,1,12000054
,angioplasty,1,12000054
,total,1,12000054
,patients,5,12000054
,myocardial,2,12000054
,myocardial infarction,2,12000054
,infarction,2,12000054
,primary,2,12000054
,angioplasty,2,12000054
,incidence,3,12000054
,related,1,12000054
,factors,1,12000054
,rupture,2,12000054
,acute,1,12000054
,acute myocardial infarction,1,12000054
,years,1,12000054
,old,1,12000054
,women,1,12000054
,nonsmokers,1,12000054
,well,1,12000054
,anterior,1,12000054
,anterior location,1,12000054
,location,1,12000054
,initial,1,12000054
,grade,1,12000054
,flow,1,12000054
,similar,1,12000054
,successful,1,12000054
,unsuccessful,1,12000054
,angiographic,1,12000054
,result,1,12000054
,gender,1,12000053
,gender differences,1,12000053
,differences,1,12000053
,acute,1,12000053
,acute myocardial infarction,1,12000053
,myocardial,1,12000053
,myocardial infarction,1,12000053
,infarction,1,12000053
,frequencies,1,12000053
,potential,1,12000053
,triggers,1,12000053
,acute,1,12000053
,acute myocardial infarction,1,12000053
,myocardial,1,12000053
,myocardial infarction,1,12000053
,infarction,1,12000053
,men,1,12000053
,women,1,12000053
,drugs,1,12000053
,infarctions,1,12000053
,use,1,12000051
,echocardiography,1,12000051
,myocardial,2,12000051
,viability,1,12000051
,patients,1,12000051
,anterior,1,12000051
,anterior wall,1,12000051
,anterior wall myocardial infarction,1,12000051
,wall,1,12000051
,myocardial infarction,1,12000051
,infarction,1,12000051
,stress,1,12000051
,stress echocardiography,1,12000051
,echocardiography,2,12000051
,myocardial,11,12000051
,contrast,2,12000051
,contrast echocardiography,1,12000051
,mce,4,12000051
,ultrasonic,2,12000051
,tissue,2,12000051
,characterization,2,12000051
,useful,1,12000051
,methods,4,12000051
,viability,6,12000051
,acute,2,12000051
,acute myocardial infarction,2,12000051
,myocardial infarction,3,12000051
,infarction,3,12000051
,study,1,12000051
,potential,1,12000051
,patients,2,12000051
,anterior,1,12000051
,anterior wall,1,12000051
,wall,1,12000051
,coronary,1,12000051
,coronary reperfusion,1,12000051
,reperfusion,1,12000051
,intracoronary,1,12000051
,injection,1,12000051
,microbubbles,1,12000051
,rest,1,12000051
,then,1,12000051
,performed,1,12000051
,days,1,12000051
,later,2,12000051
,region,1,12000051
,interest,1,12000051
,segment,2,12000051
,cyclic,2,12000051
,variation,2,12000051
,viable,2,12000051
,active,1,12000051
,contraction,2,12000051
,months,1,12000051
,segments,1,12000051
,presence,2,12000051
,contractile,1,12000051
,response,1,12000051
,segmental,1,12000051
,sensitivity,4,12000051
,specif,3,12000051
,intense,1,12000051
,enhancement,1,12000051
,synchronous,1,12000051
,differences,1,12000051
,specificity,1,12000051
,logistics,1,12000051
,clinical,1,12000051
,application,1,12000051
,cardiovascular,1,12000046
,cardiovascular event,1,12000046
,event,1,12000046
,reduction,1,12000046
,tool,1,12000046
,cert,1,12000046
,cardiac,1,12000046
,risk,1,12000046
,prediction,1,12000046
,model,1,12000046
,west,1,12000046
,scotland,1,12000046
,coronary,1,12000046
,prevention,1,12000046
,prevention study,1,12000046
,study,1,12000046
,clinical,1,12000046
,decision,1,12000046
,hypercholesterolemia,1,12000046
,awareness,1,12000046
,patient,1,12000046
,risk,14,12000046
,cardiac,1,12000046
,prediction,3,12000046
,models,2,12000046
,means,1,12000046
,observational,1,12000046
,cohorts,1,12000046
,estimates,5,12000046
,treatment,4,12000046
,benefit,1,12000046
,west,1,12000046
,scotland,1,12000046
,coronary,4,12000046
,prevention,1,12000046
,prevention study,1,12000046
,study,1,12000046
,model,4,12000046
,actual,1,12000046
,observed,1,12000046
,primary,1,12000046
,event,2,12000046
,reduction,4,12000046
,trial,2,12000046
,cox,1,12000046
,cox model,1,12000046
,risk estimates,4,12000046
,subjects,3,12000046
,men,1,12000046
,years,2,12000046
,old,1,12000046
,baseline,1,12000046
,factors,4,12000046
,predictive,1,12000046
,definite,1,12000046
,fatal,3,12000046
,coronary heart disease,3,12000046
,heart,3,12000046
,heart disease,3,12000046
,disease,3,12000046
,myocardial,1,12000046
,myocardial infarction,1,12000046
,infarction,1,12000046
,risk factors,3,12000046
,age,2,12000046
,diastolic,2,12000046
,diastolic blood pressure,2,12000046
,blood,2,12000046
,blood pressure,2,12000046
,pressure,2,12000046
,total,1,12000046
,total cholesterol/,1,12000046
,cholesterol/,1,12000046
,highdensity lipoprotein ratio,1,12000046
,lipoprotein,1,12000046
,ratio,2,12000046
,current,2,12000046
,smoking,2,12000046
,diabetes,2,12000046
,family,2,12000046
,family history,2,12000046
,history,2,12000046
,nitrate,2,12000046
,use,3,12000046
,ang,1,12000046
,placebo/,1,12000046
,pravastatin,3,12000046
,variables,1,12000046
,risk assessment,1,12000046
,assessment,1,12000046
,simple,1,12000046
,slide,1,12000046
,rule,1,12000046
,tool,2,12000046
,bands,1,12000046
,categories,1,12000046
,levels,1,12000046
,additional,1,12000046
,premature,1,12000046
,angina,1,12000046
,very,2,12000046
,risk reduction,1,12000046
,due,1,12000046
,cardiovascular,1,12000046
,cardiovascular event,1,12000046
,cert,1,12000046
,physicians,1,12000046
,patients,1,12000046
,cholesterol,1,12000046
,effects,1,12000043
,surgery,1,12000043
,postinfarction,1,12000043
,ventricular,2,12000043
,ventricular tachycardia,1,12000043
,tachycardia,1,12000043
,parameters,1,12000043
,ventricular function,1,12000043
,function,1,12000043
,heart,1,12000043
,heart failure,1,12000043
,failure,2,12000043
,cause,1,12000043
,death,1,12000043
,patients,3,12000043
,surgery,4,12000043
,ventricular,2,12000043
,ventricular tachycardia,1,12000043
,tachycardia,1,12000043
,study,1,12000043
,effects,2,12000043
,antiarrhythmic,2,12000043
,parameters,1,12000043
,left,1,12000043
,function,7,12000043
,global,1,12000043
,ejection,2,12000043
,ejection fraction,2,12000043
,fraction,3,12000043
,segmental,1,12000043
,segmental wall motion,1,12000043
,wall,3,12000043
,wall motion,3,12000043
,motion,3,12000043
,score,2,12000043
,homogeneity,2,12000043
,contraction,2,12000043
,diastolic,3,12000043
,radionuclide,1,12000043
,radionuclide ventriculography,1,12000043
,ventriculography,1,12000043
,anterior,2,12000043
,oblique,2,12000043
,image,2,12000043
,segments,1,12000043
,projections,1,12000043
,phase,2,12000043
,phase analysis,2,12000043
,analysis,2,12000043
,curve,2,12000043
,systole,1,12000043
,peak,2,12000043
,first,1,12000043
,time,1,12000043
,derivative,1,12000043
,action,1,12000043
,action potential,1,12000043
,potential,1,12000043
,subgroup,1,12000043
,aneurysmectomy,2,12000043
,coronary,2,12000043
,coronary artery,1,12000043
,coronary artery bypass,1,12000043
,coronary artery bypass grafting,1,12000043
,artery,1,12000043
,artery bypass grafting,1,12000043
,bypass,2,12000043
,bypass grafting,2,12000043
,grafting,2,12000043
,changes,2,12000043
,angiotensin,1,12000043
,enzyme,1,12000043
,enzyme inhibitor,1,12000043
,enzyme inhibitor therapy,1,12000043
,inhibitor,1,12000043
,therapy,2,12000043
,systolic,1,12000043
,improvements,2,12000043
,not,3,12000043
,coronary bypass,1,12000043
,vasodilator,1,12000043
,damage,1,12000043
,significant,1,12000043
,most,1,12000043
,poor,1,12000043
,term,1,12000043
,prognosis,1,12000043
,comparison,1,12000041
,nonionic,1,12000041
,contrast,1,12000041
,contrast medium,1,12000041
,medium,1,12000041
,primary,1,12000041
,percutaneous,1,12000041
,percutaneous transluminal coronary angioplasty,1,12000041
,transluminal,1,12000041
,coronary,3,12000041
,coronary angioplasty,1,12000041
,angioplasty,1,12000041
,acute,2,12000041
,acute myocardial infarction,1,12000041
,myocardial,1,12000041
,myocardial infarction,1,12000041
,infarction,1,12000041
,global,1,12000041
,use,1,12000041
,strategies,1,12000041
,coronary arteries,1,12000041
,arteries,1,12000041
,acute coronary syndr,1,12000041
,syndr omes,1,12000041
,clinical,4,12000041
,impact,1,12000041
,contrast,7,12000041
,contrast medium,3,12000041
,medium,3,12000041
,selection,2,12000041
,primary,2,12000041
,percutaneous,2,12000041
,percutaneous transluminal coronary angioplasty,2,12000041
,transluminal,2,12000041
,coronary,5,12000041
,coronary angioplasty,2,12000041
,angioplasty,2,12000041
,acute,2,12000041
,acute myocardial infarction,1,12000041
,myocardial,1,12000041
,myocardial infarction,1,12000041
,infarction,1,12000041
,ami,3,12000041
,not,1,12000041
,outcomes,1,12000041
,patients,2,12000041
,nonionic,1,12000041
,low,2,12000041
,osmolar,2,12000041
,setting,2,12000041
,second,1,12000041
,global,1,12000041
,use,1,12000041
,strategies,1,12000041
,coronary arteries,1,12000041
,arteries,1,12000041
,acute coronary syndromes,1,12000041
,syndromes,1,12000041
,trial,1,12000041
,relation,1,12000041
,outcome,1,12000041
,refractory,2,12000041
,ischemia,2,12000041
,days,2,12000041
,baseline,2,12000041
,angiographic,1,12000041
,characteristics,2,12000041
,similar,1,12000041
,groups,1,12000041
,less,3,12000041
,likely,2,12000041
,site,1,12000041
,occlusion,1,12000041
,left,1,12000041
,left anterior,1,12000041
,left anterior descending coronary artery,1,12000041
,anterior,1,12000041
,anterior descending coronary artery,1,12000041
,descending,1,12000041
,coronary artery,1,12000041
,artery,1,12000041
,history,1,12000041
,prior,1,12000041
,triple,1,12000041
,composite,1,12000041
,end,1,12000041
,end point,1,12000041
,point,1,12000041
,death,1,12000041
,frequently,1,12000041
,group,1,12000041
,hospital,1,12000041
,trend,1,12000041
,favoring,1,12000041
,differences,1,12000041
,statistically,1,12000041
,statistically significant,1,12000041
,significant,1,12000041
,adjustment,1,12000041
,imbalances,1,12000041
,risk,1,12000041
,model,2,12000041
,study,4,12000041
,sample,1,12000041
,odds ratio,2,12000041
,ratio,2,12000041
,entire,1,12000041
,cohort,1,12000041
,results,1,12000041
,observational,1,12000041
,observational study,1,12000041
,further,1,12000041
,randomized,1,12000041
,study design,1,12000041
,design,1,12000041
,short,1,12000039
,outcome,1,12000039
,differences,1,12000039
,women,1,12000039
,men,1,12000039
,primary,1,12000039
,percutaneous,1,12000039
,transluminal,1,12000039
,mechanical,1,12000039
,revascularization,1,12000039
,acute,1,12000039
,acute myocardial infarction,1,12000039
,myocardial,1,12000039
,myocardial infarction,1,12000039
,infarction,1,12000039
,women,7,12000039
,acute,2,12000039
,acute myocardial infarction,1,12000039
,myocardial,1,12000039
,myocardial infarction,1,12000039
,infarction,1,12000039
,ami,3,12000039
,mortality,2,12000039
,conventional,1,12000039
,medical,1,12000039
,thrombolytic,1,12000039
,thrombolytic therapy,1,12000039
,therapy,1,12000039
,men,5,12000039
,outcome,1,12000039
,primary,2,12000039
,percutaneous,2,12000039
,transluminal,1,12000039
,mechanical,1,12000039
,revascularization,3,12000039
,not,2,12000039
,study,1,12000039
,characteristics,2,12000039
,short,1,12000039
,outcomes,1,12000039
,total,1,12000039
,consecutive,1,12000039
,patients,1,12000039
,baseline,2,12000039
,clinical,2,12000039
,clinical characteristics,1,12000039
,similar,2,12000039
,more,3,12000039
,often,2,12000039
,cardiogenic,2,12000039
,cardiogenic shock,2,12000039
,shock,2,12000039
,smaller,1,12000039
,reference,1,12000039
,vessel,2,12000039
,diameters,1,12000039
,stents,1,12000039
,abciximab,3,12000039
,completion,2,12000039
,infusion,2,12000039
,bleeding,1,12000039
,success,1,12000039
,much,1,12000039
,followup,2,12000039
,mean,1,12000039
,months,1,12000039
,unfavorable,1,12000039
,cardiovascular,1,12000039
,cardiovascular events,1,12000039
,events,1,12000039
,recurrent,1,12000039
,unstable,1,12000039
,unstable angina,1,12000039
,angina,1,12000039
,target,1,12000039
,target vessel,1,12000039
,control,1,12000039
,differences,1,12000039
,multivariate analysis,1,12000039
,analysis,1,12000039
,gender,1,12000039
,independent,1,12000039
,predictor,1,12000039
,survival,1,12000039
,age,1,12000039
,acute,1,11998062
,acute coronary syndrome,1,11998062
,coronary,1,11998062
,syndrome,1,11998062
,new,1,11998062
,advances,1,11998062
,nursing,1,11998062
,strategies,1,11998062
,glycoprotein,2,11998062
,receptor,2,11998062
,inhibitors,2,11998062
,therapy,2,11998062
,acute,1,11998062
,acute coronary syndrome,1,11998062
,coronary,2,11998062
,syndrome,1,11998062
,acs,2,11998062
,article,1,11998062
,pathophysiology,1,11998062
,role,1,11998062
,nursing,1,11998062
,nursing care,1,11998062
,care,1,11998062
,patients,1,11998062
,interventions,1,11998062
,aspirin,1,11998001
,glycoprotein,1,11998001
,inhibitors,1,11998001
,acute,1,11998001
,acute coronary syndr,1,11998001
,coronary,1,11998001
,syndr omes,1,11998001
,glycoprotein,1,11998001
,receptor,1,11998001
,inhibitors,1,11998001
,vessel,1,11998001
,patency,1,11998001
,patients,2,11998001
,myocardial,1,11998001
,myocardial infarction,1,11998001
,infarction,2,11998001
,ang,1,11998001
,drugs,1,11998001
,more,1,11998001
,invasive,1,11998001
,invasive procedures,1,11998001
,procedures,1,11998001
,less,1,11998001
,risk,1,11998001
,recurrent,1,11998001
,death,1,11998001
,role,1,11995291
,iron,1,11995291
,atherosclerosis,1,11995291
,myocardial,1,11995291
,myocardial infarction,1,11995291
,infarction,1,11995291
,killer,1,11995291
,american,1,11995291
,men,2,11995291
,women,2,11995291
,death,2,11995291
,death rate,1,11995291
,rate,1,11995291
,year,3,11995291
,stroke,1,11995291
,third,1,11995291
,cause,1,11995291
,united states,1,11995291
,states,1,11995291
,combined,1,11995291
,financial,1,11995291
,burden,1,11995291
,diseases,1,11995291
,approximately,1,11995291
,interventions,1,11995291
,mortality,1,11995291
,suffering,1,11995291
,significant,1,11995291
,impact,1,11995291
,health,1,11995291
,health care,1,11995291
,health care system,1,11995291
,care,1,11995291
,system,1,11995291
,article,1,11995291
,research,1,11995291
,last,1,11995291
,decades,1,11995291
,idea,1,11995291
,stored,2,11995291
,iron,9,11995291
,role,2,11995291
,pathogenesis,2,11995291
,atherosclerosis,4,11995291
,reduction,3,11995291
,phlebotomy,2,11995291
,treatment,1,11995291
,prevention,1,11995291
,body,2,11995291
,iron stores,3,11995291
,adolescence,1,11995291
,menopause,1,11995291
,rise,1,11995291
,oxidation,1,11995291
,lipids,1,11995291
,foam,1,11995291
,foam cell,1,11995291
,cell,1,11995291
,formation,1,11995291
,available,1,11995291
,evidence,1,11995291
,hypothesis,1,11995291
,circumstantial,1,11995291
,setting,1,11995291
,prospective,1,11995291
,intervention,1,11995291
,intervention trial,1,11995291
,trial,1,11995291
,amount,1,11995291
,vascular,1,11995291
,vascular disease,1,11995291
,disease,1,11995291
,study,3,11995291
,induction,1,11995291
,iron deficiency,1,11995291
,deficiency,1,11995291
,veterans,1,11995291
,veterans administration,1,11995291
,administration,1,11995291
,cooperative,1,11995291
,cooperative study,1,11995291
,concept,1,11995291
,thrombolysis,1,11971414
,coronary,1,11971414
,care,1,11971414
,national,1,11971414
,service,1,11971414
,people,1,11971414
,myocardial,1,11971414
,myocardial infarction,1,11971414
,infarction,1,11971414
,thrombolysis,2,11971414
,possible,1,11971414
,standards,1,11971414
,angiotensin,1,11967826
,angiotensin ii,1,11967826
,binding,1,11967826
,extracellular,1,11967826
,extracellular matrix,1,11967826
,matrix,1,11967826
,rat,1,11967826
,model,1,11967826
,myocardial,1,11967826
,myocardial infarction,1,11967826
,infarction,1,11967826
,clinical,1,11967826
,evidence,2,11967826
,role,1,11967826
,angiotensin,1,11967826
,angiotensin ii,1,11967826
,ang,7,11967826
,postinfarction,1,11967826
,cardiac,1,11967826
,cardiac hypertrophy,1,11967826
,hypertrophy,2,11967826
,present,1,11967826
,study,2,11967826
,process,2,11967826
,animal,2,11967826
,animal model,1,11967826
,model,2,11967826
,myocardial,9,11967826
,myocardial infarction,2,11967826
,infarction,2,11967826
,following,1,11967826
,criteria,1,11967826
,histological,3,11967826
,studies,2,11967826
,revascularisation,1,11967826
,collagen,3,11967826
,deposition,1,11967826
,different,2,11967826
,regions,1,11967826
,myocardium,1,11967826
,cell,2,11967826
,cell type,1,11967826
,type,1,11967826
,distribution,1,11967826
,markers,1,11967826
,western,2,11967826
,western blot,1,11967826
,western blot analysis,1,11967826
,analysis,1,11967826
,receptor,3,11967826
,subtypes,1,11967826
,regulation,1,11967826
,kinetics,1,11967826
,binding,4,11967826
,receptors,1,11967826
,heart,1,11967826
,perfusion,1,11967826
,effect,2,11967826
,antagonist,2,11967826
,losartan,4,11967826
,parameters,1,11967826
,ligation,1,11967826
,left,2,11967826
,left anterior,1,11967826
,left anterior descending coronary artery,1,11967826
,anterior,1,11967826
,anterior descending coronary artery,1,11967826
,descending,1,11967826
,coronary,1,11967826
,coronary artery,1,11967826
,artery,1,11967826
,rats,4,11967826
,animal groups,1,11967826
,groups,1,11967826
,myocardial infarct,4,11967826
,infarct,4,11967826
,infarcted,2,11967826
,rat,2,11967826
,rat hearts,2,11967826
,hearts,2,11967826
,fibroblasts,2,11967826
,types,2,11967826
,iii,2,11967826
,remnant,1,11967826
,viable,1,11967826
,region,1,11967826
,left ventricle,1,11967826
,ventricle,1,11967826
,month,1,11967826
,treatment,1,11967826
,changes,2,11967826
,sham,1,11967826
,controls,2,11967826
,protein,1,11967826
,protein levels,1,11967826
,levels,1,11967826
,western blotting,1,11967826
,animals,1,11967826
,level,1,11967826
,expression,1,11967826
,endothelial,1,11967826
,endothelial cell,1,11967826
,cell lining,1,11967826
,lining,1,11967826
,directly,1,11967826
,myocytes,1,11967826
,affinity,1,11967826
,endothelium,1,11967826
,major,1,11967826
,peptide,1,11967826
,pharmacodynamics,1,11967826
,marked,1,11967826
,increase,1,11967826
,subtype,1,11967826
,potential,1,11967826
,effects,1,11967826
,current,1,11967816
,natriuretic,1,11967816
,natriuretic peptide,1,11967816
,peptide,1,11967816
,research,1,11967816
,original,1,11967816
,discovery,1,11967816
,atrial,1,11967816
,atrial natriuretic peptide,1,11967816
,natriuretic,9,11967816
,natriuretic peptide,5,11967816
,peptide,5,11967816
,nearly,1,11967816
,years,1,11967816
,ago,1,11967816
,subsequent,2,11967816
,family,1,11967816
,natriuretic peptides,4,11967816
,peptides,9,11967816
,progress,1,11967816
,physiological,1,11967816
,significance,2,11967816
,review,1,11967816
,aspects,1,11967816
,research,3,11967816
,measurement,4,11967816
,plasma,7,11967816
,levels,4,11967816
,anp,3,11967816
,brain,1,11967816
,brain natriuretic peptide,1,11967816
,bnp,5,11967816
,cardiovascular,2,11967816
,cardiovascular disease,1,11967816
,disease,3,11967816
,therapeutic,2,11967816
,potential,3,11967816
,system,1,11967816
,several,1,11967816
,benefit,1,11967816
,overall,1,11967816
,assessment,1,11967816
,prognosis,2,11967816
,cardiac,4,11967816
,cardiac disease,1,11967816
,value,4,11967816
,specific,1,11967816
,diagnostic,1,11967816
,tool,1,11967816
,unlikely,1,11967816
,procedures,2,11967816
,cardiac function,1,11967816
,function,2,11967816
,strong,1,11967816
,negative,1,11967816
,negative predictive value,1,11967816
,predictive,1,11967816
,predictive value,1,11967816
,people,1,11967816
,heart,3,11967816
,heart disease,1,11967816
,rests,1,11967816
,evidence,1,11967816
,normal,1,11967816
,normal value,1,11967816
,low,1,11967816
,low risk,1,11967816
,risk,1,11967816
,impairment,1,11967816
,consistently,1,11967816
,level,1,11967816
,myocardial,1,11967816
,myocardial infarction,1,11967816
,infarction,1,11967816
,poor,1,11967816
,poor prognosis,1,11967816
,turn,1,11967816
,high,1,11967816
,detailed,1,11967816
,investigation,1,11967816
,dysfunction,1,11967816
,option,1,11967816
,more,2,11967816
,invasive,1,11967816
,not,1,11967816
,not available,1,11967816
,available,1,11967816
,recent,1,11967816
,role,1,11967816
,effective,1,11967816
,therapy,1,11967816
,heart failure,2,11967816
,failure,3,11967816
,renal,2,11967816
,effects,1,11967816
,hypertension,2,11967816
,conditions,2,11967816
,volume,2,11967816
,volume overload,2,11967816
,number,1,11967816
,approaches,1,11967816
,endogenous,3,11967816
,activity,2,11967816
,use,2,11967816
,native,1,11967816
,well,2,11967816
,critically ill,1,11967816
,ill,1,11967816
,individuals,1,11967816
,congestive,1,11967816
,congestive heart failure,1,11967816
,renal failure,1,11967816
,limitations,1,11967816
,treatment,2,11967816
,view,1,11967816
,effort,1,11967816
,development,2,11967816
,orally,1,11967816
,active,1,11967816
,inhibition,1,11967816
,breakdown,1,11967816
,neutral,1,11967816
,neutral endopeptidase,1,11967816
,endopeptidase,2,11967816
,inhibitors,3,11967816
,dual,1,11967816
,enzyme,1,11967816
,background,1,11967816
,broad,1,11967816
,spectrum,1,11967816
,action,1,11967816
,protection,1,11967816
,benefits,1,11967816
,ace,1,11967815
,tissue,1,11967815
,tissue repair,1,11967815
,repair,1,11967815
,infarcted,1,11967815
,heart,1,11967815
,enzyme,1,11967815
,ace,4,11967815
,cells,1,11967815
,concentrations,2,11967815
,angiotensin,1,11967815
,angiotensin ii,1,11967815
,ang,5,11967815
,circulatory,1,11967815
,homeostasis,1,11967815
,myofibroblast,1,11967815
,cell,1,11967815
,cell membrane,1,11967815
,membrane,1,11967815
,local,1,11967815
,tissue,3,11967815
,tissue repair,1,11967815
,repair,1,11967815
,generation,1,11967815
,modulates,1,11967815
,expression,1,11967815
,tgfbeta1,1,11967815
,properties,1,11967815
,collagen,1,11967815
,turnover,1,11967815
,sites,4,11967815
,fibrous,2,11967815
,fibrous tissue,2,11967815
,formation,1,11967815
,response,1,11967815
,various,1,11967815
,forms,1,11967815
,injury,1,11967815
,diverse,1,11967815
,tissues,1,11967815
,persistent,1,11967815
,myofibroblasts,2,11967815
,ace activity,1,11967815
,activity,2,11967815
,infarct,2,11967815
,site,1,11967815
,metabolic,1,11967815
,progressive,2,11967815
,fibrosis,2,11967815
,remote,1,11967815
,myocardial,1,11967815
,myocardial infarction,1,11967815
,infarction,1,11967815
,activation,1,11967815
,system,1,11967815
,elevations,1,11967815
,plasma,1,11967815
,aldosterone,1,11967815
,vascular,3,11967815
,phenotype,1,11967815
,small,1,11967815
,arteries,1,11967815
,arterioles,1,11967815
,further,1,11967815
,appearance,2,11967815
,macrophages,1,11967815
,vascular remodelling,1,11967815
,locally,1,11967815
,intramural,1,11967815
,coronary,1,11967815
,vasculature,1,11967815
,myocardium,1,11967815
,structural,1,11967815
,major,1,11967815
,factor,1,11967815
,chronic,1,11967815
,chronic cardiac failure,1,11967815
,cardiac,1,11967815
,cardiac failure,1,11967815
,failure,1,11967815
,nature,1,11967815
